Hormonal Modulation of Resting-State Brain Networks: Menstrual Cycle and Oral Contraceptive Effects on Functional Connectivity

Abstract

This article synthesizes current neuroimaging research on how endogenous sex hormones across the menstrual cycle and synthetic hormones from oral contraceptives (OCs) modulate resting-state functional connectivity (RS-FC). We explore foundational evidence of hormonal effects on major brain networks like the Default Mode Network (DMN) and Executive Control Network (ECN), detail methodological approaches for investigating these subtle changes, address inconsistencies in findings and optimization of study designs, and validate results through clinical comparisons and implications. This synthesis is crucial for researchers and drug development professionals aiming to account for hormonal confounds in neuroimaging and develop hormone-aware therapeutic strategies.

Sex Hormones as Key Modulators of Intrinsic Brain Networks

Neuroactive Properties of Estradiol and Progesterone in the CNS

The ovarian sex hormones, estradiol and progesterone, are potent neuroactive steroids with extensive influence over the central nervous system (CNS). Beyond their classical reproductive functions, these hormones exert significant effects on brain structure, neural plasticity, and functional connectivity [1] [2]. The neuroactive properties of these hormones encompass both rapid non-genomic mechanisms, which alter neuronal excitability within milliseconds to seconds, and slower genomic actions that regulate gene expression over hours to days [3]. Understanding these mechanisms is crucial for research on resting-state functional connectivity (rs-FC), particularly in studies involving the menstrual cycle and oral contraceptive (OC) users, where hormonal fluctuations significantly impact brain network organization [1] [4].

This guide provides a systematic comparison of the neuroactive properties of estradiol and progesterone, summarizing experimental data, detailing methodological protocols, and visualizing key signaling pathways to support research in this evolving field.

Comparative Mechanisms of Action

Estradiol and progesterone employ distinct yet occasionally overlapping mechanisms to exert their effects on the CNS. The table below summarizes their primary modes of action, receptors, and key neuroactive metabolites.

Table 1: Comparative Mechanisms of Estradiol and Progesterone in the CNS

Feature	Estradiol	Progesterone
Primary Nuclear Receptors	Estrogen receptor α (ERα), Estrogen receptor β (ERβ) [5]	Intracellular progesterone receptors (PR) [6]
Membrane Receptors	G protein-coupled estrogen receptor (GPER), mERs [5]	Membrane progesterone receptors (mPRs), PGRMC1 [6]
Key Neuroactive Metabolites	Not as prevalent	Allopregnanolone (3α,5α-THPROG) [6] [3]
Primary Neurotransmitter Systems Modulated	Serotonin, Dopamine, Glutamate [5]	GABA (via allopregnanolone) [6] [3]
Genomic Action Timeline	Minutes to hours [3]	Minutes to hours [3]
Non-Genomic Action Timeline	Milliseconds to seconds [3]	Milliseconds to seconds [3]

Signaling Pathway Visualization

The following diagram illustrates the core signaling pathways for estradiol and progesterone in the CNS, highlighting their genomic and non-genomic mechanisms.

Experimental Data on Functional Connectivity and Structural Plasticity

Hormonal fluctuations significantly impact brain networks and structure. The following table synthesizes key experimental findings from human neuroimaging studies.

Table 2: Experimental Findings on Hormonal Effects on Brain Connectivity and Structure

Hormonal State/Intervention	Key Findings	Brain Regions/Networks Affected	Experimental Method
Menstrual Cycle (Progesterone Correlation)	Positive correlation between progesterone and eigenvector centrality [4]	Dorsolateral prefrontal cortex (DLPFC), sensorimotor cortex, hippocampus [4]	Longitudinal rs-fMRI, hormone correlation
Transgender Women (Estradiol Therapy)	Increased rs-FC between left thalamus and left sensorimotor cortex/putamen after estradiol [7]	Thalamo-cortico-striatal circuitry [7]	rs-fMRI before/after estradiol
Perimenopausal Depression (Estradiol Therapy)	E2 administration normalized aberrant connectivity in PO-MDD group [8]	Amygdala, medial prefrontal cortex, anterior cingulate cortex [8]	Pharmaco-fMRI, seed-based analysis
Hormonal Contraceptives	Changes in grey matter volumes and cerebral white matter [1]	Cortical regions, limbic system structures [1]	Structural MRI, Voxel-Based Morphometry

Detailed Experimental Protocols

To ensure reproducibility in hormonal neuroscience research, this section outlines standardized protocols for key methodologies referenced in the comparative data.

Resting-State fMRI Acquisition and Analysis for Hormonal Studies

The following workflow details the protocol for investigating hormone-mediated connectivity, based on studies of menstrual cycle and hormonal therapy [4] [7] [8].

Key Protocol Details:

• Participant Screening: Carefully screen for hormonal status (natural cycle, OC use, menopausal status), cycle regularity, and psychiatric/neurological conditions [4] [8].
• Hormonal Assessment: Collect serum or saliva samples concurrently with scanning to measure estradiol (E2) and progesterone (P4) levels. In menstrual cycle studies, verify ovulation with luteinizing hormone (LH) tests [4].
• MRI Acquisition Parameters: Use standard EPI sequences for rs-fMRI (TR/TE = 2000/30 ms, voxel size = 3×3×3 mm³, 200+ volumes). Acquire high-resolution T1-weighted structural images for registration [4] [7].
• Preprocessing Pipeline: Implement standard steps including slice timing correction, realignment, normalization to MNI space, smoothing (6-8mm FWHM), and nuisance regression (CSF, white matter, motion parameters) [4] [7] [8].
• Connectivity Analysis: Apply seed-based correlation analysis (e.g., thalamus, amygdala, striatum as seeds) or independent component analysis (ICA) to identify networks. Eigenvector centrality mapping is suitable for whole-brain, hypothesis-free approaches [4].
• Statistical Modeling: Correlate hormone levels with connectivity measures using multiple regression, including appropriate covariates (age, motion). For interventional studies, use paired t-tests or repeated measures ANOVA [4] [7] [8].

Protocol for Hormone Administration Studies

For interventional studies involving hormone administration, the following protocol ensures methodological rigor:

• Study Design: Use randomized, double-blind, placebo-controlled designs when ethically feasible. For within-subject designs, include adequate washout periods (e.g., 30 days for hormonal therapy) [7] [8].
• Hormone Administration: Transdermal estradiol (100μg/day) effectively modulates brain connectivity without first-pass liver metabolism [8]. Progesterone formulations should consider synthetic progestins versus bioidentical progesterone due to differential effects on neurosteroidogenesis [1] [9].
• Assessment Timeline: Conduct neuroimaging and behavioral assessments pre-treatment and after stabilization of hormone levels (typically 3-4 weeks for estradiol) [7] [8].

The Scientist's Toolkit: Essential Research Reagents

This section details key reagents and materials essential for investigating the neuroactive properties of estradiol and progesterone in the CNS.

Table 3: Essential Research Reagents for Hormone Neuroscience Studies

Reagent/Material	Function/Application	Examples/Notes
17β-Estradiol	Primary estrogen for in vitro and in vivo studies; binds to ERα, ERβ, and GPER [5]	Use physiological doses (e.g., 1nM for cell studies); consider water-soluble conjugates for aqueous systems
Progesterone	Primary progestin for investigating PR-mediated and non-genomic effects [6] [2]	Distinguish from synthetic progestins (e.g., MPA) which have different neuroactive properties [9]
Allopregnanolone	Neuroactive progesterone metabolite for GABAergic studies [6] [3]	Key for investigating GABA-mediated effects independent of PR signaling
ERα/ERβ Agonists/Antagonists	Selective manipulation of estrogen receptor subtypes [5]	PPT (ERα agonist), DPN (ERβ agonist); essential for receptor-specific mechanism studies
RU-486 (Mifepristone)	PR antagonist for blocking progesterone receptor signaling [6]	Useful for distinguishing PR-dependent and independent effects
Finasteride	5α-reductase inhibitor; blocks progesterone conversion to allopregnanolone [6]	Critical for studying contribution of neuroactive metabolites to progesterone effects
ELISA/RIA Kits	Quantitative measurement of hormone levels in serum, saliva, or tissue [4]	Essential for correlating hormonal status with neural measures
Primary Neuronal/Gial Cultures	In vitro systems for mechanistic studies [6] [9]	Enable controlled investigation of hormone effects on specific CNS cell types
Steroid Hormone Depleted Serum	For cell culture studies requiring controlled steroid environments [5]	Charcoal-stripped fetal bovine serum removes endogenous steroids

Resting-State fMRI as a Tool for Investigating Intrinsic Network Dynamics

Resting-state functional magnetic resonance imaging (rs-fMRI) has emerged as a cornerstone technique for probing the brain's intrinsic functional architecture. By measuring spontaneous, low-frequency fluctuations in the blood-oxygen-level-dependent (BOLD) signal in the absence of an explicit task, rs-fMRI provides a powerful lens through which to study large-scale brain network organization and dynamics. This methodology is particularly valuable for investigating how physiological states and pharmacological interventions modulate neural circuitry. One prominent application lies in understanding the neural effects of endogenous hormonal fluctuations across the menstrual cycle and their alteration by hormonal contraceptives. A growing body of neuroimaging research demonstrates that ovarian hormones—estradiol and progesterone—exert significant influence on brain function and connectivity. Rs-fMRI studies have begun to delineate how these hormonal variations affect intrinsic network dynamics, offering insights into the neural mechanisms that may underlie behavioral, cognitive, and affective changes associated with different hormonal states. This review synthesizes current evidence, comparing rs-fMRI findings between naturally cycling women and oral contraceptive (OC) users to elucidate how synthetic hormones modulate the brain's functional landscape.

Comparative Findings: Natural Cycle vs. Oral Contraceptive Use

Key Differences in Functional Connectivity and Network Properties

Table 1: Summary of Key rs-fMRI Findings in Natural Cycle vs. OC Users

Brain Metric / Network	Findings in Natural Cycle	Findings in OC Users	References
Whole-Brain Modularity & System Segregation	Statistically significantly higher; suggests a more network-structured architecture.	Significantly lower; indicates a less modular, more generally connected structure.	[10]
Characteristic Path Length	Higher; suggests more specialized information processing.	Lower; indicates increased global integration and efficiency of information transfer.	[10]
Dynamic Brain States	Prevalent states associated with natural hormonal fluctuations.	Shift in the prevalence of discrete brain states; network reorganization is constrained.	[10]
Default Mode Network (DMN) Connectivity	Reorganization, especially in prefrontal subsystems, during ovulatory hormone peaks.	Blunted or constrained DMN connectivity, particularly during would-be estrogen fluctuations.	[10] [11]
Executive Control Network (ECN) Connectivity	Altered dynamics across the cycle.	Reduced functional connectivity, particularly in regions like the left middle frontal gyrus and anterior cingulate cortex.	[11]
Anterior Cingulate Cortex (ACC) & Amygdala rs-FC	Fluctuations in connectivity with frontal and temporoparietal areas across the cycle.	Connectivity of amygdalae with frontal areas, and between ACC and temporoparietal areas, decreases with longer HC exposure.	[12]
Dynamical Complexity (Node-Metastability)	Highest during the high-estradiol pre-ovulatory phase; varies across cycle phases.	Not directly measured in the same studies, but OC use generally suppresses hormonal fluctuations linked to this dynamism.	[13]

Hormonal Influence on Dynamic Brain States

The brain's dynamics are not static but fluctuate over time. Research using dynamic functional connectivity (dFC) methods has revealed that the prevalence of specific, discrete brain states differs between natural cycles and OC use [10]. In a landmark single-subject study, modularity, system segregation, and characteristic path length were all significantly higher across the natural cycle compared to the OC cycle [10]. This suggests that the natural hormonal cycle facilitates a brain state that is more modular and specialized, while OC use promotes a state of more generalized and integrated connectivity.

Furthermore, in naturally cycling women, whole-brain dynamical complexity (measured as node-metastability) peaks during the pre-ovulatory phase, when estradiol levels are highest, and is lowest during the early follicular phase, when hormone levels are low [13]. This indicates that hormonal fluctuations directly modulate the brain's functional variability and flexibility, effects that are suppressed by the synthetic hormones in OCs.

Experimental Protocols and Methodologies

Common Rs-fMRI Analysis Methods in Hormonal Research

Table 2: Key Rs-fMRI Methodologies and Their Application

Method	Description	Application in Hormonal Research
Static Functional Connectivity	Measures the temporal correlation of BOLD signals between brain regions over an entire scan.	Used to identify stable, time-averaged differences in network integrity (e.g., within the DMN, ECN) between cycle phases or groups [11].
Independent Component Analysis (ICA)	A data-driven approach that separates the BOLD signal into statistically independent spatial components (networks).	Commonly used to identify resting-state networks (e.g., DMN, ECN) and compare their strength or connectivity between groups [11] [14].
Seed-Based Connectivity	Calculates the correlation between the BOLD time-series of a pre-defined "seed" region and all other voxels in the brain.	Employed to investigate hormone-sensitive regions like the hippocampus, amygdala, and ACC [15] [12].
Graph Theory	Models the brain as a network of nodes (regions) and edges (connections), providing metrics like modularity and characteristic path length.	Applied to quantify global and nodal properties of brain networks, revealing shifts toward more or less efficient/organized states with OC use [10].
Dynamic Functional Connectivity (dFC)	A suite of methods to capture time-varying properties of functional connectivity during the resting state.	Sliding Window Analysis: Calculates connectivity within short, sliding time windows to assess variability [16].Leading Eigenvector Dynamics Analysis (LEiDA): Identifies recurring, whole-brain patterns of phase synchrony at each time point [10] [16].Co-activation Pattern (CAP) Analysis: Identifies recurring, whole-brain patterns of co-activation at each time point [16].

Detailed Experimental Workflow

A typical rs-fMRI study investigating hormonal effects follows a structured workflow, from participant selection to data interpretation. The following diagram outlines the key stages of this process, highlighting the parallel paths for studying natural cycles and OC users.

Diagram Title: Experimental Workflow for Hormonal rs-fMRI Studies

Key Workflow Stages:

• Participant Grouping: Studies typically compare a group of naturally cycling women to a group of OC users. For natural cycle studies, participants are often scanned in key hormonal phases (e.g., early follicular-low hormones, pre-ovulatory-high estradiol, mid-luteal-high progesterone), confirmed via hormone assays or cycle tracking [15] [13]. OC users may be scanned during active and inactive pill phases [11].
• Data Acquisition: Participants undergo a resting-state fMRI scan, typically lasting 5-10 minutes, during which they are instructed to lie still with their eyes closed or fixated on a cross, without engaging in any structured task.
• Preprocessing: Raw fMRI data is preprocessed to remove artifacts and correct for physiological noise, head motion, and spatial normalization to a standard template [10].
• Analysis: The preprocessed data is subjected to one or more analytical methods (Table 2) to extract measures of static or dynamic functional connectivity.
• Statistical Comparison: The derived metrics are compared between groups (NC vs. OC) or across cycle phases to identify significant differences related to hormonal state.

The Scientist's Toolkit: Essential Reagents and Materials

Table 3: Key Research Reagent Solutions for rs-fMRI Hormonal Studies

Item / Solution	Function in Research Context
Combined Oral Contraceptive Pills	The investigative product; often contain ethinylestradiol (synthetic estrogen) and a progestin (e.g., levonorgestrel). Used to standardize and suppress the endogenous hormonal milieu in the experimental group [10] [12].
Enzyme-Linked Immunosorbent Assay (ELISA) Kits	For quantifying serum or salivary levels of endogenous (estradiol, progesterone) and synthetic hormones. Critical for verifying cycle phase in naturally cycling women and confirming hormonal suppression in OC users [13].
Schaefer Brain Atlas	A commonly used parcellation scheme (e.g., 400 regions) that divides the cerebral cortex into functionally defined regions. Serves as the network "nodes" for graph theory and other connectivity analyses [10].
Leading Eigenvector Dynamics Analysis (LEiDA)	A computational algorithm used to identify recurring, whole-brain patterns of phase synchrony at each time point (framewise). Used to characterize dynamic brain states and their temporal properties [10] [16].
fMRI Preprocessing Pipelines (e.g., fMRIPrep, DPARSF)	Standardized software toolkits for automating the preprocessing of raw fMRI data, including motion correction, normalization, and noise filtering, ensuring reproducibility [10].

Resting-state fMRI has proven to be an indispensable tool for revealing the profound impact of ovarian hormones on the brain's intrinsic network dynamics. The collective evidence indicates a clear distinction between the neural states associated with natural hormonal cycles and those under the influence of oral contraceptives. Naturally cycling brains exhibit higher modularity and dynamical complexity, particularly during periods of high estradiol, suggesting a state optimized for specialized information processing and cognitive flexibility. In contrast, the OC-associated brain is characterized by a more integrated, less modular architecture with lower characteristic path length, potentially reflecting a stabilization or blunting of native network dynamics. These findings underscore the importance of considering hormonal status as a critical variable in neuroimaging research and women's health. Future studies employing longitudinal designs and integrating multi-omics data will be key to understanding the long-term implications and individual variability in neural responses to hormonal contraceptives.

The human menstrual cycle is characterized by dynamic fluctuations in key ovarian hormones, primarily estradiol and progesterone, which define two primary phases relevant to neuroimaging research. The follicular phase begins with menses and is characterized by low levels of progesterone and gradually increasing estradiol until its peak just before ovulation. In contrast, the luteal phase occurs after ovulation and is defined by high levels of both progesterone and estradiol, with progesterone reaching its highest concentration during the mid-luteal period [13]. These cyclical hormonal variations have been shown to significantly modulate the brain's intrinsic functional architecture—the spontaneous, coordinated neural activity that occurs during rest.

Research using resting-state functional magnetic resonance imaging (rs-fMRI) has identified several large-scale brain networks that demonstrate particular sensitivity to these hormonal fluctuations. The most prominently affected networks include the default mode network (DMN), involved in self-referential thought and memory; the executive control network (ECN), crucial for higher cognitive functions; the salience network (SN), which identifies emotionally relevant stimuli; and various subcortical networks involving structures like the hippocampus and basal ganglia, which are critical for memory and motor function [13] [17] [18]. Understanding how connectivity within and between these networks differs between the follicular and luteal phases provides valuable insights into the neural mechanisms underlying cognitive and emotional changes across the menstrual cycle, with particular relevance for both basic neuroscience and drug development targeting hormone-sensitive neuropsychiatric conditions.

Comparative Analysis of Network Connectivity Across Cycle Phases

Quantitative Differences in Functional Connectivity

Table 1: Functional Connectivity Differences Between Follicular and Luteal Phases

Brain Network/Region	Connectivity Changes in Luteal vs. Follicular Phase	Associated Hormonal Mediators	Key References
Default Mode Network (DMN)	Decreased connectivity to left angular gyrus; Anterior-posterior decoupling	Progesterone, Estradiol	[13] [18]
Executive Control Network (ECN)	Increased connectivity from insula (SN) to ECN; Altered frontal-parietal dynamics	Estradiol (pre-ovulatory)	[18]
Salience Network (SN)	Increased within-network connectivity (especially between insulae); Enhanced SN-DMN coupling	Progesterone	[17] [18]
Subcortical Networks	Increased hippocampal eigenvector centrality; Enhanced caudate ALFF; Strengthened putamen-thalamic connectivity	Progesterone	[15]
Dorsal Attention Network	Variable changes; decreased dynamical complexity in pre-ovulatory vs. follicular	Estradiol, Progesterone	[13]
Whole-Brain Dynamics	Lower dynamical complexity (node-metastability) compared to pre-ovulatory phase	Progesterone, Age	[13]

Directional Effective Connectivity Changes

Table 2: Effective Connectivity Changes Measured by Spectral Dynamic Causal Modeling

Network Pathway	Direction of Change	Cycle Phase	Proposed Functional Impact
Insula (SN) → Frontal Nodes (ECN)	Increased influence	Pre-ovulatory	Enhanced salience detection for cognitive processing
DMN Anterior Posterior Nodes	Decreased coupling (decoupling)	Pre-ovulatory	Segregation of self-referential processing subsystems
Insulae (SN) Insulae	Increased reciprocal connectivity	Mid-luteal	Enhanced interoceptive and emotional awareness
Parietal ECN → Posterior DMN	Increased influence	Mid-luteal	Cognitive engagement with internal thought
Middle Frontal Gyrus → Precuneus (DMN)	Decreased connectivity	Pre-ovulatory	Reduced cognitive control over DMN

Methodological Framework for Menstrual Cycle Connectivity Research

Experimental Protocols and Workflows

The investigation of menstrual cycle effects on brain connectivity requires carefully designed experimental protocols to capture the subtle yet significant changes driven by hormonal fluctuations. The most methodologically rigorous studies employ longitudinal within-subjects designs where the same participants are scanned across multiple carefully-defined cycle phases, typically during early follicular (days 2-7 post-menstruation), pre-ovulatory (just before ovulation, characterized by estradiol peak), and mid-luteal phases (7-10 days post-ovulation, characterized by progesterone peak) [13] [15]. This approach controls for between-subjects variability and allows for direct comparison of connectivity states within the same individual.

Hormonal assessment represents a critical component of the experimental protocol. Serum samples collected at each scanning session are analyzed for estradiol and progesterone concentrations using standardized immunoassay techniques (e.g., electrochemiluminescence immunoassay) [19]. To precisely determine cycle phase, researchers often employ urinary luteinizing hormone (LH) detection kits (e.g., Clearblue Digital Ovulation kit) to identify the LH surge that precedes ovulation by approximately 24-48 hours, providing greater temporal precision than cycle counting alone [19]. For rs-fMRI data acquisition, protocols typically involve T2*-weighted echoplanar imaging sequences with specific parameters: repetition time (TR) = 2000-2500 ms, echo time (TE) = 30-40 ms, field of view = 220 mm, voxel size = 3-3.5 mm isotropic, and 150-300 volumes acquired over 5-10 minutes of resting-state scanning [19] [15].

The analytical workflow for assessing functional connectivity encompasses multiple complementary approaches. Group-independent component analysis (ICA) is used to identify intrinsic connectivity networks (ICNs) by decomposing the rs-fMRI data into spatially independent but temporally coherent networks [15]. Seed-based correlation analysis examines the temporal correlation between a predefined seed region and all other voxels in the brain [15]. For more sophisticated network characterization, eigenvector centrality mapping (ECM) quantifies the hierarchical relevance of nodes within the global connectivity architecture [15], while amplitude of low-frequency fluctuations (ALFF) measures spontaneous local oscillatory activity in specific frequency bands (typically 0.01-0.08 Hz) [15]. Most advanced is spectral dynamic causal modeling (spDCM), which estimates directed (effective) connectivity between network nodes by parameterizing the hidden coupling among neuronal populations from the cross-spectral density of BOLD signals [18].

Figure 1: Experimental Workflow for Menstrual Cycle Connectivity Studies

Signaling Pathways and Neurobiological Mechanisms

The connectivity changes observed across the menstrual cycle are mediated by complex neurobiological mechanisms through which ovarian hormones modulate neural function. Estradiol and progesterone exert their effects through both genomic and non-genomic pathways, binding to widely distributed hormone receptors throughout the brain, particularly in regions rich in estrogen receptors (ERα, ERβ) and progesterone receptors (PR-A, PR-B) [4] [20]. These include key nodes of major brain networks such as the hippocampus, prefrontal cortex, amygdala, and basal ganglia.

At the cellular level, estradiol has been shown to promote synaptogenesis and dendritic spine formation, particularly in the hippocampus, where it increases spine density on CA1 pyramidal neurons [21] [15]. Estradiol also enhances long-term potentiation (LTP) and increases the expression and function of NMDA receptors, strengthening synaptic transmission and plasticity [18]. These structural changes are reflected in human neuroimaging studies that report increased hippocampal gray matter volume during high-estrogen phases [21] [15]. Progesterone and its neuroactive metabolite allopregnanolone potentiate GABAergic inhibition through action on GABAA receptors, modulating neuronal excitability and network synchronization [17]. Additionally, both hormones influence dopaminergic neurotransmission, with progesterone increasing dopamine D2 receptor availability in the caudate and putamen during the luteal phase [4] [20].

These molecular and cellular effects collectively alter the excitatory/inhibitory balance within and between large-scale networks, resulting in the phase-dependent connectivity patterns observed in fMRI studies. The heightened SN-DMN connectivity during the luteal phase may reflect progesterone-mediated enhanced emotional salience processing, while the pre-ovulatory increase in ECN engagement may result from estradiol-enhanced prefrontal synaptic plasticity [18].

Figure 2: Neurobiological Pathways Linking Hormones to Connectivity Changes

Essential Research Reagents and Methodological Tools

Table 3: Research Reagent Solutions for Menstrual Cycle Connectivity Studies

Reagent/Tool	Specific Application	Research Function	Representative Examples
LH Detection Kits	Cycle phase determination	Precise identification of ovulation for phase-specific scheduling	Clearblue Digital Ovulation Kit [19]
Hormone Assays	Hormonal verification	Quantification of serum estradiol and progesterone levels	Electrochemiluminescence Immunoassay (Roche Elecsys) [19]
fMRI Preprocessing Tools	Data quality control	Motion correction, normalization, and artifact removal	FSL, SPM, CONN toolbox
Connectivity Analysis Software	Network identification and quantification	ICA, seed-based correlation, graph theory metrics	FSL MELODIC, DPABI, BrainConnectivity Toolbox
Effective Connectivity Platforms	Directed influence modeling	Spectral DCM for estimating causal relationships	SPM12 (DCM module), TAPAS software suite [18]
Symptom Tracking Instruments	Participant phenotyping	Daily monitoring of cycle-related symptoms	Daily Record of Severity of Problems (DRSP) [19]

Implications for Research and Drug Development

The documented differences in network connectivity between follicular and luteal phases have significant implications for both basic neuroscience research and pharmaceutical development. From a methodological perspective, these cyclic variations represent a critical source of within-subject variance that must be accounted for in neuroimaging study designs involving women of reproductive age. Failure to control for menstrual cycle phase may introduce uncontrolled variability that obscures genuine effects or creates false positives in studies of brain function and connectivity [21] [15].

For drug development, particularly for neuropsychiatric disorders with female predominance (e.g., depression, anxiety, migraine), understanding phase-dependent connectivity patterns offers valuable insights for optimizing therapeutic timing and identifying novel treatment targets. The luteal phase characterization as a "window of vulnerability" for affective symptoms [17] [22] suggests that interventions targeting the heightened SN-DMN connectivity observed during this phase may prove particularly effective for conditions like premenstrual dysphoric disorder (PMDD). Indeed, women with PMDD show distinct connectivity patterns in the executive control network compared to healthy controls, suggesting potential biomarkers for treatment development [19].

Future research in this area would benefit from standardized phase definitions and hormonal verification across studies, increased sample sizes with longitudinal designs, integration of multimodal imaging approaches, and expanded investigation of how oral contraceptive use modulates these naturally cycling network dynamics. Such methodological refinements will enhance our understanding of the complex interplay between ovarian hormones and brain network organization, ultimately informing more precise, sex-specific approaches to neuroscience research and neurotherapeutic development.

Oral contraceptives (OCs) represent one of the most widely prescribed classes of drugs globally, exerting their effects through a dual mechanism: suppressing endogenous ovarian hormone production while introducing synthetic hormones into the body. This systematic alteration of the hormonal milieu has profound implications for brain structure, function, and connectivity. This review synthesizes current research on how OCs modulate the brain's resting-state networks, comparing findings across different OC formulations, durations of use, and user populations. We examine the methodological approaches for investigating OC effects and present quantitative data on neurostructural and functional changes, providing researchers and drug development professionals with a comprehensive analysis of OC-induced neurobiological alterations.

Hormonal contraceptives (HCs) are used by over 300 million women worldwide, with 82% of reproductive-aged women in the United States reporting use at some point in their lives [23]. These medications fundamentally alter a woman's endocrine landscape through two primary mechanisms:

• Suppression of endogenous hormones: By negative feedback on the hypothalamic-pituitary-gonadal (HPG) axis, OCs diminish the production of endogenous estradiol and progesterone by the ovaries, suppressing cyclical hormonal fluctuations and inhibiting ovulation [23].
• Introduction of synthetic hormones: OCs deliver synthetic hormones—typically a synthetic progestin alone or in combination with a synthetic estrogen (usually ethinyl estradiol)—creating a unique pharmacological profile that varies by formulation [23] [24].

This review examines how this manipulated hormonal environment affects resting-state brain function and connectivity, with implications for cognitive and emotional processes.

Mechanistic Basis of Hormonal Contraception

Hypothalamic-Pituitary-Ovarian Axis Suppression

The primary mechanism through which OCs achieve contraception is by suppressing the HPG axis. Gonadotropin-releasing hormone (GnRH) secretion from the hypothalamus is inhibited, leading to reduced follicle-stimulating hormone (FSH) and luteinizing hormone (LH) release from the anterior pituitary [24] [25]. This, in turn, prevents follicular development and ovulation. The synthetic hormones in OCs create this effect through negative feedback mechanisms, fundamentally altering the normal endocrine signaling pathways.

Figure 1: Hormonal Landscape Comparison: Natural Cycle vs. Oral Contraceptive Use. OC use creates a fundamentally different hormonal environment by suppressing endogenous production while introducing stable synthetic hormones.

Formulation Variability and Neuroactive Properties

OC formulations differ significantly in their composition, which influences their effects on the brain:

• Estrogen components: Typically ethinyl estradiol (EE) in combined OCs, though some newer formulations use estradiol valerate or estetrol [26] [27].
• Progestin components: Vary in their androgenicity and pharmacological profiles:
  • Androgenic progestins: Derived from 19-nortestosterone (e.g., levonorgestrel, norethindrone) acting as androgen receptor agonists [28].
  • Anti-androgenic progestins: Derived from spironolactone or progesterone (e.g., drospirenone, cyproterone acetate) acting as androgen receptor antagonists [28].
• Administration regimens: Include monophasic, multiphasic, extended-cycle, and continuous formulations that create different patterns of hormone exposure [24].

The specific pharmacological properties of these synthetic hormones, particularly their receptor binding affinities and metabolic effects, contribute to their diverse impacts on neural structure and function [26].

Methodological Approaches in OC Research

Neuroimaging Protocols for Resting-State Analysis

Resting-state functional magnetic resonance imaging (fMRI) has emerged as a primary tool for investigating OC effects on brain networks. Standardized protocols include:

• Data acquisition: Participants undergo scanning in a awake, resting state with eyes closed or fixed on a crosshair, typically for 8-15 minutes to ensure sufficient data stability [29].
• Preprocessing steps: Include realignment, normalization, spatial smoothing, and band-pass filtering to reduce physiological noise [29] [28].
• Connectivity analysis: Independent component analysis (ICA) is commonly used to identify intrinsic connectivity networks, followed by statistical comparisons of within-network and between-network connectivity [29].
• Additional measures: Fractional anisotropy (FA) and mean diffusivity (MD) from diffusion MRI provide complementary data on white matter microstructure [23].

Hormonal Assay Methodologies

Precise measurement of hormonal levels is critical for interpreting OC effects:

• Mass spectrometry: Liquid chromatography-tandem mass spectrometry (LC-MS/MS) provides specific measurement of both endogenous (E2, P4) and exogenous (EE) hormones in saliva or serum with high specificity [26].
• Frequency of collection: Repeated measures across the OC cycle are essential, as fluctuations in endogenous and exogenous hormones can vary by route, formulation, and regimen [26].
• Comprehensive panels: Should include measurements of exogenous progestins, endogenous progesterone, and affect-relevant metabolites like allopregnanolone for a complete hormonal profile [26].

Experimental Designs for OC Studies

• Cross-sectional designs: Comparing current OC users to naturally cycling women, though susceptible to confounding factors like "survivor effects" where only women who tolerate OCs continue use [30].
• Longitudinal designs: Tracking women before, during, and after OC use to establish causal relationships, though more resource-intensive [26].
• Formulation-specific analyses: Grouping participants by progestin type (androgenic vs. anti-androgenic) and hormone dose to isolate specific effects [28].

Comparative Effects on Brain Structure and Function

Structural Neuroimaging Findings

Neuroimaging studies reveal that OC use is associated with both increases and decreases in regional brain volumes compared to naturally cycling women:

Table 1: Structural Brain Changes Associated with Oral Contraceptive Use

Brain Region	Change Direction	Effect Size/Notes	Citation
Middle frontal gyrus	Decrease	Bilateral reduction	[23]
Superior frontal gyrus	Decrease	Bilateral reduction	[23]
Hippocampus	Decrease	Left hemisphere; volume reductions	[23]
Amygdala	Decrease	Left hemisphere; volume reductions	[23]
Prefrontal cortex	Increase	Bilateral increase; androgenicity-dependent	[23]
Temporal cortex	Increase	Bilateral increase	[23]
Cerebellum	Mixed	Decrease in right hemisphere; increase elsewhere	[23]
Anterior cingulate cortex	Decrease	Right hemisphere; cortical thinning	[23]

Microstructural changes are also evident in diffusion MRI studies, with OC users showing increased fractional anisotropy (FA) and mean diffusivity (MD) in white matter tracts, suggesting alterations in axonal integrity and organization [23].

Resting-State Functional Connectivity Alterations

OC use modulates large-scale brain networks essential for cognitive and emotional processing:

Table 2: Functional Connectivity Changes in Oral Contraceptive Users

Network/Region	Connectivity Change	Associated Function	Citation
Frontoparietal network	Weaker within-network connectivity	Executive function, cognitive control	[29]
Default mode network	Weaker within-network connectivity	Self-referential thought, memory	[29]
Salience network	Weaker within-network connectivity	Emotion processing, attention	[29]
Dorsal attention-Default mode	Weaker between-network connectivity	Attention regulation, cognitive flexibility	[29]
Amygdala-prefrontal pathways	Altered connectivity	Emotion regulation, fear processing	[28]

These functional alterations appear to have behavioral consequences. For instance, one study found that both current and past OC users displayed greater fear return in safe contexts during fear conditioning experiments, with exploratory analyses linking this impairment to higher ethinyl estradiol doses and specific progestin types [26].

Androgenic vs. Anti-Androgenic Formulation Effects

The androgenicity of the progestin component significantly modulates OC effects on the brain:

Table 3: Differential Effects by Progestin Androgenicity

Parameter	Androgenic OCs	Anti-Androgenic OCs	Citation
Emotion recognition	Better facial emotion recognition	Reduced emotion recognition accuracy	[28]
Brain-behavior associations	Similar to naturally cycling women (weaker)	Strong, often opposite associations to natural cycling	[28]
Spatial cognition	Improved mental rotation performance	No improvement or slight impairment	[30]
Verbal fluency	Reduced word production	Better verbal fluency performance	[30]
Amygdala connectivity	Moderate alterations	Significant changes in limbic connectivity	[28]

These differential effects highlight the importance of considering specific OC formulations rather than treating all hormonal contraceptives as equivalent in research settings.

Temporal Dynamics: Duration of Use and Developmental Period

Acute vs. Long-Term Use Effects

The duration of OC use appears to modulate their neurobiological impact:

• Short-term effects: Initial exposure to OCs triggers rapid changes in functional connectivity and emotional processing [26].
• Long-term cumulative effects: Duration of OC use correlates with verbal fluency performance, with longer use associated with reduced word production [30]. Long-term use also affects brain activation patterns during cognitive tasks, with duration-dependent deactivation observed in the caudate and postcentral gyrus during navigation tasks [30].
• Persistence after discontinuation: Some neural effects persist after OC discontinuation, including altered fear responses and changes in brain activation during verbal tasks, suggesting potential long-term programming effects [30] [26].

Adolescent vs. Adult Use

The brain appears particularly sensitive to OC effects during adolescence, a period of ongoing neural maturation:

• Adolescent sensitivity: Significant changes in brain structure and function occur when OCs are initiated during adolescence compared to adulthood [23].
• Developmental considerations: The adolescent brain may be more vulnerable to organizational effects of synthetic hormones, potentially leading to more persistent alterations in neural circuitry [23].

The Scientist's Toolkit: Essential Research Materials

Table 4: Key Reagents and Materials for OC Neuroscience Research

Item	Function/Application	Specific Examples/Notes
3T MRI Scanner	High-resolution structural and functional imaging	Essential for resting-state fMRI data collection; provides sufficient signal-to-noise ratio
LC-MS/MS System	Hormone quantification	Liquid chromatography-tandem mass spectrometry for specific measurement of endogenous and synthetic hormones
Fear Conditioning Paradigm	Assessing fear learning and extinction	Computerized systems with physiological monitoring (skin conductance, heart rate)
Cognitive Task Batteries	Evaluating specific cognitive domains	Verbal fluency tests, mental rotation tasks, navigation paradigms
Saliva/Serum Collection Kits	Biological sample acquisition	For hormone assay; salivary collection preferred for frequent sampling
Independent Component Analysis Software	Resting-state data processing	FSL MELODIC, GIFT; identifies intrinsic connectivity networks
Androgenicity Classification Guide	Progestin categorization	Reference charts for classifying progestins by androgen receptor activity

Signaling Pathways and Experimental Workflows

Figure 2: Comprehensive Experimental Workflow for OC Neuroscience Research. This integrated approach combines neuroimaging, hormonal assays, and behavioral assessment to elucidate OC effects on the brain.

Oral contraceptive use creates a unique endocrine environment characterized by suppression of endogenous hormones and introduction of synthetic analogs, with demonstrable effects on brain structure, functional connectivity, and behavior. Key findings indicate that:

• OC use modulates resting-state connectivity within and between major brain networks, including the frontoparietal, default mode, and salience networks.
• The androgenicity of the progestin component significantly influences OC effects on emotion recognition, spatial cognition, and verbal fluency.
• Methodological considerations including precise hormone measurement, formulation-specific analyses, and attention to duration and timing of use are critical for valid interpretation of results.

Future research should prioritize longitudinal designs tracking neural changes from pre-initiation through long-term use and beyond discontinuation, direct comparisons of different formulations in randomized designs, and investigation of individual difference factors that predict sensitivity to OC effects on the brain. Such work will advance our understanding of how synthetic hormones influence neural function and guide development of optimized formulations with minimized neuropsychiatric side effects.

Resting-state functional magnetic resonance imaging (rs-fMRI) has emerged as a powerful tool for investigating the brain's intrinsic functional architecture. Research has increasingly focused on how this architecture is modulated by physiological variables, particularly the fluctuation of sex hormones in women. This guide provides a comparative analysis of two major brain networks—the Default Mode Network (DMN) and the Executive Control Network (ECN)—across the menstrual cycle and in users of oral contraceptives (OCs). The DMN is primarily associated with internally-directed cognition such as self-referential thought and mind-wandering, while the ECN is crucial for externally-oriented, goal-directed executive functions [31]. Understanding how these networks are influenced by hormonal states is critical for a comprehensive model of the female brain and for developing hormonally-informed therapies.

Experimental Protocols and Methodologies

Key studies in this field employ sophisticated rs-fMRI analytical techniques to probe brain network dynamics. The following workflow outlines a standard protocol for this research, from participant grouping to data analysis:

Experimental Workflow for Hormonal Modulation Studies. This diagram outlines the standard protocol from participant grouping to outcome analysis [32] [18].

The primary methodological approaches used in these studies include:

• Independent Component Analysis (ICA): A multivariate, data-driven method that decomposes rs-fMRI data into spatially independent but temporally coherent networks, such as the DMN and ECN, without a priori assumptions about regions of interest [15] [32].
• Seed-Based Connectivity: A hypothesis-driven approach that calculates the temporal correlation between a pre-selected "seed" region and all other voxels in the brain to map functional connectivity patterns [15].
• Spectral Dynamic Causal Modeling (spDCM): A model-based approach that estimates effective (directed) connectivity between brain regions from the cross-spectral density of BOLD signals, allowing inferences about causal influences [18].
• Dependency Network Analysis (DEPNA): A graph-based framework optimized for quantifying directional information flow and hierarchical influence across multiple brain regions and networks [33].

Quantitative Findings: DMN and ECN Across Hormonal Conditions

Menstrual Cycle Modulation in Naturally-Cycling Women

Table 1: DMN and ECN Connectivity Changes Across the Menstrual Cycle in Naturally-Cycling Women

Cycle Phase	Hormonal Profile	DMN Connectivity Changes	ECN Connectivity Changes	Key Brain Regions
Pre-Ovulatory	High Estradiol	↑ DMN connectivity with temporal areas [15]	↑ Fronto-striatal connectivity [15]	Left Middle Temporal Gyrus, Caudate
Luteal Phase	High Estradiol & Progesterone	↓ DMN connectivity with right Angular Gyrus [15] [32]	↑ Connectivity with basal ganglia [15]	Angular Gyrus, Caudate, Putamen, Thalamus
Early Follicular	Low Hormones	↑ DMN connectivity with left dorsolateral PFC [15]	Baseline state for comparison	Left Middle Frontal Gyrus

Hormonal correlations indicate that during the luteal phase, decreased DMN connectivity with the angular gyrus is associated with lower estradiol and higher progesterone, while increased oscillatory activity in the caudate is linked to the same hormonal profile [15]. Effective connectivity studies using spDCM reveal that right before ovulation (high estradiol), the left insula increases its recruitment of the ECN, while the right middle frontal gyrus decreases its influence on the precuneus, and the DMN decouples into anterior and posterior parts [18].

Oral Contraceptive Users vs. Naturally-Cycling Women

Table 2: Network Connectivity Comparison: Oral Contraceptive Users vs. Naturally-Cycling Women

Experimental Group	Hormonal Profile	DMN Connectivity	ECN Connectivity	Cognitive Implications
Naturally-Cycling (Luteal)	High Endogenous Hormones	↓ Connectivity in left Angular Gyrus [32] [11]	Altered connectivity in ACC & left MFG [32] [11]	Potential effects on attention/emotion regulation
OC Users (Active Pill)	High Synthetic Hormones, Low Endogenous	↓ Connectivity similar to luteal phase [32] [11]	Altered connectivity in ACC & left MFG [32] [11]	Synthetic hormones may mimic endogenous effects
OC Users (Inactive Pill)	Low All Hormones	Intermediate connectivity pattern	Intermediate connectivity pattern	Mixed acute vs. chronic effects

The anterior cingulate cortex (ACC) and left middle frontal gyrus (MFG)—regions critical for higher-order cognitive and emotional processing, including conflict monitoring—show significant changes in their relationship to functional networks in both OC users and naturally-cycling women in the luteal phase [32] [11]. This suggests that synthetic hormones in OCs may mimic some, but not all, of the effects of endogenous hormones on brain network dynamics.

The Scientist's Toolkit: Essential Research Reagents and Materials

Table 3: Key Reagents and Materials for Resting-State fMRI Hormonal Research

Item Category	Specific Examples	Function/Application	Example Use Case
Imaging Equipment	3T MRI Scanner, Head Coils	High-resolution functional and structural brain imaging	Acquisition of T1-weighted structural and T2*-weighted BOLD fMRI sequences [15] [32]
Hormone Assay Kits	Salivary Immunoassay Kits (e.g., Salimetrics)	Quantification of 17β-estradiol and progesterone levels	Verification of cycle phase and correlation with neural findings [32]
Data Analysis Software	AFNI, FSL, SPM, CONN, MATLAB	fMRI data preprocessing and statistical analysis	Implementation of ICA, seed-based correlation, and dynamic causal modeling [15] [34] [18]
Network Analysis Tools	Spectral DCM, DEPNA, Graph Theory Metrics	Modeling effective connectivity and network hierarchy	Quantifying directed influence between DMN and ECN [18] [33]
Participant Screening Tools	SCID-I, Menstrual Cycle Diaries	Ensuring homogeneous experimental groups	Confirming regular cycles and excluding psychiatric conditions [32] [34]

Integrated Discussion and Future Directions

The synthesized evidence demonstrates that the functional connectivity of both the DMN and ECN is not static but varies significantly with hormonal state. During the luteal phase and with OC use, a consistent pattern emerges of reduced connectivity within the DMN, particularly involving the angular gyrus and prefrontal regions. Simultaneously, subcortical-cortical connections are strengthened, with increased connectivity between striatal regions (caudate, putamen) and thalamic/prefrontal areas [15] [32]. These changes suggest a hormonal modulation of network dynamics that may underlie behavioral, emotional, and sensorimotor changes reported across the cycle.

From a methodological perspective, the field is evolving from descriptive functional connectivity towards model-based effective connectivity approaches like spDCM and DEPNA, which can infer the directionality of influence between networks [18] [33]. These advanced techniques have revealed, for instance, that the pre-ovulatory period is characterized by a decoupling of the DMN and a increased influence of the salience network over the ECN, while the luteal phase involves heightened interplay between the salience network and both the DMN and ECN [18].

Future research should prioritize longitudinal designs that track individuals across multiple cycles, incorporate more diverse OC formulations, and integrate molecular imaging to bridge the gap between hormonal mechanisms and network-level effects. Such advances will be crucial for developing hormonally-informed personalized medicine approaches in neurology and psychiatry.

Advanced Neuroimaging Methods for Capturing Hormonal Effects on Brain Connectivity

In resting-state functional magnetic resonance imaging (rs-fMRI) research, functional connectivity (FC) refers to the temporal dependence of neuronal activity patterns between anatomically separated brain regions [35]. The study of FC provides a powerful framework for understanding the brain's intrinsic functional organization and how it is influenced by various factors, including ovarian hormone levels across the menstrual cycle and oral contraceptive (OC) use [36]. Two methodological approaches have become cornerstone techniques for evaluating FC from blood-oxygen-level-dependent (BOLD) fMRI data: seed-based correlation analysis (SCA) and independent component analysis (ICA) [37] [38]. While sometimes used interchangeably, these methods are conceptually distinct, with different theoretical foundations, implementation requirements, and output interpretations.

The choice between ICA and seed-based approaches carries particular importance in neuroendocrine research, where investigators seek to identify how hormonal states affect brain network organization. Studies suggest that as the menstrual cycle proceeds from a low to high progesterone state, prefrontal connectivity increases while parietal connectivity decreases, and that OCs may mimic this connectivity pattern, potentially producing a hyperprogestogenic state in the brain despite overall reductions in endogenous steroid hormone levels [36]. Understanding the technical capabilities and limitations of each method is therefore essential for designing rigorous studies and interpreting findings in this rapidly evolving field.

Theoretical Foundations and Methodological Principles

Seed-Based Correlation Analysis (SCA)

Seed-based correlation analysis is a hypothesis-driven approach that investigates functional connectivity with a pre-defined region of interest (ROI) or "seed" [39] [40]. This method computes the temporal correlation between the BOLD time series of a seed region and all other voxels throughout the brain, producing a whole-brain connectivity map that reveals networks synchronized with the seed region [40] [35]. The core equation calculates the Pearson correlation coefficient between the seed time course R(t) and each voxel's time course S(x,t), typically followed by Fisher's z-transformation to improve normality for statistical testing [39] [35]:

[ r(x) = \frac{\sum{t=1}^{T} [S(x,t) \cdot R(t)]}{\sqrt{\sum{t=1}^{T} S^2(x,t) \cdot \sum_{t=1}^{T} R^2(t)}} ]

where (S(x,t)) is the demeaned BOLD signal at voxel (x) and time (t), (R(t)) is the average BOLD time series within the ROI, and (T) is the total number of time points [39].

Several SCA variants have been developed to address specific research questions. Multivariate SBC uses semipartial correlation to examine potential direct connectivity paths between a seed and other brain regions after controlling for the influence of other ROIs [39]. Weighted SBC characterizes condition-specific functional connectivity strength during different tasks or conditions using a weighted least squares approach [39]. Generalized Psychophysiological Interactions (gPPI) measures task-modulated effective connectivity by examining how experimental factors modulate functional associations between a seed and other brain regions [39].

A significant methodological consideration for SCA is seed selection, which can be based on task-activated regions, anatomical atlases, or prior literature. However, this selection strongly influences the resulting connectivity patterns, as demonstrated by an image-based meta-analysis showing relatively low overlap (approximately 10-34%) across meta-analytic maps derived from different seed placements within the default mode network [35].

Independent Component Analysis (ICA)

Independent component analysis is a data-driven, multivariate technique that separates mixed signals into statistically independent, non-Gaussian components without requiring a priori hypotheses [41] [42] [43]. ICA operates under the principle of blind source separation, decomposing the 4D rs-fMRI dataset into a collection of spatially independent components, each comprising a spatial map and associated time course [37] [44] [38]. Mathematically, ICA models the observed BOLD signal S(x,t) as a linear mixture of independent sources:

[ S(x,t) = \sum{k=1}^{K} Mk(x)A_k(t) ]

where (K) is the number of spatially independent components, (Mk) is the spatial map of component (k), and (Ak) is the time course of component (k) [37].

Unlike principal component analysis (PCA), which finds uncorrelated factors that explain maximum variance, ICA identifies statistically independent components that may not be orthogonal but represent maximally independent source signals [41] [42]. This capability makes ICA particularly valuable for identifying large-scale functional networks simultaneously and for separating various noise sources and artifacts from signals of interest under the assumption that spontaneous neural activity and noise are statistically independent [44].

ICA can be implemented at single-subject and group levels, with group ICA typically performed using temporal concatenation approaches that assume identical spatial components across subjects but allow for unique time courses [37]. Algorithms such as FastICA provide computationally efficient implementations that use fixed-point iteration schemes to maximize statistical independence, typically measured through functions like negentropy or mutual information [42] [43].

Comparative Analysis of ICA and Seed-Based Approaches

Table 1: Fundamental Characteristics of ICA and Seed-Based Correlation Analysis

Parameter	Independent Component Analysis (ICA)	Seed-Based Correlation Analysis (SCA)
Analytical Approach	Data-driven, exploratory [44] [38]	Hypothesis-driven, confirmatory [39] [40]
Prior Knowledge Requirement	Minimal; no need for a priori seed selection [44] [38]	Requires pre-defined seed regions based on hypotheses or prior literature [35]
Network Identification	Identifies multiple resting-state networks simultaneously [38]	Examines connectivity patterns with specific seed regions only [40]
Component Relationship	Finds statistically independent, non-Gaussian components [42] [43]	Identifies regions with correlated time courses [40] [35]
Output	Spatially independent components with associated time courses [37] [44]	Whole-brain correlation maps relative to seed region [39] [40]
Noise Handling	Effectively separates and removes various noise sources and artifacts [44]	Requires additional preprocessing for noise reduction [44]
Sensitivity to Seed Location	Not applicable	Highly sensitive; significantly affects results [35]
Typical Implementation	Group ICA with temporal concatenation [37]	Single-subject correlation analysis with group-level statistics [39]

Table 2: Practical Research Considerations for ICA and Seed-Based Methods

Consideration	Independent Component Analysis (ICA)	Seed-Based Correlation Analysis (SCA)
Optimal Application	Exploratory studies, multiple network analysis, data with unknown noise sources [44] [38]	Hypothesis testing, specific network examination, clinical applications targeting known regions [38] [35]
Experimental Design Flexibility	Well-suited for both resting-state and task-based designs [37]	Primarily used in resting-state but adaptable with gPPI for task modulation [39]
Reproducibility Concerns	Component sorting and interpretation variability	High variability due to seed selection differences [35]
Computational Demand	Higher computational requirements, especially for large datasets [42]	Less computationally intensive [39]
Analytical Complexity	Complex implementation and interpretation [38]	More straightforward implementation and interpretation [40]
Multisubject Analysis	Group ICA with dual regression for population studies [40] [38]	Standard group statistics on individual correlation maps [39]

Theoretical Relationship Between Methods

The relationship between ICA and seed-based correlation is not merely practical but can be formally expressed mathematically. As derived in [37], seed-based correlation between two voxels (x1) and (x2) can be expressed as the sum of ICA-derived connectivity measures:

[ C{ICA}(x1,x2) = \sumk WNCk(x1,x2) + \sum{k \neq l} \sum{l \neq k} BNC{k,l}(x1,x2) ]

where (WNCk) represents within-network connectivity for component (k) and (BNC{k,l}) represents between-network connectivity for components (k) and (l) [37]. This formulation demonstrates that seed-based correlation represents the aggregate of both within-network and between-network connectivities identified through ICA.

Experimental Protocols and Analytical Workflows

Seed-Based Correlation Analysis Protocol

Preprocessing Requirements: SCA requires extensive preprocessing including removal of initial time points, slice-timing correction, head motion correction, co-registration to structural images, spatial normalization, smoothing, linear trend removal, regression of nuisance signals (e.g., motion parameters, white matter, and CSF signals), and band-pass filtering (typically 0.01-0.08 Hz) [35].

Seed Selection Procedure: Seeds can be defined using spherical ROIs centered on coordinates from prior literature, task-activated regions, or anatomical atlases. A common approach uses 6mm radius spheres, though the sensitivity of results to seed location must be considered [35].

Time Series Extraction and Correlation: The average time series is extracted from the seed region and correlated with all other brain voxels. Correlation coefficients are transformed to z-scores using Fisher's transformation to improve normality for group-level analysis [39] [35].

Statistical Analysis: Group-level analyses typically use one-sample t-tests to identify consistent connectivity patterns across subjects or two-sample t-tests to examine group differences (e.g., menstrual cycle phases or OC users vs. naturally cycling individuals) [35].

SCA Workflow: From data preprocessing to connectivity maps.

Independent Component Analysis Protocol

Preprocessing and Dimensionality Reduction: Similar preprocessing steps as SCA are required, followed by dimensionality reduction typically using principal component analysis to make the ICA estimation tractable [44] [38].

Component Estimation: The ICA algorithm (e.g., FastICA, Infomax) estimates independent components by maximizing the statistical independence of output components, typically using measures like negentropy or mutual information [42] [43].

Component Identification: The resulting spatial maps are evaluated to identify meaningful resting-state networks (e.g., default mode, salience, executive control networks) while distinguishing these from noise components related to motion, physiological artifacts, or scanner artifacts [44] [38].

Group Analysis Using Dual Regression: For multi-subject studies, dual regression is used to identify subject-specific versions of group-identified networks. This involves using group-level spatial maps as regressors against individual subject data to find subject-specific time courses, then using these time courses to find subject-specific spatial maps [40] [38].

Statistical Analysis: Subject-specific spatial maps from the dual regression are entered into group-level analyses to examine differences between experimental conditions or groups [40] [38].

ICA Workflow: Including dual regression for group analysis.

Application to Menstrual Cycle and Oral Contraceptive Research

Methodological Considerations for Neuroendocrine Studies

Research on menstrual cycle phases and oral contraceptive effects presents unique methodological challenges that influence choice of analytical technique. The hypogonadal state model suggests that OCs create chronic under-exposure to endogenous ovarian hormones, while the hyperprogestogenic model proposes that OCs mimic high-progesterone states in the brain despite reduced endogenous hormone levels [36]. Each analytical technique offers different advantages for testing these competing hypotheses.

ICA's data-driven approach is particularly valuable in this domain because it can identify novel connectivity patterns that might not be predicted by existing models of hormone action [36] [44]. The ability to examine multiple networks simultaneously allows researchers to detect coordinated changes across large-scale brain systems in response to hormonal fluctuations [36] [38]. Furthermore, ICA's effectiveness in separating noise components is particularly beneficial for removing physiological signals (e.g., cardiac, respiratory) that may confound hormone-related connectivity findings [44].

Seed-based approaches remain valuable for testing specific hypotheses regarding hormone-sensitive regions identified in prior literature, such as prefrontal and parietal regions that show connectivity changes across the menstrual cycle [36] [35]. However, the known sensitivity of SCA to seed location necessitates careful justification of seed selection, particularly when comparing across studies with different methodological approaches [35].

Hybrid Approaches and Best Practices

Emerging evidence suggests that hybrid approaches leveraging both ICA and SCA may optimize analytical sensitivity for neuroendocrine research [38]. One effective workflow uses ICA to identify noise components and validate resting-state networks, then applies seed-based analysis with regions derived from ICA spatial maps to test specific group differences [38]. This approach capitalizes on the data-driven advantages of ICA while maintaining the statistical power and hypothesis-testing capabilities of SCA.

Table 3: Research Reagent Solutions for Functional Connectivity Analysis

Tool/Software	Primary Function	Application Context
FSL (FMRIB Software Library)	Comprehensive fMRI analysis suite	Group ICA, dual regression, seed-based analysis [40] [38]
CONN Toolbox	Functional connectivity toolbox	Seed-based correlation, gPPI, ROI-to-ROI connectivity [39]
DPABI (Data Processing & Analysis for Brain Imaging)	Pipeline-based neuroimaging analysis	Seed-based correlation, statistical analysis, visualization [35]
RESTplus	Resting-state fMRI data analysis	Data preprocessing, functional connectivity calculation [35]
FastICA Algorithm	Efficient ICA implementation	Blind source separation, component extraction [42]
Scikit-learn (Python)	Machine learning library	FastICA implementation, additional decomposition methods [42]

Both independent component analysis and seed-based correlation analysis provide valuable, complementary approaches for investigating resting-state functional connectivity in menstrual cycle and oral contraceptive research. ICA offers a data-driven, comprehensive method for exploring multiple simultaneous network changes without a priori hypotheses, making it particularly valuable for exploratory studies of hormonal effects on brain organization. Seed-based analysis provides a targeted, hypothesis-driven approach for investigating specific brain circuits with greater statistical simplicity and interpretability.

The emerging consensus suggests that rather than favoring one method exclusively, researchers should select the analytical approach based on specific research questions or implement hybrid methods that leverage the strengths of both techniques [38]. As neuroendocrine research advances, explicit methodological reporting—including seed coordinates for SCA and component selection criteria for ICA—will be essential for reconciling findings across studies and building a cohesive understanding of how ovarian hormones shape functional brain networks.

Resting-state functional magnetic resonance imaging (rs-fMRI) has become a cornerstone technique for investigating the intrinsic functional architecture of the human brain without requiring task performance. This is particularly valuable in menstrual cycle research, where it allows researchers to detect subtle, hormone-driven neural changes that may not manifest in overt behavioral performance [45] [46]. Within this domain, two complementary analytical metrics have emerged as particularly insightful: Eigenvector Centrality (EC) and the Amplitude of Low-Frequency Fluctuations (ALFF). These metrics provide distinct yet interconnected perspectives on brain organization and function. EC is a graph-theoretical measure that identifies highly influential "hub" regions within the brain's complex network by quantifying the importance of a node based on its connections to other important nodes [47]. In contrast, ALFF measures the magnitude of spontaneous neural activity in a given region by calculating the total power within the typical low-frequency range (0.01-0.1 Hz) of the blood-oxygen-level-dependent (BOLD) signal [15] [48]. For researchers studying oral contraceptive (OC) users and naturally cycling women, these metrics offer a powerful lens through which to examine how fluctuating hormone levels modulate brain network dynamics and regional activity, potentially underlying behavioral, emotional, and cognitive changes across the cycle.

Theoretical Foundations and Methodological Comparisons

Eigenvector Centrality: A Network Hub Identification Tool

Eigenvector Centrality (EC) operates on the principle that a brain region's importance within the overall functional network is determined not just by how many connections it has, but by how well-connected its neighbors are [47]. This recursive definition (a node is important if it is linked to other important nodes) allows EC to identify true network hubs that play crucial roles in information integration and distribution. In computational terms, for a given network graph with adjacency matrix (A), the eigenvector centrality (xi) of node (i) is proportional to the sum of the centralities of its neighbors: (xi = \frac{1}{\lambda} \sum{j} A{ij}x_j), where (\lambda) is the largest eigenvalue of (A) [47]. This metric is particularly sensitive to the global network structure and is effective at identifying regions that facilitate integration between different neural systems. In menstrual cycle research, EC has proven valuable for detecting how hormonal fluctuations alter the hierarchical organization of brain networks, particularly in subcortical regions like the hippocampus that show increased centrality during high-hormone phases [15].

ALFF: Measuring Regional Spontaneous Neural Activity

The Amplitude of Low-Frequency Fluctuations (ALFF) quantifies the intensity of spontaneous neural activity by measuring the square root of the power spectrum within the low-frequency range (typically 0.01-0.1 Hz) of the BOLD signal [48]. The calculation involves transforming the preprocessed time series of each voxel to the frequency domain using a Fast Fourier Transform, obtaining the power spectrum, and then computing the average square root across the frequency range of interest [48] [49]. ALFF reflects the magnitude of regional spontaneous neuronal activity, with higher values indicating more intense low-frequency oscillations. A variant known as fractional ALFF (fALFF) calculates the ratio of power in the low-frequency range to that of the entire frequency range, which can improve specificity by reducing physiological noise [50]. In the context of menstrual cycle research, ALFF is particularly sensitive to hormonal modulation of regional brain activity, such as the observed increase in caudate activity during the luteal phase when progesterone levels are elevated [15].

Comparative Analysis of Metrics

Table 1: Fundamental Characteristics of EC and ALFF

Feature	Eigenvector Centrality (EC)	Amplitude of Low-Frequency Fluctuations (ALFF)
Primary Focus	Global network influence and hub status	Regional spontaneous neuronal activity intensity
Theoretical Basis	Graph theory and network science	Spectral analysis of BOLD signal oscillations
Spatial Scope	Relational (depends on whole-brain connectivity)	Local (voxel-wise or region-specific)
Interpretation	High EC indicates influential network hubs	High ALFF indicates intense regional spontaneous activity
Sensitivity in Menstrual Cycle	Hippocampal centrality changes [15]	Caudate and basal ganglia activity fluctuations [15]
Complementarity	Identifies which regions become more centrally organized	Explains how regional activity intensity changes

Table 2: Advantages and Methodological Considerations

Aspect	Eigenvector Centrality (EC)	Amplitude of Low-Frequency Fluctuations (ALFF)
Key Advantages	Identifies globally influential hubs; Sensitive to subcortical regions [15]	Conceptually straightforward; Easily implemented [15]
Methodological Challenges	Computationally intensive; Difficult to relate to specific cognitive functions [15]	Sensitive to physiological noise and artifacts [15]
Temporal Dynamics	Can be computed statically or dynamically with sliding windows [47]	Typically static measure of activity magnitude
Relationship to Hormones	Linked to estrogen and progesterone fluctuations in hippocampus [15]	Associated with progesterone effects in caudate [15]

Experimental Evidence in Menstrual Cycle Research

Key Findings from Menstrual Cycle Studies

Research applying EC and ALFF to investigate menstrual cycle-related brain changes has revealed distinct patterns of neural modulation across different phases. In a comprehensive longitudinal study of 60 naturally cycling women, researchers observed heightened EC in the hippocampus during the luteal phase, when both estradiol and progesterone levels are elevated [15]. This finding suggests that the hippocampus assumes a more central role in global brain networks during high-hormone phases, potentially reflecting estrogen-dependent synaptic remodeling observed in animal studies [15]. Concurrently, ALFF analyses in the same cohort revealed increased oscillatory activity in the caudate nucleus during the luteal phase, which was specifically related to decreased estradiol and increased progesterone levels [15]. This pattern of subcortical modulation aligns with the known trophic effects of progesterone on basal ganglia structure and function [15]. These hormone-dependent alterations in network centrality and regional activity may underlie the behavioral, emotional, and sensorimotor changes that some women experience across their menstrual cycles, though often without overt changes in cognitive performance due to compensatory mechanisms [46].

Comparative Sensitivity to Hormonal Fluctuations

The differential sensitivity of EC and ALFF to distinct hormonal influences provides compelling evidence for their complementary nature in menstrual cycle research. EC measures appear particularly responsive to estrogen fluctuations, as evidenced by the increased hippocampal centrality during cycle phases characterized by higher estradiol levels [15] [46]. This estrogen-EC relationship may be mediated by estradiol's known effects on hippocampal spine density and synaptic plasticity mechanisms [15]. In contrast, ALFF measures show stronger associations with progesterone variations, particularly in striatal regions like the caudate that demonstrate increased low-frequency fluctuations during the luteal phase when progesterone peaks [15]. This progesterone-ALFF relationship in the basal ganglia corresponds with structural MRI studies showing progesterone-dependent gray matter volume increases in these regions [46]. The temporal dynamics of these metrics also differ, with EC changes potentially reflecting more stable network reorganization across phases, while ALFF alterations may represent more acute neuromodulatory effects on regional activity patterns.

Experimental Protocols and Methodologies

Standardized rs-fMRI Acquisition Parameters

To ensure reproducibility and valid comparison across menstrual cycle phases, consistent MRI acquisition parameters are essential. The typical protocol involves using a 3.0-Tesla Siemens or Philips scanner equipped with a 64-channel phased-array head coil [48]. For functional imaging, gradient echo-planar imaging (EPI) sequences are employed with the following standard parameters: repetition time (TR) = 2000-2500 ms, echo time (TE) = 30-35 ms, flip angle = 90°, field of view (FOV) = 216-220 mm, matrix size = 72×72, voxel size = 3×3×3 mm³, and 54-25 axial slices covering the whole brain [48] [49]. Approximately 200 volumes are acquired during an 8-10 minute resting-state scan where participants are instructed to remain awake with eyes closed, avoid systematic thinking, and minimize head movement [48]. High-resolution 3D T1-weighted anatomical images are also acquired for spatial normalization (voxel size = 0.87×0.87×1 mm³ to 1×1×1 mm³) [49]. These parameters optimize the balance between spatial and temporal resolution while maintaining adequate signal-to-noise ratio for detecting subtle hormone-related functional changes.

Core Data Preprocessing Pipeline

Table 3: Essential Preprocessing Steps for Menstrual Cycle rs-fMRI Studies

Processing Step	Implementation Details	Purpose in Menstrual Cycle Research
Discard Initial Volumes	Remove first 5-10 time points [48] [49]	Eliminate magnetic saturation effects and allow participant adaptation
Slice Timing Correction	Correct acquisition time differences between slices	Account for temporal misalignment of slice acquisition
Head Motion Correction	Realign volumes to a reference image; Exclude participants with >3mm translation or >3° rotation [48]	Minimize confounding effects of head movement, which may vary across cycle phases
Spatial Normalization	Warp individual brains to standard space (e.g., MNI) using T1 segmentation	Enable group-level analysis and cross-study comparisons
Nuisance Covariate Regression	Regress out white matter, CSF signals, and global mean signal [48]	Reduce non-neural physiological contributions to BOLD signal
Spatial Smoothing	Apply Gaussian kernel (FWHM = 4-6mm) [48] [49]	Improve signal-to-noise ratio and accommodate anatomical differences
Temporal Filtering	Bandpass filter (0.01-0.1 Hz) [48] [49]	Isolate low-frequency fluctuations of neural origin

Computational Implementation of EC and ALFF

For Eigenvector Centrality mapping, the fastECM toolbox (https://github.com/amwink/bias/tree/master/matlab/fastECM) provides a computationally efficient implementation that calculates EC without having to compute or store the entire connectivity matrix, instead using matrix-vector products to estimate centrality values [47]. This approach is typically applied to preprocessed rs-fMRI data within gray matter masks, with EC computed either statically across the entire time series or dynamically using sliding windows (e.g., 100 partially-overlapping windows of 100 time points each) to capture temporal variations in network centrality [47]. For ALFF calculation, the DPABI or REST toolboxes are commonly used to transform the preprocessed time series to the frequency domain via Fast Fourier Transform, compute the power spectrum, and then calculate the average square root within the 0.01-0.1 Hz frequency range [48] [49]. The resulting ALFF values are typically standardized by dividing by the global mean ALFF value to facilitate between-subject comparisons [49]. Both metrics undergo spatial smoothing (FWHM = 4-6mm) before statistical analysis to improve robustness [48].

Figure 1: Experimental Workflow for EC and ALFF Analysis in Menstrual Cycle Research

Table 4: Essential Materials and Tools for Menstrual Cycle Connectivity Research

Tool/Resource	Specification/Version	Primary Function
MRI Scanner	3.0-Tesla (Siemens/Philips) with 64-channel head coil	High-quality rs-fMRI data acquisition
Hormone Assay Kits	Salivary estradiol and progesterone immunoassays	Confirm menstrual cycle phase and hormone levels
Ovulation Tests	Commercial LH surge detection kits (e.g., Pregnafix)	Precisely time pre-ovulatory and luteal phase scans
Analysis Software	DPABI_V8.2, SPM12, fastECM toolbox	Data preprocessing, ALFF calculation, and centrality mapping
Standardized Atlases	Schaefer 100×7, Automated Anatomical Labeling (AAL)	Region-of-interest definition and cross-study comparison
Neuropsychological Scales	CES-D, GAD-7, PHQ-9, DRSP	Quantify behavioral, emotional, and premenstrual symptoms

Integrated Analysis and Interpretation Framework

The true power of combining EC and ALFF emerges when these metrics are interpreted within an integrated framework that accounts for their complementary insights into brain organization and function. In menstrual cycle research, this integrated approach reveals how hormonal fluctuations simultaneously alter both the hierarchical organization of brain networks (captured by EC) and the intensity of regional spontaneous activity (captured by ALFF). For instance, the observed increase in hippocampal EC during the luteal phase [15] coincides with literature showing estradiol-dependent structural plasticity in this region [46], suggesting that hormones may enhance the hippocampus's influence within global brain networks. Simultaneously, progesterone-mediated increases in caudate ALFF [15] may reflect heightened oscillatory activity in fronto-striatal circuits that could influence sensorimotor processing and habit formation during high-progesterone phases. This integrated perspective helps explain how ovarian hormones modulate brain function across multiple spatial scales, from local regional activity to global network architecture.

When applying this integrated framework to study OC users, researchers should consider how synthetic hormones in contraceptives might differentially affect these metrics compared to natural cycles. The consistent hormone environment created by OCs may reduce the cyclic fluctuations in both EC and ALFF observed in naturally cycling women, potentially leading to more stable network configurations and regional activity patterns. Alternatively, OCs might induce unique alterations in these metrics that reflect the different pharmacological profile of synthetic versus endogenous hormones. By systematically measuring both EC and ALFF across the cycle in OC users and naturally cycling controls, researchers can disentangle the distinct contributions of estrogen and progesterone to functional brain organization, while also clarifying how synthetic hormones modulate these relationships.

Eigenvector Centrality and Amplitude of Low-Frequency Fluctuations represent distinct but highly complementary approaches to quantifying functional brain organization in menstrual cycle research. While EC identifies influential network hubs that may shift their central positioning in response to hormonal fluctuations, ALFF detects changes in the intensity of regional spontaneous neural activity that likewise vary across cycle phases. The experimental evidence clearly demonstrates that these metrics capture different aspects of hormone-brain interactions, with EC being particularly sensitive to estrogen effects in the hippocampus and ALFF showing stronger associations with progesterone modulation of striatal regions. For researchers investigating the neural effects of oral contraceptives or natural menstrual cycles, employing both metrics within a standardized acquisition and processing pipeline provides a more comprehensive understanding of how ovarian hormones shape brain function across multiple spatial scales. This integrated approach holds significant promise for elucidating the neurobiological mechanisms underlying hormone-mediated changes in cognition, emotion, and behavior across the female lifespan.

The quest to understand the brain's complex functional architecture relies on leveraging the complementary strengths of multiple neuroimaging modalities. Functional magnetic resonance imaging (fMRI) provides high spatial resolution for localizing neural activity, while magnetoencephalography (MEG) offers unparalleled temporal resolution for capturing neural oscillations. Integrating these two modalities enables researchers to investigate brain function with both high spatial and temporal precision, creating a more complete picture of neural dynamics. This integration is particularly valuable in specialized research domains such as investigating resting-state functional connectivity changes across the menstrual cycle in oral contraceptive users, where subtle neurophysiological fluctuations require precise measurement. This guide objectively compares standalone and integrated approaches, presents experimental data, and provides detailed methodologies for researchers and drug development professionals seeking to implement these advanced multi-modal techniques.

Technical Comparison of fMRI and MEG

fMRI and MEG capture fundamentally different aspects of neural activity through distinct biophysical mechanisms. Understanding these differences is essential for effective experimental design and data interpretation in multi-modal studies.

Table 1: Fundamental Technical Characteristics of fMRI and MEG

Feature	fMRI	MEG
Primary Signal Source	Hemodynamic (Blood Oxygenation Level Dependent - BOLD) response [51]	Magnetic fields from neuronal electrical currents [51] [52]
Spatial Resolution	High (millimeter range) [51] [52]	Moderate (millimeter to centimeter range with source reconstruction) [51] [52]
Temporal Resolution	Low (seconds) due to hemodynamic delay [52]	High (milliseconds) [52]
Depth Sensitivity	Whole-brain coverage	Superior for superficial cortical sources [51]
Primary Frequency Bands	Not directly applicable	Theta (4-8 Hz), Alpha (8-13 Hz), Beta (15-30 Hz), Gamma (>30 Hz) [53] [51] [54]
Key Strengths	Excellent spatial localization, whole-brain coverage, widespread availability	Direct neural activity measurement, excellent temporal resolution, sensitivity to neural oscillations [51] [52]
Principal Limitations	Indirect neural measure, poor temporal resolution, susceptibility artifacts	Weaker spatial resolution for deep sources, complex source reconstruction, expensive instrumentation [52]

The BOLD signal measured by fMRI reflects changes in blood oxygenation that occur several seconds after neural events, providing an indirect metabolic correlate of neural activity rather than direct measurement [51]. In contrast, MEG directly detects magnetic fields generated by synchronized intraneuronal electrical currents with millisecond temporal precision, making it ideal for studying oscillatory dynamics across frequency bands from theta to gamma [53] [51].

Experimental Evidence for Modality Integration

Empirical Support for Multi-Modal Approaches

Direct comparisons of fMRI and MEG in the same subjects performing identical tasks demonstrate both convergence and complementarity between the modalities. In cognitive tasks such as picture naming, group-level activation patterns show fair convergence between MEG and fMRI, with both modalities identifying similar cortical regions including bilateral occipitotemporal cortex, parietal areas, and left inferior frontal and dorsal premotor regions [52]. However, systematic discrepancies often emerge, particularly at the individual subject level, highlighting the unique contributions of each modality [52].

Studies investigating the relationship between electrophysiological and hemodynamic signals have demonstrated that oscillatory fluctuations measured by MEG play a critical role in various brain functions, with specific frequency bands linked to distinct cognitive processes [51]. Theta-band activity (4-8 Hz) has been associated with memory processes, while beta-band oscillations (15-30 Hz) are modulated during sensorimotor tasks [51] [54]. These frequency-specific oscillatory patterns provide complementary information to the spatial activation maps generated by fMRI.

Advancements in Hardware Integration

The emergence of novel MEG technologies, particularly optically pumped magnetometer (OPM)-based systems, offers enhanced flexibility and signal strength compared to conventional superconducting quantum interference device (SQUID)-based MEG [51]. OPM sensors can be positioned closer to the scalp, improving signal quality and making them more adaptable for diverse populations, including pediatric applications [51]. These technological advances create new opportunities for more sophisticated fMRI-MEG integration paradigms.

Methodological Protocols for Multi-Modal Research

Experimental Design Considerations

Effective integration of fMRI and MEG requires careful experimental planning to accommodate the distinct technical requirements of each modality while ensuring task comparability across recording sessions.

Parallel Task Design: When collecting fMRI and MEG data in separate sessions, maintain identical stimulus presentation parameters, task timing, and behavioral response measures to ensure maximal comparability between datasets [52]. For cognitive tasks, this might involve using the same visual stimuli, response requirements, and block structures across both modalities.

Resting-State Protocols: For investigations of intrinsic brain connectivity, standardize resting-state acquisition parameters across modalities. Ensure consistent instruction to participants (e.g., "keep your eyes open and fixate on a cross"), session duration (typically 8-15 minutes), and environmental conditions to minimize non-neural sources of variance [53] [13].

Sensorimotor Paradigm: For studies targeting specific neural systems, implement task designs that robustly engage target networks. For example, a right-hand grasping task reliably activates the sensorimotor cortex and produces characteristic beta-band (15-30 Hz) oscillatory power decreases during movement followed by post-movement rebound [51]. This approach enables clear identification of modality-specific responses within the same functional system.

Table 2: Representative Experimental Findings Across Methodologies

Study Focus	fMRI Findings	MEG Findings	Integrated Insights
Menstrual Cycle Effects	Whole-brain dynamical complexity peaks in pre-ovulatory phase; hormone levels correlate with DMN, limbic, and attention network dynamics [13]	Lower median and peak alpha frequency during menstrual phase; reduced theta intensity in right temporal/limbic regions and gamma in left parietal areas [53]	Hormonal fluctuations systematically modulate both hemodynamic and electrophysiological properties of large-scale networks
Working Memory Encoding	Activation in dorsolateral prefrontal cortex, parietal areas, and inferior frontal gyrus during encoding [54]	Theta oscillatory activity (4-8 Hz) predicts successful encoding and correlates with memory performance [54]	Prefrontal-parietal network identified by fMRI shows time-locked theta synchronization during successful encoding
Visual Processing	Category-specific responses in ventral temporal cortex; hierarchical tuning along visual pathway [55]	Rapid sequential activation from occipital to temporal and frontal regions within 200-400ms [52]	Spatial localization from fMRI constrains temporal sequence of information processing from MEG

Data Acquisition Parameters

fMRI Acquisition: For BOLD imaging, use a multiband echo planar imaging sequence with TR=2s and multiband factor of 2 to optimize temporal resolution and whole-brain coverage [56]. Acquire high-resolution T1-weighted anatomical images (e.g., MPRAGE sequence) for precise spatial normalization and source reconstruction for MEG [56].

MEG Acquisition: Record neuromagnetic signals at a sampling rate of 1200 Hz or higher to adequately capture high-frequency oscillatory activity [56]. For OPM-MEG systems, ensure proper sensor positioning and calibration to maximize signal-to-noise ratio [51]. Simultaneously record electrooculogram and electrocardiogram to identify and remove artifacts associated with eye movements and cardiac activity.

Simultaneous EEG-fMRI: For truly simultaneous acquisition, use MRI-compatible EEG systems with appropriate artifact suppression techniques. Implement synchronization protocols to align temporal data across modalities, and carefully address gradient and pulse artifacts in the EEG data [54].

Analytical Approaches for Data Integration

Functional Connectivity Mapping

The choice of connectivity metric significantly influences the resulting functional network architecture. While Pearson's correlation remains the most common approach, benchmarking studies reveal substantial variation in network properties across different pairwise statistics [57].

Table 3: Functional Connectivity Metric Comparison

Metric Family	Temporal Characteristics	Key Applications	Performance Notes
Covariance/Correlation	Zero-lag linear dependence	General connectivity mapping; established analytic pipelines	Shows moderate inverse relationship with physical distance; widely validated [57]
Precision-Based	Partial correlation accounting for common network influences	Emphasis on direct connections; structure-function coupling	Highest correspondence with structural connectivity; identifies hubs in default and frontoparietal networks [57]
Spectral Measures	Frequency-specific coherence	Oscillatory coupling in specific bands	Shows mild-to-moderate correlation with most other measures; frequency-dependent sensitivity [57]
Information-Theoretic	Nonlinear and non-Gaussian dependencies	Complex dynamical interactions; information flow	Captures different mechanisms of information flow; complementary to linear methods [57]

Source Reconstruction and Spatial Alignment

For MEG data, implement anatomically constrained source reconstruction using each participant's T1-weighted structural MRI. The minimum norm estimate (MNE) approach provides distributed cortical activation maps, while beamformer methods (e.g., synthetic aperture magnetometry) offer improved spatial precision for focal sources [51] [52].

Advanced source localization techniques that project sensor-level power-spectrum ratios onto source space can improve accuracy for oscillatory activities [51]. This approach is particularly effective for localizing sensorimotor beta-band oscillations and visual gamma responses.

Integrated Data Analysis Frameworks

fMRI-Informed MEG Analysis: Use fMRI activation maps as spatial constraints for MEG source reconstruction to improve localization accuracy while preserving MEG's temporal resolution [52]. This approach is particularly valuable for distinguishing temporally overlapping but spatially distinct neural sources.

MEG-Informed fMRI Analysis: Incorporate MEG-derived temporal features as regressors in general linear models of fMRI data to identify brain areas whose BOLD responses correlate with specific oscillatory patterns [54]. For example, theta power time courses during working memory encoding can reveal networks that remain undetected using standard fMRI modeling approaches.

Dynamic Causal Modeling (DCM): Implement DCM to estimate effective connectivity between brain regions and how it is influenced by experimental manipulations. This framework can incorporate both fMRI and MEG data to infer directed influences between brain regions and their modulation by cognitive tasks or physiological states.

Application to Menstrual Cycle Research

The integration of fMRI and MEG offers particular promise for investigating how hormonal fluctuations across the menstrual cycle modulate brain dynamics. Research has demonstrated that the menstrual cycle significantly alters spontaneous neural oscillations, with quantitative MEG parameters showing lower median frequency and peak alpha frequency during the menstrual phase compared to other cycle phases [53]. Simultaneously, fMRI studies reveal that whole-brain dynamical complexity peaks during the pre-ovulatory phase, with significant hormone-mediated reorganization of default mode, control, and attention networks [13].

For studies including oral contraceptive users, multi-modal approaches can elucidate how synthetic hormones alter both the temporal dynamics (via MEG) and network organization (via fMRI) of brain activity compared to naturally cycling women. This is particularly relevant for drug development targeting hormone-sensitive neuropsychiatric conditions.

Figure 1: Multi-Modal Integration Framework for Menstrual Cycle Research

The Scientist's Toolkit: Essential Research Reagents

Table 4: Essential Materials and Analytical Tools for fMRI-MEG Studies

Item	Specification	Research Function
High-Density MEG System	275+ channels; CTF MEG or Elekta Neuromag systems [56]	Recording neuromagnetic signals with optimal spatial sampling
MRI Scanner	3T+ field strength; Siemens Prisma or comparable [56]	High-resolution BOLD and anatomical imaging
Structural Imaging Sequence	T1-weighted MPRAGE [56]	Precise anatomical reference for source reconstruction
Functional Imaging Sequence	Multiband EPI with TR≤2s [56]	BOLD signal acquisition with minimized temporal autocorrelation
Optically Pumped Magnetometers	OPM-MEG systems [51]	Enhanced flexibility and signal strength for specialized applications
Physiological Monitoring	EOG/ECG recording during MEG [53]	Artifact identification and removal
Hormonal Assay Kits	Salivary or serum E2/P4 measurements [13]	Objective cycle phase verification and hormone level quantification
Analytical Software Suite	SPM, FSL, MNE-Python, FieldTrip	Comprehensive data processing and statistical analysis
Connectivity Toolbox	PySPI or BrainConnectivityToolbox [57]	Implementation of diverse pairwise interaction statistics

Integrating fMRI and MEG provides researchers with a powerful multi-modal framework for investigating brain function across spatial and temporal domains. The complementary nature of these modalities enables comprehensive characterization of neural dynamics, from slow hemodynamic fluctuations to rapid oscillatory synchronization. For menstrual cycle research, this approach offers unique insights into how hormonal variations modulate both the spatial organization and temporal dynamics of brain networks. The continued refinement of integration methods, coupled with advancements in hardware technology and analytical techniques, promises to further enhance our understanding of brain function in health and disease across diverse physiological states.

Longitudinal vs. Cross-Sectional Designs for Tracking Hormonal Fluctuations

For researchers investigating how hormonal fluctuations affect the brain, particularly in the context of the menstrual cycle and oral contraceptive (OC) use, selecting an appropriate study design is fundamental. The choice between longitudinal and cross-sectional approaches fundamentally shapes the research questions that can be answered, the validity of the conclusions, and the resources required [58] [59]. This guide provides an objective comparison of these two designs, focusing on their application in studies of resting-state functional connectivity (rs-FC), the menstrual cycle, and OC effects. We present experimental data and methodologies to help researchers and drug development professionals select the optimal design for their specific scientific objectives.

Core Design Definitions and Comparative Framework

Fundamental Design Characteristics

In a cross-sectional study, researchers collect data from a population at a single point in time. This design provides a snapshot of society, comparing different groups (e.g., OC users vs. naturally cycling women) simultaneously [58] [59]. In contrast, a longitudinal study involves repeatedly collecting data from the same sample over an extended period, allowing researchers to observe changes within individuals, such as hormonal fluctuations across a menstrual cycle or changes following OC initiation [58] [59].

The table below summarizes the key operational differences:

Table 1: Fundamental Characteristics of Research Designs

Characteristic	Longitudinal Design	Cross-Sectional Design
Time Frame	Repeated observations over an extended period	Observations at a single point in time
Sample	Observes the same group multiple times	Observes different groups (a "cross-section")
Primary Output	Tracks changes within participants over time	Provides a snapshot of the population
Data Collection	Sequential, often resource-intensive	Simultaneous, generally more efficient

Visualizing Design Structures

The following diagram illustrates the fundamental structure and data collection patterns of longitudinal versus cross-sectional designs.

Application in Hormonal Fluctuation and Resting-State Connectivity Research

Direct Comparison of Strengths and Limitations

The choice between designs has profound implications for inferring cause-and-effect relationships and understanding temporal dynamics in endocrine neuroscience.

Table 2: Design Comparison for Hormone and Brain Connectivity Research

Research Consideration	Longitudinal Design	Cross-Sectional Design
Establishing Causality	More likely to suggest cause-and-effect relationships by establishing sequences of events [58].	Does not provide definite information about cause-and-effect relationships [58].
Tracking Change	Detects developments or changes at both group and individual level [58].	Cannot track within-individual change; infers change from group differences.
Hormonal Fluctuation	Ideal for characterizing within-person hormone changes (e.g., across menstrual cycle) [60] [61].	Compares hormone levels between different groups (e.g., OC users vs. non-users) [28].
Resource Requirements	Time-consuming, expensive, higher risk of participant attrition [58].	Can be done more quickly and cost-effectively [58].
OC Use & Brain Changes	Can measure neural changes before and after OC initiation [62].	Compares brain structure/function in existing OC users vs. non-users [28] [62].

Experimental Evidence and Data Outputs

Both designs have generated critical insights, as demonstrated by the following experimental data.

Table 3: Experimental Data from Published Studies

Study Design	Hormonal/Brain Measure	Key Finding	Experimental Data
Longitudinal [60]	LH, FSH, SHBG, AMH across menopausal transition	LH and FSH increased until ~5 and 7 years postmenopause, then declined.	Multilevel models from 1,608 women with 4,037 repeated measures.
Longitudinal [61]	Cognitive performance across menstrual cycle	Women performed better in working memory and attention during pre-ovulatory vs. menstrual phase.	42 women tested twice; Digit span backwards max (p=0.02), TMT-B (p=0.01).
Cross-Sectional [28]	Emotion recognition & amygdala connectivity in OC users	Androgenic vs. anti-androgenic OC users showed differential emotion recognition and brain-behavior associations.	72 participants (20 men, 32 OC users, 20 naturally cycling women).
Cross-Sectional [62]	rs-FC of ACC and amygdala in HC users	rs-FC of amygdalae with frontal areas decreased with longer HC exposure.	231 healthy young women; seed-based connectivity analysis.

Detailed Experimental Protocols

Longitudinal Protocol for Menstrual Cycle Research

A combined longitudinal and cross-sectional study by cited researchers provides a robust methodological blueprint [61].

Population: 71 healthy young adults (42 women, 29 men) aged 20-36. Hormone Assessment: Blood samples analyzed for estradiol, progesterone, and testosterone via electrochemiluminescence immunoassay (ECLIA). Cognitive Testing: Standardized tests for attention, processing speed, working memory, and visuospatial abilities. Longitudinal Component: Women tested twice: during menstrual (low-estradiol) and pre-ovulatory (high-estradiol) phases. Cross-Sectional Component: Men tested once; comparison of men vs. women at each menstrual phase. Analysis: Two analytical strategies: 1) within-subject comparison of women across phases, 2) between-group comparison across three groups (menstrual women, pre-ovulatory women, and men).

Cross-Sectional Protocol for OC and Brain Connectivity

A cross-sectional investigation into hormonal contraceptives and salience network connectivity exemplifies this approach [62].

Population: 231 healthy young women from five different MRI studies, including OC users and naturally cycling women. HC Exposure: Duration of HC use recorded; progestin type classified by androgenicity (androgenic vs. anti-androgenic). MRI Acquisition: T1-weighted structural images and resting-state functional MRI (rs-fMRI) scans. Image Analysis: Focus on ACC and amygdala using: (i) gray matter volume, (ii) fractional amplitude of low-frequency fluctuations (fALFF), and (iii) seed-based connectivity during resting state. Statistical Analysis: Investigation of the relationship between HC use duration and brain measures, controlling for progestin androgenicity.

Research Reagent Solutions and Essential Materials

Table 4: Essential Research Materials for Hormonal and Neuroimaging Studies

Research Tool	Function/Application	Example Use Case
Electrochemiluminescence Immunoassay (ECLIA)	Quantitative measurement of reproductive hormones (e.g., estradiol, progesterone, testosterone) in blood samples.	Hormone level verification in menstrual cycle phase studies [61].
Resting-State fMRI (rs-fMRI)	Assesses functional connectivity between brain regions in the absence of an explicit task.	Investigating intrinsic network organization changes related to OC use [62].
Roche Elecsys Modular Analytics Cobas e411	Automated immunoassay system for measuring FSH, LH, SHBG using electrochemiluminescence.	Hormone assessment in large cohort studies [60].
T1-weighted MPRAGE Sequence	High-resolution structural MRI for assessing brain volume and morphology.	Measuring hippocampal volume changes across the menstrual cycle [63].
Seed-Based Connectivity Analysis	Computational method to map functional connections from a specific "seed" brain region.	Quantifying connectivity between amygdala and frontal areas in OC users [62].
Multilevel Models (MLM)	Statistical approach for analyzing repeated measures data, accounting for within-subject correlations.	Modeling hormone changes over time in longitudinal designs [60].

Integrated Analysis and Decision Framework

Visualizing the Research Decision Pathway

The following diagram outlines a logical framework for selecting the appropriate research design based on study goals and constraints.

Synthesis for Resting-State Connectivity Research

For research on resting-state functional connectivity in menstrual cycle and OC users, the integrated evidence suggests:

Cross-sectional designs efficiently identify neural correlates associated with different hormonal states (e.g., OC users vs. naturally cycling women) and can explore relationships between cumulative HC exposure duration and brain connectivity [62]. However, they cannot determine whether observed differences are pre-existing or caused by the hormonal state.

Longitudinal designs are necessary to establish that hormonal changes precede and potentially cause alterations in brain connectivity. They are ideal for mapping the natural trajectory of rs-FC changes across the menstrual cycle [61] or for measuring the direct impact of initiating OC use on the brain [62].

The most rigorous approach, when feasible, is a combined longitudinal and cross-sectional design [61], which allows researchers to simultaneously track within-individual changes over time while maintaining the ability to compare distinct population groups. This design offers the most comprehensive understanding of how hormonal fluctuations, whether endogenous or pharmaceutical, modulate brain network dynamics.

Best Practices for Participant Grouping and Hormonal Verification

In resting-state functional connectivity (RS-fMRI) research, particularly studies involving the menstrual cycle and oral contraceptive (OC) users, rigorous participant grouping and hormonal verification are paramount. These studies investigate how fluctuations in endogenous hormones (e.g., estradiol and progesterone) across the menstrual cycle, or the introduction of synthetic hormones via OCs, influence the brain's intrinsic functional organization [64] [15]. Inconsistent findings in the literature often stem from inadequate methodological control of hormonal status, underscoring the need for standardized, best-practice protocols [15]. This guide objectively compares common methodologies for participant grouping and hormonal verification, providing researchers with a framework to enhance the reliability and interpretability of their findings.

Participant Grouping Criteria

Accurate classification of participants into distinct hormonal groups is the foundational step. The following table summarizes the key criteria for grouping naturally cycling women and oral contraceptive users.

Table 1: Criteria for Participant Grouping in Hormonal RS-fMRI Studies

Group	Key Grouping Criteria	Common Verification Methods	Methodological Notes & Challenges
Naturally Cycling (Follicular Phase)	• Days 1-14 of cycle (approx.) [64]• Low progesterone-to-estradiol ratio [64] [65]	• Self-reported cycle day [64]• Urinary luteinizing hormone (LH) surge detection [66]• Serum/urinary hormone level quantification [66] [15]	• Cycle length variability requires adjustment (e.g., counting from next expected period) [64].• The follicular phase is characterized by a low Pg/E2 ratio, not just absolute days [64].
Naturally Cycling (Luteal Phase)	• Days 15-28 of cycle (approx.) [64]• High progesterone-to-estradiol ratio [64] [65]	• Self-reported cycle day [64]• Urinary pregnanediol glucuronide (PdG) rise post-LH peak [66]• Serum/urinary hormone level quantification [66] [15]	• The luteal phase is defined by a high Pg/E2 ratio [64].• Confirmation of ovulation via PdG rise is critical to distinguish from anovulatory cycles [66].
Oral Contraceptive Users	• Continuous use of combined estrogen-progestin pills [67] [68]• Age of onset (Pubertal vs. Adult-onset) is a critical factor [67] [68]• Duration of use should be documented	• Self-reported pill use and prescription verification [68]	• Pill type (androgenic vs. anti-androgenic) can influence findings and should be recorded [68].• Pubertal-onset use is associated with altered FC in salience and other networks compared to adult-onset [67].

Advanced Considerations for Grouping

Beyond basic grouping, several factors significantly impact functional connectivity outcomes and must be considered in study design:

• Pubertal vs. Adult-Onset OC Use: The brain is particularly sensitive to hormonal organization during puberty. Research shows that women who began OC use during puberty exhibit heightened functional connectivity in the salience network compared to those who started in adulthood, highlighting the long-term, organizing effects of synthetic hormones during critical developmental windows [67] [68].
• Exclusion Criteria: To control for confounding variables, studies typically exclude individuals with irregular menstrual cycles, peri- or post-menopausal status, current pregnancy or lactation, use of hormone-altering medications other than OCs, and current psychiatric or neurological diagnoses [64].
• Cycle Phase Verification: Relying solely on self-reported cycle days is a common source of error. The gold standard involves biochemical confirmation. For example, the luteal phase can be verified by a rise in urinary PdG, a metabolite of progesterone, following an LH peak [66]. One study validated a method where a specific PdG threshold confirmed ovulation with 100% specificity, providing a clear, objective marker [66].

Hormonal Verification Methods

Selecting an appropriate method for quantifying hormone levels is crucial for accurate group assignment and for exploring hormone-brain-behavior relationships. The table below compares common analytical techniques.

Table 2: Comparison of Hormonal Verification and Assay Methods

Method	Principle	Key Metrics	Advantages	Disadvantages
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) [65]	Separates and detects hormones based on mass-to-charge ratio.	Selectivity, specificity, sensitivity, linearity, recovery, decision limit (CCα) [65].	• High specificity and sensitivity [65]• Can detect multiple hormones simultaneously [65]• Does not require derivatization, reducing analysis time and error [65]	• Expensive instrumentation [65]• Requires technical expertise [65]• Can be subject to matrix effects in complex samples [65]
Enzyme-Linked Immunosorbent Assay (ELISA) [66]	Uses antibodies and colorimetric detection to quantify hormones.	Coefficient of variation (CV), recovery percentage, correlation with gold standard [66].	• Widely accessible and relatively low-cost [66]• High-throughput capability [66]• Well-established protocols	• Potential for antibody cross-reactivity [69]• May have a narrower dynamic range than LC-MS/MS [66]
Immunoassay-Based Home Kits (e.g., Inito) [66]	Lateral flow assays with smartphone-based quantitative readout.	CV, recovery percentage, correlation with ELISA [66].	• Enables high-frequency, at-home sampling [66]• Provides quantitative data and visual trend tracking [66]• User-friendly	• Accuracy must be rigorously validated against lab-based methods [66]• May have limitations in detection range [66]
Receptor Binding Assays [69]	Measures the ability of a compound to bind to a specific hormone receptor.	Half-maximal inhibitory concentration (IC50) [69].	• Directly measures receptor interaction [69]• Useful for screening hormonally active agents [69]	• Cannot distinguish between agonists and antagonists [69]• Does not account for in vivo pharmacokinetics [69]

Method Validation and Selection

Regardless of the chosen method, validation is essential. Key parameters include accuracy (how close a measurement is to the true value), precision (reproducibility of measurements, often reported as Coefficient of Variation or CV), and sensitivity (lowest detectable amount) [66] [65]. For example, one study validated a novel smartphone-connected reader, reporting an average CV of less than 6% for urinary E3G, PdG, and LH measurements, demonstrating high precision for a home-use device [66].

No single assay is perfect for all scenarios. The choice depends on the research question, required precision, sample type (serum, urine, saliva), budget, and throughput needs. The trend is toward quantitative, longitudinal hormone profiling to capture dynamic patterns rather than single time-point measurements [66].

Analytical Considerations for RS-fMRI Data

Once participants are correctly grouped and hormonal status is verified, specific analytical strategies for RS-fMRI data can help isolate hormone-related effects.

• Addressing Motion and Confounds: Motion artifact is a major confound in RS-fMRI. Participant-level de-noising pipelines must be carefully selected. Global signal regression (GSR) minimizes the motion-connectivity relationship but introduces distance-dependent artifact. Censoring methods (e.g., "scrubbing") mitigate both motion and distance-dependence but use more degrees of freedom. The choice involves a trade-off and should align with specific scientific goals [70].
• Multimodal Analysis Approach: Hormonal fluctuations may elicit subtle changes that affect different aspects of brain dynamics. A hypothesis-driven, multimodal analysis focusing on regions of high functional relevance (e.g., hippocampus, striatum) is recommended. This can include:
  • Independent Component Analysis (ICA): To identify intrinsic connectivity networks (ICNs) like the Default Mode Network [15] [45].
  • Amplitude of Low-Frequency Fluctuations (ALFF): To measure spontaneous local oscillatory activity [15].
  • Eigenvector Centrality Mapping (ECM): To assess a region's importance within the global network hierarchy [15].
  • Seed-Based Connectivity: To examine temporal correlations between a pre-defined seed region and the rest of the brain [15] [45].

Integrated Experimental Protocol

Below is a detailed methodology synthesizing best practices for a RS-fMRI study comparing menstrual cycle phases.

Aim: To investigate differences in resting-state functional connectivity between the follicular and luteal phases of the menstrual cycle.

Participants:

• Recruit naturally cycling, premenopausal women.
• Exclusion Criteria: Irregular cycles, hormonal contraceptive use, current pregnancy/lactation, psychiatric/neurological disorders, other substance dependence [64].

Procedure:

• Initial Screening: Determine typical cycle length (26-30 days is often required) and history [64].
• Longitudinal Tracking: Participants self-report cycle days and use urinary ovulation kits (e.g., LH tests) at home to estimate the day of ovulation [66].
• Session Scheduling:
  • Follicular Phase Session: Schedule between days 5-9 after onset of menses [64].
  • Luteal Phase Session: Schedule approximately 7 days after a detected LH surge [66].
• Biochemical Verification: On the scan day, collect a first-morning urine sample. Analyze for E3G, PdG, and LH using a validated quantitative method (e.g., ELISA or LC-MS/MS) to confirm the expected hormonal profile for the phase [66] [15].
• RS-fMRI Acquisition: Acquire T1-weighted structural images and approximately 5-15 minutes of resting-state BOLD fMRI data while participants fixate on a crosshair, letting their minds wander [71] [45].
• Post-Scan Report: Use standardized interviews or questionnaires to retrospectively assess participants' ongoing experiences during the scan (e.g., drowsiness, specific thoughts), as these can influence functional connectivity metrics [71].

Data Analysis:

• Preprocessing: Implement a rigorous preprocessing pipeline for fMRI data, including motion correction, normalization, and band-pass filtering (typically 0.01-0.08 Hz) [45].
• Denoising: Apply a participant-level de-noising strategy, such as censoring of high-motion volumes, to mitigate motion artifacts [70].
• Connectivity Analysis: Employ a multimodal analytical approach:
  • Use ICA to identify major resting-state networks (e.g., Default Mode, Salience, Executive Control) [15] [45].
  • Conduct seed-based analysis using a priori regions of interest (e.g., dorsal Anterior Cingulate Cortex, hippocampus) based on hypotheses [64] [15].
  • Calculate ALFF/ECM in subcortical regions like the caudate and putamen, which are sensitive to hormonal fluctuations [15].
• Statistical Analysis: Compare connectivity strength and network metrics between the follicular and luteal phase groups, using hormonal levels (e.g., Pg/E2 ratio) as covariates in the models.

The Scientist's Toolkit

Table 3: Essential Reagents and Materials for Hormonal RS-fMRI Research

Item	Function/Application	Example/Notes
LC-MS/MS System [65]	Gold-standard for simultaneous, highly specific quantification of multiple hormones in biological samples.	Used for validating other assays and for high-precision hormone measurement in serum/urine [65].
Validated ELISA Kits [66]	Accessible and reliable quantification of specific hormones (e.g., E2, Pg, LH) in serum, urine, or saliva.	Kits for urinary PdG and E3G are available and can be correlated with serum levels [66].
Quantitative Home Hormone Monitor [66]	Enables high-frequency, longitudinal hormone profiling in a participant's natural environment.	Devices like the Inito Fertility Monitor measure urinary E3G, PdG, and LH, providing fertile window and ovulation data [66].
Luteinizing Hormone (LH) Urine Tests	Detects the LH surge that precedes ovulation, critical for pinpointing the start of the luteal phase.	Standard over-the-counter ovulation prediction kits.
fMRI Preprocessing Software	Handles motion correction, normalization, and filtering of raw BOLD data.	Examples: SPM, FSL, AFNI, CONN toolbox [45].
Independent Component Analysis (ICA) Tool	Data-driven decomposition of RS-fMRI data to identify intrinsic connectivity networks (ICNs).	MELODIC tool in FSL [45].
Seed-Based & ALFF Analysis Tools	For hypothesis-driven connectivity analysis and measuring local spontaneous brain activity.	Available in toolboxes like REST, DPARSF [45].

Addressing Inconsistencies and Optimizing Research Protocols

Resolving Contraditory Findings in Menstrual Cycle RS-fMRI Literature

Resting-state functional magnetic resonance imaging (rs-fMRI) has emerged as a powerful tool for investigating intrinsic brain organization, providing insights into the large-scale neural networks that underlie human cognition and behavior. Within the context of a broader thesis on resting-state functional connectivity in menstrual cycle research, particularly concerning oral contraceptive (OC) users, understanding the impact of naturally cycling hormonal fluctuations is fundamental. The menstrual cycle, characterized by dynamic changes in estradiol and progesterone levels, offers a unique natural model for examining how sex hormones modulate brain connectivity [13]. However, the existing literature presents contradictory findings, with some studies reporting significant cycle-dependent connectivity changes while others find minimal effects. This review systematically compares these conflicting results, examines the methodological sources of variation, and provides a framework for reconciling discrepancies through standardized experimental protocols and analytical approaches.

Comparative Analysis of Key Studies and Findings

Table 1: Summary of Conflicting Study Findings on Menstrual Cycle RS-fMRI

Study Reference	Sample Size	Cycle Phases Studied	Key Positive Findings	Key Null Findings	Methodological Approach
Hidalgo-Lopez et al., 2020 [15]	60 women	Early follicular, pre-ovulatory, mid-luteal	• ↓ DMN-right angular gyrus connectivity in luteal phase• ↑ Eigenvector centrality for hippocampus in luteal phase• ↑ ALFF for caudate in luteal phase• ↑ Putamen-thalamic connectivity in luteal phase• ↑ Fronto-striatal connectivity in pre-ovulatory phase	None reported	ROI-based multimodal analysis (ICA, eigenvector centrality, ALFF, seed-based)
Hjelmervik et al., 2014 [72] [14]	16 women, 15 men	Menstrual, follicular, luteal	Sex differences in two fronto-parietal networks with women showing higher functional connectivity	No menstrual cycle effects on resting states in fronto-parietal networks	Independent component analysis focused on fronto-parietal networks
Hidalgo-Lopez et al., 2024 [13]	60 women	Early follicular, pre-ovulatory, mid-luteal	• Pre-ovulatory phase showed highest whole-brain dynamical complexity• Early follicular showed lowest dynamical complexity• Large-scale network reconfiguration across cycle phases	None reported	Dynamic intrinsic ignition framework measuring metastability
Syan et al., 2020 (Schizophrenia study) [73]	13 patients, 13 controls	Early follicular, mid-luteal	Specific hormone-network correlations: progesterone with DMN and fronto-parietal networks in controls	No cycle phase-related alterations in RS-FC in either group	Seed-based connectivity and network analysis

Quantitative Comparison of Methodological Parameters

Table 2: Experimental Design and Methodological Variations Across Studies

Study Parameter	Hidalgo-Lopez et al. (2020)	Hjelmervik et al. (2014)	Hidalgo-Lopez et al. (2024)	Pletzer et al. (2016)
Sample Size	60	16 women	60	32 scans (single subject)
Design Type	Longitudinal	Longitudinal	Longitudinal	Longitudinal (single subject)
Cycle Verification	Hormonal assessment	Subjective reporting + saliva samples	Hormonal assessment	Hormonal assessment
Analytical Method	Multimodal (ICA, EC, ALFF, seed-based)	Independent component analysis	Dynamic intrinsic ignition	Eigenvector centrality mapping
Networks/Regions	Hippocampus, caudate, putamen, DMN	Fronto-parietal networks	Whole-brain, 8 resting-state networks	Dorsolateral prefrontal cortex, sensorimotor cortex
Primary Outcome	Subcortical functional connectivity changes	Network stability across cycle	Dynamical complexity (metastability)	Progesterone-correlated connectivity changes

Methodological Protocols in Menstrual Cycle RS-fMRI Research

Standardized Experimental Workflow

The following diagram illustrates a comprehensive methodological workflow for menstrual cycle rs-fMRI studies, integrating best practices from the reviewed literature:

Hormonal Signaling Pathways in Brain Connectivity Modulation

The following diagram illustrates the proposed neurobiological mechanisms through which hormonal fluctuations influence functional connectivity:

The Scientist's Toolkit: Essential Research Reagents and Materials

Table 3: Key Research Reagent Solutions for Menstrual Cycle RS-fMRI Studies

Reagent/Material	Specification	Research Function	Example Application
3T MRI Scanner	Siemens MAGNETOM Vida, Philips Achieva, GE Discovery	High-field magnetic resonance imaging for BOLD signal acquisition	Standardized rs-fMRI data collection across participants [48]
Hormonal Assay Kits	Estradiol, progesterone, LH ELISA kits	Quantitative verification of menstrual cycle phases	Confirming hormonal levels corresponding to presumed cycle phase [15] [13]
Data Processing Software	DPABI, FSL, SPM, CONN, AFNI	Preprocessing and analysis of rs-fMRI data	Implementing standardized preprocessing pipelines [48]
Connectivity Toolboxes	CONN toolbox, GIFT (ICA), BCT (Graph Theory)	Specialized analysis of functional connectivity measures	Calculating network metrics (eigenvector centrality, ALFF) [15]
Physiological Monitoring	Pulse oximeter, respiratory belt, EEG	Monitoring physiological confounds during scanning	Recording physiological data for nuisance regression [48]
Head Motion Stabilization	Foam padding, custom head molds	Minimizing head movement artifacts	Reducing motion-related variance in BOLD signal [15]

Critical Analysis of Contradictory Findings

The contradictory findings in menstrual cycle rs-fMRI literature can be largely attributed to several methodological factors:

Analytical Approach Variations: Studies employing different analytical methods show varying sensitivity to cycle effects. Hidalgo-Lopez et al. (2020, 2024) utilized multimodal and dynamic approaches that detected significant subcortical and whole-brain changes [15] [13], whereas Hjelmervik et al. (2014) used ICA focused solely on fronto-parietal networks and found no cycle effects [72]. This suggests that menstrual cycle impacts may be network-specific, with subcortical and default mode networks showing greater sensitivity to hormonal fluctuations.

Sample Size and Statistical Power: Studies with larger sample sizes (N=60) consistently detect significant effects [15] [13], while smaller studies (N=16) report null findings [72]. This indicates that menstrual cycle effects on functional connectivity may be subtle and require adequate statistical power for detection.

Cycle Phase Definition and Verification: The method of cycle phase determination significantly impacts results. Studies using hormonal verification [15] [13] detect more consistent effects compared to those relying on self-report [72]. Individual variability in cycle length and hormonal profiles necessitates biochemical confirmation of cycle phases.

Temporal Dynamics Analysis: Traditional static connectivity approaches may miss cycle-related changes that manifest as dynamic temporal fluctuations. The dynamic intrinsic ignition framework employed by Hidalgo-Lopez et al. (2024) revealed significant phase differences in whole-brain metastability that static approaches might not capture [13].

Reconciling the Evidence: A Proposed Framework

Based on the comparative analysis, menstrual cycle effects on resting-state functional connectivity appear to be:

• Regionally Specific: Strongest effects observed in subcortical regions (hippocampus, basal ganglia) and specific cortical networks (DMN), with less consistent effects in fronto-parietal control networks [15] [72].

• Hormonally Mediated: Progesterone appears particularly influential during the luteal phase, affecting hippocampus, caudate, and putamen connectivity [15] [20], while estradiol fluctuations impact whole-brain dynamical complexity, peaking in the pre-ovulatory phase [13].

• Analytically Dependent: Detection of cycle effects depends heavily on methodological approach, with multimodal and dynamic analyses revealing changes that simpler approaches might miss.

• Behaviorally Relevant: The observed connectivity changes likely underlie documented behavioral, emotional, and sensorimotor fluctuations across the menstrual cycle [15], though more research is needed to establish direct brain-behavior relationships.

The contradictory findings in menstrual cycle rs-fMRI literature largely reflect methodological differences rather than genuine biological inconsistencies. When appropriate methodologies are employed—including adequate sample sizes, hormonal verification of cycle phases, and multimodal analytical approaches—consistent patterns of hormone-dependent functional connectivity changes emerge. Future research in this field, particularly studies comparing naturally cycling women with OC users, should adopt these standardized methodologies to ensure reliable and comparable results. The reconciliation of these apparent contradictions advances our understanding of sex hormone effects on brain function and provides a more solid foundation for investigating menstrual cycle-related disorders and hormonal contraceptive effects on brain connectivity.

Resting-state functional connectivity (RSFC) research has become a cornerstone for understanding the intrinsic organization of the human brain. Investigations into how the menstrual cycle and oral contraceptive (OC) use influence RSFC hold significant promise for elucidating sex-specific neurobiological processes. However, the validity of this research is critically dependent on the rigorous control for key confounding variables. This guide objectively compares the impact of three major confounding factors—tobacco use, psychiatric conditions, and menstrual cycle irregularity—on experimental outcomes in menstrual cycle and OC RSFC studies. We summarize supporting experimental data and provide detailed methodologies to aid researchers, scientists, and drug development professionals in designing robust and interpretable studies.

Comparative Data on Confounding Factors

The table below summarizes the documented effects of tobacco use, psychiatric conditions, and menstrual cycle irregularity on menstrual function and brain-related outcomes, highlighting their potential as confounders in neuroimaging research.

Table 1: Impact of Key Confounding Factors on Menstrual and Neurophysiological Measures

Confounding Factor	Documented Effects on Menstrual Function	Documented Effects on Brain & Behavior	Key Supporting Findings
Tobacco Use	Shortened menstrual cycle length [74]; Increased cycle variability [74]; Shorter follicular phase [74]	Increased emotional distress during late luteal phase [75]; Altered tobacco demand across cycle [75]; Modulates link between biological rhythm and mental health [76]	Heavy smoking (≥20 cigs/day) associated with ~4x risk of short cycles (<25 days) [74].
Psychiatric Conditions	Significant association with shorter cycle length (≤28 days) [77]; Association with lifetime disorders in Caucasians [77]	Altered HPG axis function [77]; Potential bidirectional influences on course of illness [77]	Shorter cycles linked to 1.5-2x greater risk of current/lifetime affective, anxiety, and substance use disorders [77].
Cycle Irregularity	N/A (Primary variable)	Associated with lower likelihood of current anxiety disorder [77]; Altered HPG axis dynamics [77]	Women with irregular cycles were less than half as likely to have a current anxiety disorder [77].

Detailed Experimental Protocols

To ensure the replicability of findings and proper control of confounders, this section outlines the key methodological details from foundational studies in this domain.

Table 2: Summary of Key Experimental Protocols from Cited Literature

Study Focus	Participant Characteristics & Screening	Menstrual Cycle / OC Phase Verification	Key Data Collection Methods & Instruments
RSFC in NC & OC Users [32] [11]	N=91; Age 18-40; No psychiatric/neurological/endocrine disorders; No hormonal contraception (last 3 months) for NC group; ≥3 months OC use for OC group [32].	NC: Follicular (days 2-6), Luteal (days 18-24) via self-report. OC: Active pills (days 11-17), Inactive pills (days 2-6) [32]. Salivary hormones assayed [32].	fMRI: Resting-state scan. Analysis: Independent Component Analysis (ICA) targeting aDMN and ECN [32] [11].
Psychiatric Disorders & Menstrual Characteristics [77]	N=628; Pregnant, Medicaid-eligible; Mean age 22.2 years [77].	Menstrual length and regularity assessed by retrospective self-report [77].	Diagnosis: Diagnostic Interview Schedule IV (DIS-IV). Analysis: Logistic regression controlling for race [77].
Smoking Abstinence & Menstrual Phase [78]	N=147; Premenopausal smokers; Regular cycles (24-36 days); Stable mental/physical health; No recent MDD or lifetime PMDD [78].	Follicular (days 2-7) vs. Luteal (2-7 days post LH surge); Urinary luteinizing hormone (LH) test for luteal phase; Crossover design [78].	Smoking Status: Ad libitum smoking (2 days) followed by verified abstinence (4 days). Symptomatology: Daily self-report measures. Biochemical Verification: Carbon monoxide, salivary cotinine, plasma nicotine [78].
Emotional Distress & Tobacco Demand [75]	N=32; Daily female smokers; Not on hormonal contraception; Normal cycles [75].	Phase categorization: Follicular (estradiol-dominant), Early-Mid Luteal (progesterone-dominant), Late Luteal (decreasing hormones) via self-report [75].	Assessments: Negative Affect (PANAS), Emotion Dysregulation (DERS), Distress Tolerance (DTS). Tobacco Demand: Hypothetical Cigarette Purchase Task (CPT). Timing: Demand assessed ~60 min post-smoking [75].

Signaling Pathways and Conceptual Workflows

The following diagrams illustrate the proposed neuroendocrine pathways through which these confounding factors may influence resting-state brain networks and the recommended workflow for controlling them in experimental design.

Neuroendocrine Pathways of Confounding Factors

Experimental Control Workflow

The Scientist's Toolkit: Essential Research Reagents & Materials

This table details key reagents and instruments critical for conducting and controlling studies in this field.

Table 3: Essential Research Reagents and Materials for Menstrual Cycle RSFC Studies

Item Name	Function/Application	Specific Usage Example
Salivary Hormone Immunoassay Kits	To non-invasively measure concentrations of steroid hormones (e.g., estradiol, progesterone).	Verification of menstrual cycle phase (low E2/P4 in early follicular; high P4 in luteal) and confirmation of hormonal suppression in OC users [32].
Urinary Luteinizing Hormone (LH) Kits	To detect the pre-ovulatory LH surge for precise pinpointing of ovulation and the luteal phase.	Ensuring accurate timing of luteal phase testing in crossover studies, e.g., testing 2-7 days post-LH surge [78].
Structured Clinical Interviews (e.g., DIS-IV, SCID)	To provide standardized, reliable diagnosis of current and lifetime psychiatric disorders based on DSM/ICD criteria.	Screening out participants with current disorders or characterizing the sample's psychiatric history as a key confounding variable [77].
Carbon Monoxide (CO) Monitor & Salivary Cotinine Assays	To biochemically verify smoking status and adherence to abstinence protocols.	Differentiating between ad libitum smoking and abstinence phases; confirming self-reported smoking status [78].
Resting-State fMRI Acquisition Sequences	To measure spontaneous, low-frequency fluctuations in the BOLD signal for functional connectivity analysis.	Mapping intrinsic brain networks like the Default Mode Network (DMN) and Executive Control Network (ECN) [32] [11].
Independent Component Analysis (ICA) Software	A data-driven method to identify spatially independent networks from resting-state fMRI data.	Isolating and comparing the functional connectivity of specific networks (e.g., DMN, ECN) across experimental groups [32] [11].

Standardizing the definition of menstrual cycle phases is a critical prerequisite for generating reliable and reproducible research, particularly in studies investigating resting-state functional connectivity (rs-fc) in naturally cycling women versus oral contraceptive (OC) users. The inherent hormonal fluctuations of the natural cycle are known to modulate brain network dynamics [13] [15], and a lack of precise, consistent criteria for phase stratification can lead to inconsistent findings and hinder cross-study comparisons. This guide objectively compares the established and emerging methodologies for defining cycle phases, providing researchers with a clear framework for experimental design in neuroendocrine and drug development research.

Comparative Analysis of Phase Definition Criteria

A comparison of the primary methods used to define menstrual cycle phases reveals a trade-off between precision, cost, and participant burden.

Table 1: Comparison of Menstrual Cycle Phase Definition Methods

Method	Key Parameters Measured	Follicular Phase Criteria	Ovulatory Phase Criteria	Luteal Phase Criteria	Key Advantages & Limitations
Gold-Standard Hormonal Assay [79] [13]	Serum Estradiol (E2), Progesterone (P), Luteinizing Hormone (LH)	Low E2 and P levels.	LH surge peak, E2 peak.	High P levels (often >5 ng/mL [13]), moderate E2.	Advantage: High accuracy, quantitative. Limitation: Invasive, expensive, requires multiple blood draws.
Urinary Hormone Kits	Urinary Luteinizing Hormone (LH)	Not typically defined.	Detection of urinary LH surge.	Not typically defined.	Advantage: Excellent for pinpointing ovulation. Limitation: Only identifies peri-ovulatory window.
Basal Body Temperature (BBT) [80] [81]	Waking Body Temperature	Lower, stable temperatures.	Not directly detected.	Sustained temperature shift (>0.2°C) for 10-13 days [81].	Advantage: Inexpensive, simple. Limitation: Retrospective, confounded by sleep/timing.
Calendar/Rhythm Method [81]	Cycle Day & Duration	Early Follicular: Days 1-5 [13]. Pre-Ovulatory: ~Days 10-13 [13].	Assumed at ~Day 14 in a 28-day cycle.	Mid-Luteal: ~7 days after ovulation [13].	Advantage: Low burden. Limitation: Highly inaccurate, ignores inter-/intra-individual variation [81].
Novel Digital Biomarkers [80]	Circadian Rhythm Nadir Heart Rate (minHR)	Algorithm-based classification using minHR and cycle day.	Algorithm-based prediction.	Algorithm-based classification using minHR and cycle day.	Advantage: Robust to sleep timing vs. BBT, objective. Limitation: Requires proprietary devices/algorithms.

Experimental Protocols for Phase Verification

Detailed methodologies are crucial for replicating phase-definition in scientific studies. Below are protocols from key neuroimaging studies.

Protocol 1: Multimodal Hormonal and Calendar-Based Verification

This protocol, adapted from a whole-brain dynamics study, uses a combination of methods to ensure phase accuracy [13].

• Participant Screening: Recruit naturally cycling women with regular cycles (e.g., 23-38 days [13]) and no hormonal medication. Exclude for pregnancy, lactation, menopause, or psychiatric/neurological disorders.
• Cycle Monitoring: Participants self-report cycle start date. Cycle length is confirmed over at least one prior cycle.
• Phase Calculation:
  • Early Follicular Phase: Scanning occurs on cycle days 1-5, characterized by menses and low progesterone levels [13].
  • Pre-Ovulatory Phase: Scanning is scheduled around cycle day 10-13, timed for the late follicular phase before the LH surge [13].
  • Mid-Luteal Phase: Scanning is scheduled for approximately 7 days after a detected ovulation (e.g., via urinary LH kit) or based on a calendar estimate (e.g., cycle day 17-24) [13].
• Hormonal Validation: On the scanning day, serum samples are collected and analyzed for estradiol and progesterone. Data is often excluded if hormone levels do not match the expected phase profile (e.g., low progesterone in the mid-luteal phase) [13].

Protocol 2: Hormone-Only Verification for rs-fc Studies

This method, used in ROI-based menstrual cycle research, prioritizes direct hormonal measurement for phase classification [15].

• Blood Sampling & Assay: A single blood sample is collected immediately before the fMRI scan.
• Phase Assignment via Hormone Levels: Phase is defined purely by hormone concentration thresholds, without calendar-based estimation:
  • Pre-Ovulatory Phase: Characterized by high estradiol levels.
  • Luteal Phase: Characterized by high progesterone levels [15].
• Data Analysis: Functional connectivity measures (e.g., eigenvector centrality, ALFF) are then correlated with the absolute levels of estradiol and progesterone.

Methodological Impact on Resting-State Functional Connectivity Findings

The choice of phase definition criteria directly impacts the observed neural outcomes, contributing to heterogeneity in the literature.

• Calendar Method Limitations: Relying solely on cycle day leads to misclassification. A large database study showed the mean follicular phase length is 16.9 days, with a 95% CI of 10-30 days, meaning ovulation (and the start of the luteal phase) can occur from cycle day 10 to 30 [81]. Scanning a woman on cycle day 21 based on a 28-day cycle model could capture her in the late follicular, ovulatory, or mid-luteal phase, fundamentally confounding rs-fc measurements.
• Hormonal Verification Precision: Studies using hormonal verification consistently detect phase-specific rs-fc changes. For example, one study found that compared to the luteal phase, the follicular phase shows decreased connectivity between the dorsal anterior cingulate cortex (dACC) and regions like the ventral striatum, which was inversely correlated with attentional bias to smoking cues [64]. Another found the pre-ovulatory phase exhibits the highest whole-brain dynamical complexity [13], while the luteal phase shows heightened eigenvector centrality in the hippocampus and increased ALFF in the caudate [15].

Standardization Workflow for Phase Definition. This diagram outlines the decision paths for different methodological fidelity levels, highlighting the increased risk of misclassification with the calendar method.

The Scientist's Toolkit: Essential Reagents & Materials

Table 2: Key Research Reagents and Solutions for Phase Definition Studies

Item	Function in Research	Example Application
Enzyme-Linked Immunosorbent Assay (ELISA) Kits	Quantify serum or salivary concentrations of steroid (estradiol, progesterone) and gonadotropic (LH, FSH) hormones.	Used for gold-standard hormonal verification of menstrual cycle phase prior to or during fMRI sessions [13] [15].
Urinary Luteinizing Hormone (LH) Test Strips	Detect the urinary LH surge, which precedes ovulation by 24-48 hours.	Pinpointing the ovulatory event to accurately schedule pre-ovulatory or post-ovulatory (luteal) scanning sessions [81].
High-Precision Digital Thermometers	Measure waking Basal Body Temperature (BBT) with high resolution (e.g., 0.01°C).	Tracking the biphasic temperature shift to retrospectively confirm ovulation and luteal phase onset [80] [81].
Wearable Digital Sensors	Continuously monitor physiological parameters (e.g., heart rate, skin temperature) during sleep.	Used in novel algorithms (e.g., circadian rhythm nadir heart rate) to classify cycle phases under free-living conditions [80].
fMRI Phantom Test Tools	Ensure calibration and signal fidelity of the MRI scanner.	Critical for maintaining measurement consistency across multiple scanning sessions in longitudinal rs-fc cycle studies [64] [13].

Hormonal Signaling in the Menstrual Cycle. This diagram illustrates the core hypothalamic-pituitary-ovarian (HPO) axis feedback loops, showing how hormone levels regulate phase transitions and endometrial changes.

Standardizing the definition of menstrual cycle phases is not a mere technicality but a fundamental aspect of research quality. Gold-standard hormonal verification, while burdensome, provides the highest fidelity data and is recommended for studies where neural effect sizes are expected to be subtle. Emerging digital biomarkers offer a promising, objective, and less invasive alternative, especially for larger-scale studies. The consistent application of rigorous phase criteria is the cornerstone for advancing our understanding of how ovarian hormones modulate brain network dynamics and for developing targeted interventions in women's health.

The study of oral contraceptives (OCs) has evolved beyond mere contraceptive efficacy to encompass their broad physiological and neurological impacts. A growing body of research examines how OC formulations, particularly their progestin components, modulate brain function and resting-state networks. The synthetic progestins within combined oral contraceptives (COCs) are not interchangeable; they possess distinct chemical structures, receptor binding affinities, and androgenic properties that can influence their clinical profiles and neurological effects. This guide systematically compares progestin types—gestodene (GSD), desogestrel (DSG), drospirenone (DRSP), and levonorgestrel (LNG)—by analyzing experimental data on their clinical performance and safety. Furthermore, it situates these findings within emerging research on resting-state functional connectivity in OC users, providing a framework for researchers and drug development professionals to account for formulation-specific effects in experimental design and interpretation.

Progestin Classification and Androgenic Activity

Progestins are synthetic compounds that mimic the action of natural progesterone and are structurally categorized based on their parent hormone [82] [83].

• Progesterone Derivatives: Also known as pregnanes, these include medroxyprogesterone acetate and nomegestrol acetate [82].
• Testosterone Derivatives: The majority of progestins used in contraceptives belong to this group. They are further subdivided based on their specific structure and androgenic potential [82]:
  • Estranes (e.g., norethindrone, norethindrone acetate) have more androgenic activity [82].
  • Gonanes (e.g., levonorgestrel, desogestrel, norgestimate, gestodene) generally have less androgenic activity than estranes [82]. Drospirenone is a unique gonane derived from spironolactone and possesses anti-androgenic and anti-mineralocorticoid properties [82] [84].

The androgenic activity of a progestin is a critical differentiator. Androgenic progestins act as agonists at the androgen receptor, while anti-androgenic progestins (e.g., drospirenone, dienogest) bind selectively to the progesterone receptor or act as androgen receptor antagonists [28] [84]. This distinction is crucial as it underlies many of the metabolic, dermatological, and potentially neurological differences observed between formulations.

Comparative Efficacy and Safety Profile of Common Progestins

A 2025 network meta-analysis of 18 randomized controlled trials directly compared the performance of four common progestins in COCs [85] [86]. The findings are summarized in the table below.

Table 1: Comparative Clinical Outcomes of Progestins in Combined Oral Contraceptives (Network Meta-Analysis) [85] [86]

Progestin	Breakthrough Bleeding (OR, 95% CI)	Irregular Bleeding (OR, 95% CI)	Contraceptive Efficacy Ranking (SUCRA)	Adverse Event Ranking (SUCRA)
Gestodene (GSD)	0.41 (0.26, 0.66)	0.67 (0.52, 0.86)	3rd (SUCRA not specified)	4th (Highest AE rate)
Desogestrel (DSG)	Not statistically significant	Not statistically significant	1st (51.3%)	3rd
Drospirenone (DRSP)	Not statistically significant	Not statistically significant	2nd	1st (66.9%)
Levonorgestrel (LNG)	Not statistically significant	Not statistically significant	4th (Least effective)	2nd

Key Clinical Implications from Comparative Data

• Gestodene (GSD) demonstrates superior cycle control, with a statistically significant lowest incidence of breakthrough and irregular bleeding, attributed to its potent anti-ovulatory effects and strong progesterone receptor binding [85]. However, it was associated with the highest rate of adverse events [85] [86].
• Desogestrel (DSG) is recommended for routine contraception due to its balanced profile, ranking highest for contraceptive efficacy with good specificity for progesterone receptors [85].
• Drospirenone (DRSP) offers the most favorable safety profile with the lowest adverse event rate, linked to its anti-androgenic and anti-mineralocorticoid properties which mitigate androgenic side effects like acne and hirsutism [85] [84].
• Levonorgestrel (LNG), while less optimal for routine cycle control, remains the gold-standard for emergency contraception due to its rapid onset and well-established pharmacokinetics [85].

Experimental Protocols for Assessing Progestin Effects on Brain Function

Research into how OCs, particularly their progestin components, affect the brain relies on sophisticated neuroimaging techniques. Below is a detailed methodology from a key study investigating resting-state functional connectivity (RSFC).

Protocol: Investigating Resting-State Functional Connectivity in OC Users and Naturally Cycling Women

Objective: To determine the effects of menstrual cycle phase and oral contraceptive use on the intrinsic functional architecture of the brain, specifically within cognitive and affective networks [11].

Participant Groups: The study included four hormonally distinct groups to disentangle the effects of endogenous and synthetic hormones [11]:

• Naturally Cycling - Follicular Phase: Characterized by low endogenous levels of estrogen and progesterone.
• Naturally Cycling - Luteal Phase: Characterized by high endogenous levels of estrogen and progesterone.
• OC Users - Active Pill Phase: Characterized by the presence of synthetic hormones and suppressed endogenous hormones.
• OC Users - Inactive Pill Phase: Characterized by low synthetic and low endogenous hormones.

Hormone Assays: Salivary levels of estradiol and progesterone were measured to confirm hormonal status in all participants [11].

fMRI Data Acquisition:

• Scan Type: Resting-state functional MRI (rs-fMRI).
• Procedure: Participants were instructed to keep their eyes closed, remain awake, and not focus on any particular thought.
• Parameters: Using a 3T MRI scanner, T2*-weighted functional images were acquired to measure Blood-Oxygen-Level-Dependent (BOLD) signals over time [11].

Data Preprocessing and Analysis:

• Preprocessing: Standard steps included realignment, normalization to a standard stereotactic space, and spatial smoothing.
• Seed-Based Correlation Analysis: The primary analysis method.
  • Seeds: Regions of interest (ROIs) were defined in the anterior Default Mode Network (aDMN) and the Executive Control Network (ECN).
  • Connectivity Calculation: For each participant, the time series of BOLD signals from the seed region was extracted. The correlation between this time series and the time series of every other voxel in the brain was computed, creating a functional connectivity map for each seed [11].
• Group Comparison: Statistical models (e.g., ANOVA) were used to compare functional connectivity strength between the four participant groups.

Diagram: Experimental Workflow for Resting-State Functional Connectivity Study

Mechanisms of Action: From Receptors to Neural Networks

The physiological and neurological effects of progestins are mediated through a complex network of receptors. Understanding this signaling is key to interpreting OC formulation effects.

Diagram: Progestin Signaling Pathways and Neurological Modulation

The diagram illustrates that progestins exert their effects through multiple receptor systems [84]:

• Nuclear Receptors (nPR): Mediate slow genomic actions, leading to transcriptional changes and classic physiological effects like endometrial transformation [84].
• Membrane Receptors (mPR, PGRMC1): Mediate rapid non-genomic signaling, influencing neuroprotection, synaptic function, and cell cycle processes [84]. Altered connectivity in OC users has been observed in networks subserving these functions, such as the executive control network (ECN) [11].
• Mitochondrial Receptors (PR-M): Regulate energy production, which may underlie progesterone-dependent increases in basal body temperature [84].

Critically, the androgenic properties of a progestin can moderate its action at these receptors. For example, androgenic progestins may blunt the anti-anxiety effects typically associated with progesterone, while anti-androgenic progestins may promote them. These differential interactions likely contribute to the findings that androgenic and anti-androgenic OC users show distinct brain-behavior associations, particularly in amygdala connectivity and emotion recognition [28].

The Scientist's Toolkit: Key Reagents and Materials

Table 2: Essential Research Materials for Hormonal Contraceptive and Neuroimaging Studies

Item	Specific Example / Type	Research Function
Salivary Hormone Kits	Salivary estradiol, progesterone	Confirm participant hormonal status (e.g., follicular vs. luteal phase) without the need for blood draws [11].
3T MRI Scanner	Philips, Siemens, or GE 3T scanners	High-field magnetic resonance imaging system for acquiring resting-state BOLD signals with sufficient spatial and temporal resolution [11].
fMRI Analysis Software	SPM, FSL, CONN	Software packages for preprocessing, analyzing, and visualizing functional connectivity data from rs-fMRI experiments [11].
Standardized Cognitive Tasks	Emotion Recognition Task (ERT)	Behavioral paradigm to assess functional correlates of hormonal manipulation on emotion processing; often used alongside neuroimaging [28].
Defined Progestin Formulations	COCs with androgenic (e.g., LNG) vs. anti-androgenic (e.g., DRSP) progestins	Critical independent variable for isolating the effect of progestin type and androgenicity on physiological and neurological outcomes [28].
Cochrane Risk of Bias Tool (RoB 2.0)	N/A	Standard tool for assessing methodological quality and risk of bias in randomized controlled trials included in systematic reviews and meta-analyses [85].

The Impact of Small Sample Sizes and Statistical Power on Reproducibility

In neuroscience and clinical research, the reliability of scientific findings is fundamentally intertwined with statistical power, which is primarily determined by sample size. A study with low statistical power not only has a reduced chance of detecting a true effect but also substantially reduces the likelihood that a statistically significant result reflects a true effect [87]. This power failure phenomenon has profound implications for research reproducibility, particularly in complex fields such as resting-state functional connectivity in menstrual cycle and oral contraceptive (OC) users research. Empirically, estimates indicate the median statistical power of studies in the neurosciences is alarmingly low, between approximately 8% and 31% [87] [88]. This low power leads to overestimates of effect size and low reproducibility of results, creating an ethical dimension to the problem as unreliable research is inefficient and wasteful [87].

The consequences of low statistical power extend beyond individual study limitations to affect entire research domains. When studies are underpowered, the literature becomes contaminated with unreliable findings, making it difficult to distinguish true effects from statistical artifacts. This is particularly problematic in resting-state functional connectivity research involving menstrual cycle phases and OC users, where effect sizes may be modest and sample recruitment challenging. The resulting reproducibility crisis undermines scientific progress and wastes valuable research resources that could be better allocated to sufficiently powered studies [87].

Quantitative Impact of Sample Size on Research Outcomes

Statistical Power and Its Consequences for Research Reliability

Table 1: Consequences of Low Statistical Power in Neuroscience Research

Aspect	Impact of Low Power	Empirical Evidence
Detection of True Effects	Reduced chance of detecting true effects	Median power in neuroscience: 8-31% [87]
Interpretation of Significant Results	Reduced likelihood that statistically significant results reflect true effects	Positive predictive value decreases substantially with low power [87]
Effect Size Estimation	Overestimation of effect size magnitude	Underpowered studies show inflated effect sizes [87] [88]
Reproducibility	Low reproducibility of results	High failure rate in replication attempts [87]
Research Efficiency	Inefficient and wasteful use of resources	Ethical concerns regarding research conduct [87]

The relationship between sample size and statistical power follows a predictable mathematical pattern, yet its implications are often underestimated in practice. Statistical power represents the probability that a study will detect an effect when there is a genuine effect to be detected. As sample size decreases, power diminishes exponentially rather than linearly, creating a scenario where modest reductions in sample size can dramatically increase the likelihood of both false positives and false negatives [89]. This problem is compounded by the fact that low power also reduces the likelihood that a statistically significant result reflects a true effect, fundamentally undermining the interpretation of research findings [87].

The ethical dimensions of this problem are significant. Underpowered research represents an inefficient allocation of scarce scientific resources, including funding, personnel time, and participant involvement. Perhaps more importantly, it can lead to misleading conclusions that may influence future research directions or even clinical applications [87]. In the context of resting-state functional connectivity research on menstrual cycle and OC users, these methodological weaknesses can propagate through the literature, creating false leads and confusing patterns of results that hinder genuine scientific progress.

Power Analysis in Resting-State Functional Connectivity Research

Table 2: Sample Size and Power Considerations in Functional Connectivity Studies

Research Context	Sample Size Characteristics	Power Implications
Menstrual Cycle & OC Research	Divided into multiple groups (follicular, luteal, active/inactive OC)	Between-group comparisons suffer from reduced power due to subgroup splitting [32] [11]
Rare Disease Drug Development	Inherently small populations	Traditional statistical approaches often cannot be used; innovative methods required [90] [91]
Behavioral Neuroscience	Small sample sizes common	Can maintain power by reducing chance levels and increasing trials per subject [92]
fMRI Studies	Often limited by cost and practicality	Low power leads to inflated effect sizes and reduced reproducibility [87] [93]

In resting-state functional connectivity research, particularly studies investigating menstrual cycle phases and OC users, sample size challenges are exacerbated by the need to divide participants into multiple groups. A typical study design might include four hormonally distinct groups: early follicular naturally-cycling women, luteal naturally-cycling women, OC users during the inactive week of pill use, and OC users during the active phase of pill use [32] [11]. This partitioning effectively reduces the sample size for each comparison, dramatically lowering statistical power unless the overall sample is substantially increased.

Research by Desachy et al. (2025) demonstrates that statistical power in behavioral neuroscience can be enhanced without necessarily increasing sample sizes through specific methodological adjustments: reducing the probability of succeeding by chance (chance level), increasing the number of trials used to calculate subject success rates, and employing statistical analyses suited for discrete values [92]. These principles can be adapted to functional connectivity research to improve power within practical constraints.

Case Study: Resting-State Functional Connectivity in Menstrual Cycle and OC Users Research

Experimental Protocols and Methodologies

A representative study by researchers at the University of California, Irvine investigated whether and to what extent resting state functional connectivity is modulated by sex hormones in women, both across the menstrual cycle and when altered by oral contraceptive pills [32] [11]. The experimental protocol involved:

Participant Recruitment and Screening: Participants were recruited from the university student population and surrounding community (N=91 after exclusions). Exclusion criteria included: age under 18 or over 40; history of drug or alcohol abuse; psychiatric, endocrine, or neurological disorders; epilepsy; strokes; brain tumors; current pregnancy or breastfeeding; irregular periods; left-handedness; or non-removable metal implants [32].

Group Assignment and Hormonal Verification: Participants were divided into four hormonally distinct groups: (1) early follicular naturally-cycling women (n=20, scanned during cycle days 2-6), (2) luteal naturally-cycling women (n=25, scanned during days 18-24), (3) OC users during inactive pill week (n=22, scanned during days 2-6 of inactive pill use), and (4) OC users during active pill phase (n=24, scanned during days 11-17 of active pill use) [32] [11]. Salivary progesterone and 17β-estradiol assays were performed using commercially available immunoassay kits to verify hormonal status.

fMRI Data Acquisition and Analysis: Resting-state data were collected using fMRI. Participants were instructed to keep their eyes open during scanning. Data were pre-processed, and two subjects were excluded for excessive head motion (>4mm or 4 degrees). Independent Components Analysis (ICA) was used to evaluate differences in resting state activity between groups, focusing on the default mode network (DMN) and executive control network (ECN) [32].

Key Findings and Sample Size Considerations

The study revealed that resting state dynamics were altered both by the menstrual cycle and by oral contraceptive use [11]. Specifically, the connectivity of the left angular gyrus, the left middle frontal gyrus, and the anterior cingulate cortex were different between groups. These regions are important for higher-order cognitive and emotional processing, including conflict monitoring, suggesting potential consequences for attention, affect, and emotion regulation [32] [11].

Despite these important findings, the sample size limitations must be acknowledged. With approximately 20-25 participants per group, the study had limited power to detect small to moderate effects. This limitation is common in fMRI research due to the high costs and practical challenges of data collection. The researchers addressed this by focusing on specific networks (DMN and ECN) rather than conducting whole-brain analyses, thereby reducing the multiple comparisons problem but potentially missing effects in other networks [32].

A subsequent study by Menting-Henry et al. (2022) further explored these relationships with a sample of 72 participants (20 men, 20 naturally cycling women, 16 users of androgenic contraceptives, 16 users of anti-androgenic contraceptives) [93]. This research found that sex and oral contraceptive use emerged as a moderator of brain-behavior associations, with anti-androgenic OC users showing strong brain-behavior associations, usually in the opposite direction as naturally cycling women [93]. The inclusion of male participants provided a valuable comparison group but further divided the limited sample size across more conditions.

Strategies for Enhancing Statistical Power in Connectivity Research

Methodological Improvements for Power Enhancement

Table 3: Strategies to Enhance Power in Small Sample Neuroscience Research

Strategy	Mechanism	Application Example
Reduce Chance Level	Increases sensitivity to detect true effects by lowering random success probability	Behavioral tasks with lower guessing probability [92]
Increase Trial Numbers	Improves reliability of individual participant measures	More trials per condition in fMRI paradigms [92]
Use Appropriate Discrete Analyses	Better suited for categorical data common in behavioral measures	Statistical methods designed for success rate data [92]
Adaptive Trial Designs	Allows modifications during trial without additional approvals	FDA-supported adaptive designs for clinical trials [94]
Composite Endpoints	Combines multiple clinically relevant outcomes	Global tests combining patient-level or endpoint data [91]
Leverage RWE/RWD	Informs trial design using real-world evidence	Using real-world data to optimize study parameters [90] [94]

Several innovative approaches can enhance statistical power without necessarily increasing sample sizes, addressing the fundamental challenges in resting-state functional connectivity research. Desachy et al. (2025) developed "SuccessRatePower," a power calculator based on Monte Carlo simulations that accounts for specialized aspects of experimental designs evaluating success rates [92]. Their work demonstrates that statistical power can be substantially increased by: (1) reducing the probability of succeeding by chance (chance level), (2) increasing the number of trials used to calculate subject success rates, and (3) employing statistical analyses suited for discrete values [92].

In the context of rare disease drug development, where small sample sizes are unavoidable, additional strategies have been developed. These include using innovative statistical endpoints, designs, and analysis methods; creating composite endpoints or multiple primary endpoints to fully capture clinically relevant outcomes; and applying global tests that combine tests at the patient level or across endpoints [90] [91]. These approaches recognize that traditional methods relying on large sample statistics often cannot be used due to inherent sample size limitations.

Statistical Approaches for Small Sample Research

Advanced statistical approaches offer promising avenues for enhancing power in small sample research. Adaptive clinical designs are gaining momentum as developers look for ways to make trials more efficient [94]. According to FDA guidance, "in some cases, an adaptive design can provide a greater chance to detect a true drug effect (i.e., greater statistical power) than a comparable non-adaptive design" [94]. Such designs are particularly beneficial for sponsors by enabling more efficient trials and for patients by reducing exposure to trials that would be unlikely to benefit them.

Bayesian methods represent another powerful approach for small sample research. These computationally intensive simulations allow analysts to explore different design schemes and make informed decisions about optimal trial designs [94]. When combined with expert statistical and regulatory guidance, these approaches can maintain scientific rigor while acknowledging the practical constraints of research involving specialized populations or expensive methodologies like fMRI.

The Scientist's Toolkit: Essential Research Reagents and Materials

Table 4: Essential Research Materials for Resting-State Connectivity Studies

Research Material	Function/Application	Example from Literature
Salivary Immunoassay Kits	Hormonal verification for participant grouping	Salimetrics progesterone and 17β-estradiol assays [32]
fMRI-Compatible Equipment	Data acquisition without magnetic interference	Standard fMRI scanners with appropriate head coils [32] [93]
Independent Components Analysis Software	Identification of functional networks from resting-state data	ICA analysis of DMN and ECN networks [32] [11]
Power Analysis Tools	Sample size estimation and power calculation	G*Power 3; SuccessRatePower for behavioral tasks [92]
Motion Correction Algorithms	Minimize artifacts from participant movement	Exclusion of subjects with >4mm or 4 degrees motion [32]
Hormonal Contraceptive Documentation	Accurate characterization of OC type and regimen	Classification into androgenic vs. anti-androgenic progestins [93]

The reliability of resting-state functional connectivity research depends not only on appropriate statistical approaches but also on precise methodological implementation. Several key research materials are essential for maintaining quality and consistency across studies in this domain. Salivary immunoassay kits provide crucial verification of hormonal status, ensuring that participant groups are accurately categorized according to menstrual cycle phase or OC use [32]. This biochemical confirmation is essential for validating the experimental manipulation and ensuring that observed effects genuinely relate to hormonal status rather than misclassification.

Specialized software for independent components analysis enables researchers to identify and analyze specific functional networks from resting-state fMRI data. In menstrual cycle and OC research, focused examination of networks such as the default mode network and executive control network provides a targeted approach that can enhance statistical power by reducing multiple comparisons [32] [11]. Similarly, specialized power analysis tools, including both general programs like G*Power 3 and domain-specific tools like SuccessRatePower for behavioral tasks, help researchers optimize their experimental designs within practical constraints [92].

The impact of small sample sizes on statistical power and reproducibility represents a critical challenge in resting-state functional connectivity research, particularly in studies investigating menstrual cycle phases and oral contraceptive users. The inherently limited sample sizes in these specialized research areas necessitate careful methodological planning and innovative statistical approaches to maintain scientific rigor. By implementing power-enhancing strategies such as reducing chance levels, increasing trial numbers, using appropriate discrete analyses, and employing adaptive designs, researchers can improve the reliability and reproducibility of their findings without necessarily expanding sample sizes.

The broader scientific community must recognize that underpowered research not only produces unreliable results but also represents an ethical concern through its inefficient use of resources and potential to generate misleading conclusions. Moving forward, researchers in resting-state functional connectivity should prioritize power considerations in their study designs, clearly report power limitations in their publications, and continue to develop and implement innovative methodologies that enhance statistical power within practical constraints. Through these concerted efforts, the field can advance toward more reproducible and reliable findings that genuinely illuminate the complex relationships between hormonal status, brain connectivity, and cognitive function.

Clinical Validation and Comparative Effects Across Populations

Hormonal Connectivity Changes in Clinical Populations (e.g., Schizophrenia)

The study of resting-state functional connectivity (rsFC) has unveiled significant insights into the neurobiology of schizophrenia, revealing a complex interaction between sex hormones and brain network organization. Sex differences in schizophrenia prevalence, onset age, symptom profiles, and treatment response have long been observed, with males exhibiting earlier onset and more severe negative symptoms [95]. The estrogen protection hypothesis posits that estrogen may exert protective effects against schizophrenia, potentially explaining why women often demonstrate later onset and better prognosis [95] [96]. These hormonal effects extend beyond estrogen to include progesterone and testosterone, each contributing to the modulation of neural circuits relevant to psychotic disorders [95]. This review synthesizes current evidence on how hormonal fluctuations across the menstrual cycle and hormonal contraceptive use influence functional brain connectivity in schizophrenia, with implications for targeted therapeutic interventions.

Hormonal Influences on Brain Connectivity: Key Findings

Table 1: Hormonal Effects on Functional Connectivity in Clinical and Non-Clinical Populations

Hormonal Condition	Neural Connectivity Changes	Associated Clinical Symptoms	Research Population
Low Estrogen Phase (Menstrual)	↓ Default Mode Network connectivity; ↑ symptom severity [95] [97]	Exacerbation of psychotic symptoms; higher hospitalization rates [95]	Women with schizophrenia [95]
High Estrogen Phase (Follicular)	↑ Prefrontal connectivity; tighter network coherence [10]	Reduced symptom severity; improved cognitive control [95] [72]	Naturally cycling women [10]
High Progesterone Phase (Luteal)	↑ Hippocampal eigenvector centrality; ↑ caudate ALFF; ↑ putamen-thalamic connectivity [15]	Potential protective effects against symptom exacerbation [95] [64]	Naturally cycling women [15]
Oral Contraceptive Use	↓ Brain network modularity; ↓ characteristic path length; blunted DMN connectivity [10] [93]	Altered emotion recognition; potential mood effects [10] [93]	Healthy OC users [10] [93]
Hormonal Therapy (Raloxifene)	Not explicitly measured in studies, but improved cognitive symptoms [96]	Improvement in positive, negative, and cognitive symptoms [96]	Schizophrenia patients (especially postmenopausal) [96]

Menstrual Cycle Phase and Connectivity in Schizophrenia

The menstrual cycle exerts profound effects on functional brain organization, with significant implications for schizophrenia symptomatology. During the low estrogen menstrual phase, women with schizophrenia experience worsening of psychotic symptoms, a phenomenon supported by increased psychiatric admissions during this period [95]. Research indicates a negative correlation between estrogen levels and antipsychotic medication requirements, suggesting that estrogen may enhance treatment response [95]. Neuroimaging studies reveal that the premenstrual phase is associated with decreased functional connectivity in networks critical for cognitive control and emotional regulation, potentially underlying symptom exacerbation [95] [64].

By contrast, the high estrogen follicular phase is characterized by enhanced network coherence and stronger within-network connectivity, particularly in prefrontal regions implicated in cognitive control [10]. This phase corresponds with reduced symptom severity and improved medication efficacy in women with schizophrenia [95]. The luteal phase, characterized by elevated progesterone, demonstrates increased subcortical-cortical connectivity, including heightened eigenvector centrality in the hippocampus and increased amplitude of low-frequency fluctuations (ALFF) in the caudate [15]. These neurophysiological changes may contribute to the neuroprotective effects observed during this phase, potentially mitigating symptom severity [95] [64].

Oral Contraceptive Effects on Brain Networks

Oral contraceptive (OC) use significantly alters intrinsic brain connectivity patterns, with potential implications for women with schizophrenia. Combined OCs suppress endogenous hormone production, creating a stable hormonal environment similar to the early follicular phase [10] [93]. Neuroimaging research reveals that OC users exhibit reduced brain modularity and decreased characteristic path length, indicating a less segregated network architecture compared to naturally cycling women [10]. The default mode network (DMN) shows blunted connectivity patterns in OC users, particularly during mid-cycle when estrogen fluctuations would normally enhance DMN reorganization [10].

The androgenic profile of progestins in OCs further modulates their neurobiological impact. Androgenic OCs produce connectivity patterns and emotion recognition profiles more similar to naturally cycling women, whereas anti-androgenic OCs generate distinct patterns, often in the opposite direction [93]. These findings highlight the importance of considering OC formulation when evaluating brain connectivity in women with schizophrenia, particularly given the potential for OCs to be used as adjunctive treatments for hormonal stabilization.

Experimental Protocols and Methodologies

Resting-State fMRI in Hormonal Research

Table 2: Key Methodological Approaches in Hormonal Connectivity Research

Methodological Approach	Primary Application	Key Metrics	Advantages
Independent Component Analysis (ICA)	Identification of intrinsic connectivity networks (ICNs)	Network spatial maps; temporal correlation	Data-driven; no prior ROI selection; reliable network identification [15]
Seed-Based Connectivity	Hypothesis-driven FC analysis from predefined regions	Correlation coefficients between seed and voxels	Straightforward interpretation; comprehensible results [15]
Amplitude of Low-Frequency Fluctuations (ALFF)	Measurement of spontaneous neural activity	Power within 0.01-0.08 Hz range	Characterizes local oscillatory activity; easily implemented [15]
Eigenvector Centrality Mapping	Assessment of node importance in global network	Influence measure based on connections	Identifies hub regions; sensitive to subcortical areas [15]
Graph Theory Analysis	Quantification of whole-brain network organization	Modularity, characteristic path length, system segregation	Reveals global network architecture; relates to information processing [10]

Resting-state fMRI protocols for investigating hormonal effects require careful methodological consideration. Data acquisition typically involves 5-10 minute scans during eyes-open or eyes-closed resting conditions, with instructions to remain awake and let thoughts pass freely [64]. Preprocessing pipelines include motion correction, normalization to standard space, band-pass filtering (0.01-0.1 Hz), and regression of nuisance signals (white matter, cerebrospinal fluid, motion parameters) [98]. For menstrual cycle studies, phase verification is critical through hormone assays (estradiol, progesterone) or cycle tracking applications [15] [64].

Longitudinal designs with repeated measures across cycle phases provide the most robust evidence for hormonal effects on connectivity. The "28andMe" project exemplifies this approach with daily scanning across a complete natural cycle and a subsequent OC cycle [10]. For clinical populations with schizophrenia, medication status must be carefully documented, particularly given that antipsychotics can induce hyperprolactinemia, which interferes with endogenous hormone production [95].

Signaling Pathways and Experimental Workflow

Diagram 1: Hormonal Modulation of Brain Connectivity in Schizophrenia

The Scientist's Toolkit: Essential Research Reagents and Materials

Table 3: Essential Research Materials for Hormonal Connectivity Studies

Research Tool Category	Specific Examples	Research Application	Key Considerations
Hormonal Assays	ELISA kits for estradiol, progesterone, testosterone; salivary vs. serum collection	Verification of cycle phase; correlation with connectivity measures	Timing relative to cycle; assay sensitivity; method standardization [15] [64]
Neuroimaging Phantoms	fMRI head phantoms; motion simulation platforms	Quality control; scanner calibration; motion artifact assessment	Signal stability across longitudinal sessions; multicenter consistency [98]
Data Processing Software	FSL, AFNI, SPM, CONN, DPABI	Preprocessing and analysis of rs-fMRI data	Pipeline reproducibility; handling of motion artifacts; network modeling [15] [98]
Clinical Assessment Tools	PANSS, BPRS, SANS	Quantification of schizophrenia symptom severity	Correlation of connectivity changes with clinical measures [95] [96]
Hormonal Manipulations	Raloxifene, estradiol patches, combined OCs	Experimental and therapeutic modulation of hormone levels	Dose-response relationships; timing of intervention [95] [96]

Implications for CNS Drug Development

The integration of functional neuroimaging into CNS drug development holds significant promise for advancing treatments for schizophrenia. Phase I trials can utilize rsFC to demonstrate CNS penetration and target engagement of novel compounds, providing objective evidence of biological activity beyond subjective ratings [99]. Phase II studies can employ connectivity biomarkers to differentiate drug responders from non-responders and identify neural signatures of efficacy, potentially reducing trial failure rates [99]. For hormonal interventions, rsFC offers a sensitive measure of target engagement in relevant brain networks, helping to establish optimal dosing and timing protocols.

The individual variability in hormonal response necessitates personalized approaches to treatment. RsFC biomarkers may help identify patients most likely to benefit from hormonal adjunctive therapies, such as raloxifene or estrogen augmentation [96]. Furthermore, monitoring connectivity changes during treatment could provide early indicators of therapeutic response, potentially shortening the duration of clinical trials and reducing costs [99]. As our understanding of hormone-connectivity relationships in schizophrenia deepens, the integration of neuroimaging biomarkers across drug development phases offers a path toward more effective, personalized treatments for this complex disorder.

This guide provides a comparative analysis of resting-state functional connectivity (RSFC) between naturally cycling (NC) women and users of oral contraceptives (OCs). Grounded in the context of menstrual cycle and OC research, it synthesizes functional magnetic resonance imaging (fMRI) findings, psychological data, and cognitive performance metrics to delineate the neural and behavioral correlates of endogenous versus synthetic hormone profiles. Supporting experimental data is summarized in structured tables, with detailed methodologies and visual workflows provided to aid research and development professionals in replicating and building upon these findings.

The fluctuating levels of endogenous sex hormones during the natural menstrual cycle are known to modulate brain function and connectivity [100] [11]. Oral contraceptives (OCs) significantly alter this neuroendocrine environment by suppressing the production of endogenous estradiol and progesterone, replacing them with stable, daily doses of synthetic hormones [101] [93]. This hormonal manipulation aims primarily at contraception but concurrently exerts profound effects on the central nervous system. Research investigating the resting-state functional connectivity (RSFC), which reflects the spontaneous, synchronized activity of brain networks, has revealed that these distinct hormonal milieus are associated with significant differences in the dynamics of key neural networks, such as the default mode network (DMN) and the executive control network (ECN) [100] [32]. These networks are critical for higher-order cognitive and affective processing, and understanding their modulation by hormones is crucial for a complete picture of female brain health. This guide objectively compares the experimental findings on RSFC and related psychological measures between naturally cycling women and OC users.

Comparative Data Synthesis

The following tables synthesize quantitative and qualitative findings from key studies comparing naturally cycling women and OC users.

Table 1: Neural and Psychological Well-being Comparisons

Metric	Naturally Cycling (NC) Women	Oral Contraceptive (OC) Users	Key Findings & Effect Size
DMN Connectivity	Dynamic across cycle [32]	Altered connectivity vs. NC [100] [11]	Increased angular gyrus, decreased middle frontal gyrus & anterior cingulate connectivity in OC users [100]
ECN Connectivity	Dynamic across cycle [32]	Altered connectivity vs. NC [100] [11]	Changes in anterior cingulate and middle frontal gyrus connectivity [100]
Psychological Variability	Higher day-to-day variability in agitation, risk-taking, energy [101]	Lowered variability ("emotional blunting") [101]	Levene’s test confirmed significantly reduced variability in OC users (R²m = .004-.019) [101]
Positive Well-being	Higher happiness, attractiveness, energy ratings [101]	Lower ratings for happiness, attractiveness, risk-taking, energy [101]	Small but significant group effects (R²m = .004-.019) [101]
Calmness & Sleep	Lower relaxation and sleep quality ratings [101]	Higher relaxation, sexual desire, and better sleep quality [101]	Small significant group effects (R²m = .005-.01) [101]
Emotion Recognition	-	Impaired accuracy, negativity bias [102]	Altered amygdala connectivity predicts performance; moderated by OC type [93]
Stress Response (CAR)	Robust cortisol awakening response [103]	Blunted cortisol awakening response [103]	61% reduction in OC users (p=0.006) [103]

Table 2: Cognitive and Menstrual Cycle Regularity Outcomes

Domain	Naturally Cycling (NC) Women	Oral Contraceptive (OC) Users	Key Findings
Topographic Memory (Learning)	Lower learning performance on Walking Corsi Test [104]	Superior learning performance (both active and inactive pill phases) [104]	OC users learned an 8-step path more effectively than NC women [104]
Verbal Memory	No significant change across cycle [104]	Enhanced verbal memory during active pill phase [104]	Positive effect of OCs on specific memory domains [104]
Menstrual Regularity	Natural cycle variability [105]	Highest rate of cycle regularity [105]	85% of OC users had cycles within 28-32 days (P < 0.05) [105]

Experimental Protocols

This section details the core methodologies employed in the cited resting-state functional connectivity and psychological studies to facilitate replication and critical evaluation.

Resting-State fMRI Protocol

The foundational protocol for investigating hormone-mediated network dynamics is outlined below [100] [11] [32].

• 1. Participant Selection & Grouping: Participants are typically healthy, right-handed women aged 18-40, with no history of neurological or psychiatric disorders. They are divided into two main groups:

  • Naturally Cycling (NC): No hormonal contraceptive use for at least 3 months. Further subdivided based on cycle phase, verified by salivary hormone assays:
    • Early Follicular (EF): Scanned on cycle days 2-6, characterized by low estradiol and progesterone.
    • Mid-Luteal (ML): Scanned on cycle days 18-24, characterized by high estradiol and progesterone.
  • Oral Contraceptive (OC) Users: Must have used combined (not progestin-only) OCs for at least 3 months on a 28-day cycle. Subdivided based on pill phase:
    • Active Pill (AP): Scanned on days 11-17 of active pill use (high synthetic hormones, low endogenous).
    • Inactive Pill (IP): Scanned on days 2-6 of the placebo pill week (low synthetic and endogenous hormones).

• 2. Pre-scanning Procedures:

  • Hormone Assays: Collect saliva samples immediately before and after the scan. Samples are frozen, centrifuged, and the supernatant is assayed for estradiol and progesterone using commercial immunoassay kits to confirm hormonal group status.
  • Instruction: Participants are instructed to lie still with their eyes open, fixate on a crosshair, and not fall asleep.

• 3. fMRI Data Acquisition:

  • Scanner: A 3T MRI scanner (e.g., Philips, Siemens) is standard.
  • Sequence: A T2*-weighted echo-planar imaging (EPI) sequence is used for functional scans to measure the BOLD signal. Typical parameters: TR=2000ms, TE=30ms, flip angle=90°, voxel size=3mm³.
  • Structural Scan: A high-resolution T1-weighted anatomical scan is also acquired for co-registration.

• 4. Data Preprocessing:

  • Pipelines using software like SPM, FSL, or CONN are employed.
  • Steps include slice-timing correction, realignment for head motion correction, co-registration of functional and anatomical images, normalization to a standard space (e.g., MNI), and spatial smoothing.
  • Nuisance regression is critical, typically including signals from white matter, cerebrospinal fluid, and motion parameters.

• 5. Functional Connectivity Analysis:

  • Independent Component Analysis (ICA): A data-driven approach used to identify spatially independent networks, such as the DMN and ECN, without a priori seed selection [100] [32].
  • Seed-Based Analysis: A hypothesis-driven approach where the time series from a pre-defined "seed" region (e.g., in the amygdala) is correlated with the time series of every other voxel in the brain to create a functional connectivity map [93].
  • Group Statistics: Group-level differences in connectivity (e.g., NC vs. OC, or between cycle phases) are tested using general linear models (GLM) in software like SPM or FSL, with appropriate multiple comparisons correction.

Daily Diary & Psychological Assessment Protocol

This protocol captures the fine-grained, day-to-day fluctuations in psychological well-being [101].

• 1. Participant Grouping: Similar grouping as the fMRI protocol (NC vs. OC users), with hormonal status verified.
• 2. Daily Data Collection: Over a period of at least 28 days, participants provide:
  • Salivary Samples: Daily collection for subsequent assay of estradiol, progesterone, and testosterone levels.
  • Self-Reports: Daily online or app-based questionnaires rating affective and physical symptoms (e.g., happiness, energy, agitation, sexual desire, attractiveness, sleep quality) on Likert scales.
• 3. Data Analysis:
  • Averages: Linear Mixed Models (LMMs) are used to compare group averages on each psychological domain, accounting for within-participant repeated measures.
  • Variability: Levene’s test is applied to compare the day-to-day variability (instability) of scores between NC and OC groups.
  • Network Models: Time-varying relationships between hormones and well-being can be explored using network analysis to visualize how the interplay of variables changes over time.

Signaling Pathways and Workflows

The following diagrams visualize the core neuroendocrine concepts and experimental workflows described in this guide.

Hormonal Modulation of Brain Networks

Diagram Title: Hormonal Influence on Brain and Behavior

Resting-State fMRI Experimental Workflow

Diagram Title: Resting-State fMRI Analysis Pipeline

The Scientist's Toolkit: Research Reagent Solutions

This table details key materials and tools essential for conducting research in this field.

Table 3: Essential Research Reagents and Materials

Item	Function & Application	Example Use Case
Salivary Hormone Immunoassay Kits	To accurately measure levels of estradiol, progesterone, and testosterone from saliva samples for participant group verification.	Salimetrics kits used to confirm low hormone levels in follicular phase and OC users [100] [32].
3T MRI Scanner with EPI Capability	To acquire high-resolution T1 anatomical images and T2*-sensitive BOLD functional images during rest.	Philips, Siemens, or GE scanners used for acquiring resting-state fMRI data [100] [32].
fMRI Preprocessing Pipelines (SPM, FSL, CONN)	Software toolboxes for standard preprocessing steps (realignment, normalization, smoothing) and advanced connectivity analyses.	Group ICA implemented in GIFT (MATLAB) or FSL's MELODIC to identify DMN and ECN [100] [32].
Daily Diary & Ecological Momentary Assessment (EMA) Platforms	Smartphone apps or online portals for the repeated, real-time collection of psychological and behavioral data in a participant's natural environment.	Collecting daily ratings of happiness, energy, and agitation across a 28-day cycle [101].
Standardized Cognitive & Behavioral Tests	Validated tasks to assess specific cognitive domains and emotional processing that may be influenced by hormonal status.	Walking Corsi Test (topographic memory) [104]; Facial Emotion Recognition Tasks [93] [102].

Linking Connectivity Changes to Behavioral Outcomes in Cognition and Emotion

Resting-state functional connectivity (RSFC) provides a powerful window into the intrinsic organization of the brain, revealing spatially distributed networks that exhibit correlated low-frequency oscillations at rest [32] [68]. Research demonstrates that these functional networks are not static but are dynamically modulated by neuroactive steroids, particularly sex hormones. Fluctuations in endogenous hormones across the menstrual cycle and the administration of synthetic hormones via oral contraceptives (OCs) can significantly alter brain connectivity [32]. These alterations have consequential implications for behavioral outcomes in cognitive and emotional domains, forming a critical interface for neuroendocrinology research. Understanding how hormonal contraceptives influence the relationship between brain network dynamics and behavior is especially pressing given that OCs are used by approximately 100 million women worldwide, yet their potential cognitive and affective side effects remain insufficiently explored [32].

This guide synthesizes current experimental data to objectively compare neural connectivity and associated behavioral outcomes between naturally-cycling women and OC users. It details the methodological protocols necessary for replicating these investigations and provides visualizations of key concepts to aid researchers and drug development professionals in navigating this complex field.

Experimental Data Comparison: OC Users vs. Naturally-Cycling Women

The following tables summarize key experimental findings from neuroimaging studies, comparing resting-state functional connectivity and behavioral correlates between oral contraceptive users and naturally-cycling women.

Table 1: Key Resting-State Network Differences and Cognitive-Affective Correlates

Neural Network/Region	Direction of Change in OC Users	Associated Cognitive/Affective Process	Behavioral Outcome Correlates
Anterior Cingulate Cortex (ACC)	↓ Connectivity in Salience Network [68]	Conflict monitoring, emotion regulation [32]	Potential implications for attention and affect [32]
Left Middle Frontal Gyrus	Altered connectivity in Executive Control Network [32]	Higher-order cognitive processing [32]	Changes in verbal memory, verbal fluency [32]
Left Angular Gyrus	↓ Connectivity in Default Mode Network [32]	Theory of mind, social cognition [68]	---
Amygdala-Prefrontal Circuitry	Strengthened inverse connectivity post-therapy [106]	Emotion regulation, fear learning [32] [106]	Improved long-term symptom reduction in anxiety [106]
Executive Control Network (ECN)	Altered dynamics [32]	Reasoning, working memory [68]	Performance on mental rotation tasks [32]
Default Mode Network (DMN)	Altered dynamics [32]	Self-referential thought, social cognition [32] [68]	Differences in memory retention for emotional stories [32]

Table 2: Impact of OC Use Timing on Neural and Behavioral Outcomes

Experimental Factor	Neural Outcome	Behavioral Correlation
Pubertal-Onset OC Use	Increased RSFC in Salience and Subcortical Limbic Networks; more white matter volume in fusiform gyrus [68]	Lasting vulnerability to depression in adulthood [68]
Adult-Onset OC Use	Less pronounced RSFC alterations compared to pubertal-onset [68]	Lower relative risk for depression vs. pubertal-onset [68]
Cycle Phase in Naturally-Cycling	Differing RSFC in Follicular (low hormone) vs. Luteal (high hormone) phases [32]	---
OC Pill Phase (Active vs. Inactive)	Differing RSFC during active (synthetic hormones) vs. inactive (low hormones) pill phase [32]	---

Detailed Experimental Protocols

Participant Recruitment and Screening

Robust participant screening is fundamental to this research. Studies typically recruit women aged 18-40 from university and community populations [32] [68]. Key exclusion criteria include: a history of psychiatric, neurological, or endocrine disorders; drug or alcohol abuse; irregular menstrual cycles; left-handedness; and MRI contraindications [32]. Naturally-cycling women must be free of hormonal contraception for at least three months prior to the study. Participants are assigned to hormonally distinct groups based on meticulous cycle tracking: early follicular (cycle days 2-6, low endogenous hormones), luteal (cycle days 18-24, high endogenous hormones), OC users during active pill phase (high synthetic hormones), and OC users during inactive pill phase (low synthetic and endogenous hormones) [32]. This grouping allows for the dissociation of endogenous and synthetic hormonal effects.

Hormonal Assay and Confirmation

Hormonal levels are biochemically confirmed to validate group assignments. Saliva samples are collected immediately before and after scanning via direct expectoration. Samples are frozen at -20°C until assayed. After thawing and centrifugation, the supernatant is assayed for progesterone and 17β-estradiol using commercially available immunoassay kits, such as those from Salimetrics. These assays have detection sensitivities of 5 pg/mL and 0.1 pg/mL, respectively [32]. This objective confirmation is crucial for verifying the hormonal milieu corresponding to each experimental condition.

fMRI Data Acquisition and Preprocessing

Functional MRI data are acquired using standard parameters on 3T MRI scanners. During the resting-state scan, participants are instructed to keep their eyes closed [68] or fixate on a cross, remaining awake without engaging in any structured task. Preprocessing of the functional images is a critical pipeline that typically includes slice-timing correction, realignment for head motion correction, co-registration to structural images, normalization into a standard stereotactic space (e.g., MNI), and spatial smoothing. Participants with excessive head motion (e.g., >4mm or 4 degrees of translation/rotation) are excluded from the analysis [32].

Functional Connectivity Analysis

Two primary analytical approaches are used to investigate resting-state dynamics:

• Independent Components Analysis (ICA): A data-driven method used to identify spatially distributed, temporally coherent networks without a priori seeds. Studies using ICA have identified group differences in the Default Mode Network and Executive Control Network [32].
• Seed-Based Correlation Analysis: A hypothesis-driven approach where the time series from a pre-defined "seed" region (e.g., the amygdala) is correlated with the time series of every other voxel in the brain to create a functional connectivity map. This method is often used to examine specific circuits, such as amygdala-prefrontal pathways [106].

Statistical comparisons (e.g., t-tests, ANCOVAs) are then conducted on the resulting connectivity maps to identify significant differences between the hormonal groups.

Visualizing Key Concepts and Workflows

Experimental Workflow for Hormonal Modulation Studies

The following diagram outlines the sequential phases of a comprehensive research study investigating the effects of hormonal status on brain connectivity and behavior.

Neural Networks Modulated by Hormonal State

This diagram illustrates the key brain networks whose functional connectivity is modulated by hormonal fluctuations, linking them to their primary cognitive and affective functions.

The Scientist's Toolkit: Essential Research Reagents and Materials

Table 3: Key Reagents and Materials for Hormonal Neuroimaging Research

Item	Function/Application
Salivary Immunoassay Kits (e.g., Salimetrics)	Quantification of salivary progesterone and 17β-estradiol levels to objectively confirm participant hormonal status.
3T MRI Scanner	High-field magnetic resonance imaging for acquiring both structural and functional brain data.
Standardized Cognitive Tasks	Assessment of behavioral domains like verbal memory, verbal fluency, and mental rotation to link connectivity changes to performance.
Data Analysis Software (e.g., FSL, SPM, CONN)	Software toolkits for preprocessing fMRI data and performing functional connectivity analyses (ICA, seed-based).
Statistical Software (e.g., R, SPSS)	Platforms for performing group-level statistical comparisons (t-tests, ANCOVA) of connectivity outcomes and their correlation with behavioral data.

Implications for Drug Development and Individualized Treatment Strategies

The traditional model of medication dosing largely overlooks a fundamental aspect of female physiology: the rhythmic fluctuations of sex hormones during the menstrual cycle. Growing evidence from neuroimaging and clinical studies demonstrates that endogenous ovarian hormones and hormonal contraceptives significantly modulate brain network organization and functional connectivity [107] [13] [62]. These neural changes have profound implications for drug development and individualized treatment strategies in women, particularly for neuroactive compounds. The resting-state functional connectivity (rs-FC) research provides a critical window into these mechanisms, revealing that ovarian hormones estradiol and progesterone influence brain dynamics in ways that may alter medication efficacy, side effect profiles, and dosing requirements across the menstrual cycle or during hormonal contraceptive use [108] [13] [62]. This paradigm shift away from "one-size-fits-all" dosing toward hormonally-informed treatment strategies represents a frontier in precision medicine for women's health.

Methodological Foundations in Menstrual Cycle and OC Research

Standardizing Menstrual Cycle Phase Determination

Robust methodology is essential for credible research on hormonal influences on brain function. The field has moved beyond self-reported cycle timing to biochemical confirmation of menstrual phases. The early follicular phase (cycle days 3-5) is characterized by low estradiol and progesterone; the pre-ovulatory phase (days 11-13) shows high estradiol; and the mid-luteal phase (days 20-22) features high progesterone and estradiol [109] [13]. Hormonal assays typically measure serum levels of estradiol, progesterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) to objectively define these phases [110] [13].

Neuroimaging Protocols for Hormonal Research

Resting-state functional magnetic resonance imaging (rs-fMRI) protocols for hormonal research typically involve:

• Image Acquisition: Scanning sessions conducted at standardized times of day to control for circadian influences, using standardized parameters on 3T MRI scanners [108] [13].
• Preprocessing Pipelines: Including realignment, normalization, spatial smoothing, and band-pass filtering, often with nuisance regression for physiological signals [111] [13].
• Connectivity Analysis: Employing seed-based approaches (e.g., focusing on salience network regions like amygdala and anterior cingulate cortex) [62], graph theory measures (modularity, characteristic path length) [111], and dynamic functional connectivity methods to capture time-varying network properties [13].

Accounting for Hormonal Contraceptive Formulations

Research on oral contraceptive (OC) users must document critical formulation details:

• Estrogen Component: Typically ethinyl estradiol dosage (e.g., 20μg vs. 30μg) [108] [111].
• Progestin Type: Classified as androgenic (e.g., levonorgestrel) or anti-androgenic (e.g., drospirenone) based on receptor binding properties [62].
• Duration of Use: Documenting both short-term (one cycle) versus long-term exposure (months to years) [62].
• Monophasic vs. Phasic Formulations: Maintaining consistent hormonal levels versus fluctuating doses across the cycle [108].

Table 1: Key Methodological Considerations in Hormonal Brain Research

Domain	Parameters	Technical Specifications
Cycle Phase Determination	Serum hormones (estradiol, progesterone, LH, FSH), urinary luteinizing hormone, menstrual diaries	Electrochemiluminescence immunoassays for hormones; daily symptom tracking [110] [109]
Neuroimaging Acquisition	rs-fMRI parameters, scanner type, time of day control	3T MRI scanners, TR/TE=2000/30ms, voxel size=3×3×3mm³, 8-12 minutes resting state [111] [13]
Hormonal Contraceptive Documentation	Progestin androgenicity, estrogen dose, regimen duration, monophasic/phasic	Classification based on pharmaceutical data; participant medical history verification [108] [62]

Comparative Neural Dynamics: Natural Cycle vs. Oral Contraceptive Use

Whole-Brain Dynamics Across the Natural Menstrual Cycle

The brain exhibits remarkable dynamism across the menstrual cycle in naturally cycling women. Research utilizing intrinsic ignition framework analysis has revealed that:

• Pre-ovulatory Phase Superiority: The pre-ovulatory phase (high estradiol) demonstrates significantly higher whole-brain dynamical complexity compared to early follicular and mid-luteal phases, indicating enhanced information processing capacity during this high-estrogen state [13].
• Network-Specific Reconfigurations: Resting-state networks reconfigure differentially across cycle phases. The default mode network (DMN), limbic, and subcortical networks show increased dynamical complexity during pre-ovulatory and mid-luteal phases compared to early follicular phase [13].
• Hormonal Correlates: Multilevel modeling reveals that estradiol and progesterone significantly influence whole-brain, DMN, limbic, dorsal attention, somatomotor, and subcortical networks, with each hormone exhibiting distinct modulatory patterns [13].

A serial-sampling single-subject study (the "28andMe" project) scanning one woman daily across complete natural and OC cycles found that graph theory measures showed higher modularity, system segregation, and characteristic path length during the natural cycle compared to OC use, suggesting a more structured network architecture during natural hormonal fluctuations [111].

Oral Contraceptive-Induced Neural Changes

Oral contraceptives fundamentally alter brain network dynamics through several mechanisms:

• Connectivity Reductions: Longer OC use duration correlates with decreased functional connectivity of amygdalae with frontal areas and between anterior cingulate cortex (ACC) and temporoparietal areas, independent of progestin androgenicity [62].
• Loss of Neural Idiosyncrasy: OCPs increase between-subject similarity in functional connectomes, suggesting a reduction in individual neural distinctiveness during contraceptive use [108].
• Network-Level Effects: OC use is associated with widespread connectivity changes in subcortical, executive, and somatomotor circuits, with intraclass correlations indicating significantly reduced idiosyncrasy in default mode, executive, limbic, salience, somatomotor, and subcortical networks [108].

Table 2: Comparative Neural Effects of Natural Cycle vs. Oral Contraceptives

Neural Characteristic	Natural Menstrual Cycle	Oral Contraceptive Use
Whole-Brain Dynamics	Higher dynamical complexity in pre-ovulatory phase [13]	Reduced dynamical complexity and network modularity [108] [111]
Network Segregation	Higher modularity and system segregation [111]	Lower modularity and characteristic path length [111]
Individual Variability	Maintained individual connectome idiosyncrasy [108]	Increased between-subject similarity, reduced idiosyncrasy [108]
Salience Network Connectivity	Cyclical fluctuations in amygdala-ACC connectivity [62]	Duration-dependent decreases in amygdala-frontal and ACC-temporal connectivity [62]

Molecular and Metabolic Fluctuations Across the Cycle

The metabolic landscape shifts significantly across the menstrual cycle, creating a varying biochemical environment for drug actions:

• Amino Acid Availability: Thirty-nine amino acids and derivatives decrease significantly during the luteal phase, potentially creating an anabolic state that may influence drug precursors and neurotransmitter synthesis [110].
• Lipid Dynamics: Eighteen lipid species are reduced in the luteal phase, including phospholipids like lysophosphatidylcholines (LPCs) and phosphatidylcholines (PCs), which could impact blood-brain barrier permeability and drug distribution [110].
• Vitamin Fluctuations: Vitamin D (25-OH vitamin D) shows significant decreases in luteal versus menstrual phases, while pyridoxic acid (vitamin B6 metabolite) elevates during menstruation, potentially affecting cofactor-dependent drug metabolism [110].

Molecular Mechanisms: From Hormonal Fluctuations to Neural Connectivity

The following diagram illustrates the proposed pathway through which hormonal fluctuations modulate brain connectivity and subsequently influence medication responses:

Diagram Title: Hormonal Modulation of Brain Connectivity and Treatment Implications

This mechanistic framework illustrates how hormonal states translate to clinical implications via multilevel biological processes. Natural cyclic hormonal fluctuations create a dynamically changing neural environment, while oral contraceptives induce a more stable but fundamentally altered neural state with reduced individual variability [108] [13] [62]. These differential effects have significant implications for drug development and personalized treatment approaches.

The Scientist's Toolkit: Essential Research Reagents and Methodologies

Table 3: Essential Research Tools for Hormonal Neuropharmacology Studies

Tool Category	Specific Examples	Research Applications
Hormonal Assays	Electrochemiluminescence immunoassays for estradiol, progesterone, LH, FSH; Liquid chromatography-mass spectrometry (LC-MS) for metabolic profiling	Precise menstrual cycle phase determination; Monitoring hormonal levels in intervention studies [110] [109]
Neuroimaging Analysis Platforms	FSL, CONN, DPABI, AFNI; Graph theory analysis tools; Dynamic functional connectivity pipelines; Intrinsic ignition framework algorithms	Quantifying functional connectivity changes; Analyzing network properties and dynamics [111] [13]
Hormonal Modulation Reagents	Monophasic combined OCs (ethinyl estradiol + levonorgestrel); Transdermal estradiol patches; Vaginal progesterone gels	Experimental manipulation of hormonal states; Modeling OC effects on brain function [108] [111]
Metabolic Profiling Technologies	LC-MS/MS and GC-MS platforms; Targeted metabolomics panels for amino acids, lipids, acylcarnitines; Clinical chemistry analyzers	Comprehensive metabolic mapping across menstrual phases; Identifying drug-metabolism interactions [110]

Implications for Drug Development and Clinical Translation

Clinical Evidence for Hormonally-Modulated Treatment Responses

The clinical relevance of these neural and metabolic fluctuations is particularly evident in neuropsychiatric conditions:

• Case Evidence in Schizophrenia: A 33-year-old woman with treatment-refractory schizophrenia demonstrated dramatic monthly fluctuations in psychopathology, with symptom exacerbations premenstrually requiring antipsychotic dose adjustments. Through self-titration, she established a cycle-dependent dosing regimen (olanzapine 5-15 mg/day), with higher doses required perimenstrually, resulting in unprecedented clinical stability and functional improvement [107].
• Catamenial Psychiatric Patterns: Psychiatric literature documents recurrent patterns of menstrual-cycle-linked symptom exacerbation, including "catamenial schizophrenia" with premenstrual psychotic decompensation and post-menstrual remission, suggesting that a subgroup of women may benefit from hormonally-informed dosing strategies [107].

Strategic Implications for Pharmaceutical Development

The evidence for hormonally-mediated neural changes necessitates strategic shifts in drug development:

• Clinical Trial Design: Inclusion of menstrual cycle phase and hormonal contraceptive use as stratification variables; powered subgroup analyses to detect hormonally-mediated response differences [107] [108].
• Dosing Optimization: Exploration of cycle-dependent dosing regimens for drugs with central nervous system targets; consideration of hormonal status in personalized medicine approaches [107].
• Formulation Strategies: Development of hormone-responsive drug delivery systems that adjust release profiles according to cycle phase; combination products that account for hormonal milieu [107].
• Safety Profiling: Enhanced assessment of side effect variations across menstrual phases; recognition that adverse drug reactions may be phase-dependent [107] [108].

The integration of resting-state functional connectivity research on menstrual cycle and oral contraceptive effects represents a transformative opportunity for drug development and individualized treatment strategies. The evidence compellingly demonstrates that female hormonal states significantly modulate brain network organization, functional connectivity, and metabolic environments—all critical determinants of drug efficacy and safety. Moving forward, the field must adopt more sophisticated approaches that account for these hormonal influences throughout the medication lifecycle, from target identification and clinical trial design to dosing recommendations and personalized treatment planning. This hormonally-aware framework promises to advance precision medicine for women, potentially improving therapeutic outcomes while reducing adverse effects through biologically-informed individualization strategies.

The study of resting-state functional connectivity (RSFC) in the context of the female menstrual cycle and oral contraceptive (OC) use represents a critical frontier in neuroimaging research. This field bridges women's health, neuroendocrinology, and clinical biomarker discovery, offering unprecedented opportunities for understanding how hormonal fluctuations shape brain network organization. Current research has progressed from simply documenting differences between hormone states to elucidating complex network-level changes that may underlie behavioral symptoms and cognitive variations reported by women across their cycles and during OC use. The translation of these mechanistic insights into clinically useful biomarkers requires rigorous methodological standardization, validation across diverse populations, and the development of analytical frameworks that can accommodate the dynamic nature of hormonal influences on brain function [108] [10].

The significance of this research extends beyond basic science to direct clinical applications. Functional connectivity measures show promise as potential biomarkers for predicting individual susceptibility to mood-related side effects from OCs, understanding cycle-related exacerbations of neurological conditions, and developing personalized hormonal treatments that account for neurobiological impacts. However, progress has been hampered by methodological inconsistencies across studies, limited replication efforts, and insufficient attention to the molecular mechanisms linking hormonal exposure to network-level changes in brain connectivity [112] [113].

Current Methodological Approaches in Hormonal Neuroimaging

Dominant Experimental Paradigms

Research investigating hormonal effects on brain connectivity has primarily utilized two complementary approaches: between-group comparisons of naturally cycling women and OC users, and within-subject longitudinal designs tracking connectivity changes across hormonal states.

Table 1: Experimental Designs in Hormonal Connectivity Research

Design Type	Key Features	Advantages	Limitations
Between-Group Comparison	Compares naturally cycling women in specific phases with OC users in active/inactive pill phases [11]	Captures population-level differences; controls for self-selection bias	Cross-sectional; cannot establish causality
Longitudinal Natural Cycle	Repeated measures across menstrual cycle phases (follicular, ovulatory, luteal) [15] [97]	Within-subject control; tracks dynamic changes	Requires precise cycle monitoring; resource-intensive
Randomized Controlled Crossover	Participants randomly assigned to OC or placebo in crossover design [108]	Establishes causal effects; controls for confounding factors	Ethical considerations; limited duration of intervention
Deep Phenotyping	Intensive longitudinal sampling (daily) across complete cycles [10]	High-resolution temporal data; captures individual dynamics	Single-subject focus; limited generalizability

Analytical Frameworks and Connectivity Measures

The field has employed diverse analytical approaches to quantify hormonal effects on brain connectivity, each with distinct strengths for capturing different aspects of network organization.

Table 2: Analytical Methods in Hormonal Connectivity Research

Method Category	Specific Techniques	Neural Measures	Hormonal Sensitivity
Seed-Based Connectivity	ROI-to-whole brain correlation [108] [15]	Functional coupling between specific regions	Amygdala, putamen, dACC connectivity changes across cycle/OC use
Network-Based Analysis	Independent Component Analysis (ICA) [15] [11]	Intrinsic connectivity networks (DMN, ECN, salience)	DMN and ECN alterations in luteal phase and OC users
Graph Theory Metrics	Modularity, system segregation, characteristic path length [10]	Global network organization	Higher modularity in natural cycle vs. OC use
Multivariate Pattern Analysis	Functional connectome fingerprinting [108]	Individual identification from connectomes	OC use reduces brain idiosyncrasy (between-subject similarity increases)
Dynamic Connectivity	Leading Eigenvector Dynamic Analysis [10]	Time-varying connectivity states	Altered prevalence of brain states with OC use
Spectral Analysis	Amplitude of low-frequency fluctuations (ALFF) [15]	Regional spontaneous activity	Increased caudate ALFF in luteal phase

Figure 1: Experimental Workflow in Hormonal Connectivity Research

Key Findings: Menstrual Cycle Effects on Brain Networks

Phase-Dependent Connectivity Changes

Naturally cycling women demonstrate dynamic reorganization of functional brain networks across menstrual phases, with particularly pronounced effects in subcortical and cognitive control regions.

The luteal phase, characterized by elevated progesterone and estradiol levels, is associated with heightened eigenvector centrality in the hippocampus and increased amplitude of low-frequency fluctuations (ALFF) in the caudate [15]. This phase also demonstrates stronger putamen-thalamic connectivity, potentially reflecting progesterone-mediated modulation of sensorimotor pathways. Conversely, the pre-ovulatory phase shows enhanced fronto-striatal connectivity, possibly linked to estradiol facilitation of cortico-striatal communication [15].

Network-level analyses reveal that the default mode network (DMN) shows decreased connectivity with the right angular gyrus during the luteal phase [15], while the executive control network (ECN) displays phase-dependent modulations that may underlie cycle-related cognitive changes. These network reorganizations are not limited to resting states but appear to influence task-based processing and cognitive performance across multiple domains.

Spectral and Temporal Dynamics

Advanced electrophysiological measures using magnetoencephalography (MEG) provide complementary evidence for cycle-dependent neural oscillations. Significant reductions in median frequency and peak alpha frequency occur during the menstrual phase, alongside increased Shannon spectral entropy, suggesting complex alterations in the temporal organization of spontaneous neural activity [97].

Region-specific oscillatory changes include reduced theta intensity within the right temporal cortex and right limbic system during menstruation, and diminished high gamma intensity in the left parietal cortex [97]. These frequency-specific effects likely reflect distinct mechanisms of hormonal regulation, with implications for understanding cycle-related symptoms in neurological and psychiatric conditions.

Oral Contraceptive Effects on Brain Network Organization

Network-Level Changes and Individual Variability

Oral contraceptive use induces widespread alterations in functional brain organization that extend beyond reproductive networks to encompass cognitive and affective circuits. A key finding from recent randomized controlled trials is that OCs increase between-subject similarity in functional connectomes, suggesting a loss of individual idiosyncrasy during active hormone exposure [108]. This convergence in brain network architecture across individuals may reflect the constraining influence of synthetic hormones on naturally occurring neural variability.

Intraclass correlations indicate that idiosyncrasy is significantly reduced in multiple large-scale networks including the default mode, executive control, limbic, salience, somatomotor, and subcortical networks [108]. This widespread reduction in individual differentiation suggests that synthetic hormones may constrain the natural expression of individually unique connectivity patterns, potentially through standardized suppression of endogenous hormonal fluctuations.

Dynamic Connectivity and Graph Theory Measures

Single-subject deep phenotyping approaches reveal that OC use alters dynamic properties of functional connectivity. Natural cycles are characterized by higher modularity, system segregation, and characteristic path length compared to OC cycles, suggesting a more structured network architecture during natural hormonal fluctuations [10]. The shift toward reduced modularity and characteristic path length during OC use indicates a generally increased connectivity structure with less distinct network boundaries.

Dynamic functional connectivity analyses further demonstrate that OC use shifts the prevalence of discrete brain states, potentially reflecting altered temporal organization of network interactions [10]. These changes in dynamic connectivity properties may underlie the mood and cognitive effects reported by some OC users, though direct links between specific connectivity alterations and behavioral symptoms require further investigation.

Molecular Mechanisms and System-Level Effects

Hormonal Signaling Pathways

The connectivity changes observed across menstrual phases and during OC use likely reflect the complex interplay of multiple hormonal mechanisms operating at different temporal and spatial scales.

Figure 2: Hormonal Signaling Pathways to Brain Connectivity

Estradiol appears to facilitate tighter coherence within functional brain networks, while progesterone generally has opposing effects and largely decreases inter-region connectivity [10]. These opposing effects manifest most strikingly during the ovulatory peak, when eigenvector centrality increases in several networks, particularly in default mode subnetworks localized to prefrontal cortex regions [10]. This reorganization is blunted during OC use, despite similar mid-cycle estradiol peaks, suggesting that synthetic hormones constrain natural network dynamics.

At the cellular level, sex hormones exert trophic effects on dendritic spine density and synapse formation. Animal research demonstrates estrogen-dependent synaptic remodeling in the hippocampus and prefrontal cortex [15], while progesterone increases dendritic spine number and density in cortical neuron cultures [15]. These structural changes provide a plausible mechanism for the functional connectivity alterations observed in human neuroimaging studies, though direct evidence linking cellular changes to network-level effects in humans remains limited.

Neurotransmitter System Interactions

Hormonal effects on brain connectivity are further mediated through interactions with major neurotransmitter systems, particularly the serotonergic and GABAergic systems. OC use has been shown to alter serotonergic neurotransmission, which is crucial for maintaining mental health [10]. Progesterone metabolites also influence GABAergic transmission, potentially explaining cycle-dependent and OC-related changes in emotional processing and anxiety [11].

These neurotransmitter interactions may be particularly relevant for understanding the mood-related side effects experienced by some OC users. The association between functional connectivity changes and increases in negative affect, with specific connectivity edges showing significant correlations with DRSP symptom scores [108], suggests that network-level alterations may mediate the relationship between hormonal exposure and behavioral symptoms.

Methodological Considerations and Technical Approaches

The Scientist's Toolkit: Essential Research Solutions

Table 3: Essential Methodological Tools for Hormonal Connectivity Research

Category	Specific Tools/Techniques	Application in Hormonal Research	Key Considerations
Hormone Assessment	Salivary immunoassays, Serum hormone testing, Cycle tracking applications	Verify cycle phases, confirm OC compliance, correlate connectivity with hormone levels	Timing relative to cycle, assay sensitivity, pulsatile secretion patterns
Neuroimaging Acquisition	Resting-state fMRI, Magnetoencephalography (MEG), Structural MRI	Measure functional connectivity, neural oscillations, gray matter volume	Scanner stability, acquisition parameters, motion artifact control
Preprocessing Tools	FSL, SPM, AFNI, CONN toolbox	Data cleaning, motion correction, physiological noise removal	Pipeline standardization, handling hormonal effects on physiological signals
Connectivity Analysis	Seed-based correlation, Independent Component Analysis (ICA), Weighted Gene Co-expression Network Analysis (WGCNA)	Identify network changes, module detection, multivariate patterns	Multiple comparison correction, template selection, statistical power
Graph Theory Metrics	Modularity, System Segregation, Characteristic Path Length, Eigenvector Centrality	Quantify global network organization, node importance	Atlas selection, thresholding strategies, metric interpretation
Dynamic Connectivity	Leading Eigenvector Dynamic Analysis, Sliding window approaches	Capture time-varying connectivity states	Window length selection, state classification, statistical modeling
Statistical Modeling	Linear mixed effects, Circular statistics for cycle phase, Mediation analysis	Account for repeated measures, phase continuity, mechanism testing	Non-independence of observations, missing data, causal inference

Protocol Details: Key Experimental Methods

Resting-State fMRI Acquisition Protocol (adapted from multiple sources [108] [15] [11]):

• Scanner Requirements: 3T MRI scanner with standard head coil
• Sequence Parameters: Gradient-echo EPI sequence, TR=2000ms, TE=30ms, flip angle=75°, voxel size=3×3×3mm³, 32-40 slices covering whole brain
• Duration: 8-10 minutes of resting-state acquisition (240-300 volumes)
• Participant Instructions: Keep eyes open, fixate on crosshair, remain awake, avoid structured thinking
• Physiological Monitoring: Cardiac and respiratory recording for noise correction

Hormonal Phase Verification Protocol:

• Natural Cycle Participants: Track cycles for 2-3 months prior to study, confirm phase with salivary progesterone (>3 pg/mL for luteal phase) [11] and LH surge testing for ovulation confirmation
• OC Participants: Verify compliance with pill use, distinguish active vs. inactive pill phases [11]
• Exclusion Criteria: Hormonal disorders, psychiatric medications, irregular cycles, perimenopausal status

Seed-Based Connectivity Analysis Protocol [108] [15]:

• Seed Selection: A priori regions based on hypothesized hormonal sensitivity (amygdala, putamen, dACC, hippocampus)
• Preprocessing: Slice timing correction, motion realignment, spatial normalization, smoothing (6mm FWHM)
• Nuisance Regression: 24 motion parameters, white matter and CSF signals, global signal regression debated
• Statistical Analysis: Voxelwise correlation with seed region, cluster-level FWE correction p<0.05

Future Directions: Toward Clinical Biomarker Development

Mechanism-Centric Biomarker Discovery

The transition from associative findings to clinically useful biomarkers requires a shift from gene-centric to mechanism-centric approaches [112]. Rather than focusing on individual connectivity changes in isolation, mechanism-centric approaches consider upstream and downstream regulatory networks, offering the potential to identify driver (rather than passenger) alterations in brain organization.

Network medicine approaches developed in oncology research, including gene co-expression networks (WGCNA, lmQCM), regulatory networks, and protein-protein interaction networks [112], provide valuable templates for understanding the multiscale organization of hormonal effects on brain connectivity. These methods allow identification of tightly connected gene modules or connectivity patterns that can be associated with clinical features to determine functionally relevant molecular structures.

Personalized Prediction and Intervention

Ultimately, the goal of this research is to develop biomarkers that can predict individual susceptibility to hormonal effects on brain function and behavior. The association between specific connectivity patterns and mood symptoms [108] suggests that pre-treatment neuroimaging might identify women at risk for negative psychological side effects from OCs, enabling personalized contraceptive selection.

Future research should prioritize longitudinal designs that track connectivity changes within individuals across multiple hormonal transitions, incorporate multi-omic data to link molecular mechanisms with network-level effects, and develop computational models that can predict individual trajectories of hormonal brain modulation. The integration of mechanism-centric biomarkers with clinical outcomes represents the most promising path toward translating current mechanistic understanding into clinically actionable tools.

The study of resting-state functional connectivity in the context of menstrual cycle and oral contraceptive effects has progressed from documenting basic differences to elucidating complex network-level reorganizations with behavioral relevance. Future research must prioritize mechanistic understanding through enhanced experimental designs, method standardization, and the application of computational approaches that can capture the dynamic, multiscale nature of hormonal brain modulation. The development of clinically useful biomarkers from this research has the potential to transform women's health by enabling personalized hormonal treatments that account for neurobiological impacts and minimize adverse effects.

Conclusion

The evidence unequivocally demonstrates that both the natural menstrual cycle and oral contraceptive use significantly modulate resting-state functional connectivity, particularly within networks subserving higher-order cognition and emotion like the DMN and ECN. These are not merely statistical observations but have profound implications for neuropsychiatric drug development, clinical trial design, and personalized medicine. Future research must prioritize standardized methodologies, larger longitudinal studies, and a deeper exploration of how specific synthetic hormones in different OC formulations alter brain networks. Acknowledging and accounting for these hormonal influences is paramount for accurate data interpretation in neuroscience and for developing more effective, gender-specific pharmacological interventions.

References

• 1. Estrogen- and progesterone-mediated structural ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5679703/]
• 2. Progesterone Actions During Central Nervous System ... [https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2019.00503/full]
• 3. Neuroactive steroids: mechanisms of action and ... [https://www.sciencedirect.com/science/article/abs/pii/S0306453002000641]
• 4. Progesterone mediates brain functional connectivity changes ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4337344/]
• 5. The impact of estradiol on serotonin, glutamate, and ... [https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2024.1348551/full]
• 6. Progesterone in the Brain: Hormone, Neurosteroid and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7432434/]
• 7. Effects of Estradiol Therapy on Resting-State Functional ... [https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2019.00817/full]
• 8. Estradiol modulates resting-state connectivity in ... [https://www.sciencedirect.com/science/article/abs/pii/S0165032724019530]
• 9. Progesterone-induced Neuroprotection: Factors that may ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC3672388/]
• 10. Effects of an Oral Contraceptive on Dynamic Brain States ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC9237452/]
• 11. Oral contraceptive pill use and menstrual cycle phase are ... [https://www.sciencedirect.com/science/article/abs/pii/S1053811913012202]
• 12. Hormonal contraceptive exposure relates to changes in ... [https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2023.1131995/full]
• 13. Whole-brain dynamics across the menstrual cycle [https://www.nature.com/articles/s44294-024-00012-4]
• 14. Resting States Are Resting Traits – An fMRI Study of Sex ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4110030/]
• 15. Human menstrual cycle variation in subcortical functional ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7046575/]
• 16. Review of Dynamic Resting‐State Methods in Neuroimaging [https://pmc.ncbi.nlm.nih.gov/articles/PMC12532080/]
• 17. Hormonal Cycles, Brain Network Connectivity, and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC6481680/]
• 18. Spectral dynamic causal modelling in healthy women ... [https://www.nature.com/articles/s42003-021-02447-w]
• 19. Resting-state functional connectivity in women with PMDD | Translational Psychiatry [https://www.nature.com/articles/s41398-019-0670-8]
• 20. Progesterone mediates brain functional connectivity ... [https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2015.00044/full]
• 21. Hippocampal volume and functional connectivity changes ... [https://www.sciencedirect.com/science/article/abs/pii/S1053811915004887]
• 22. Hormonal Cycles, Brain Network Connectivity, and ... [https://www.sciencedirect.com/science/article/abs/pii/S0166223618302194]
• 23. Beyond Birth Control: The Neuroscience of Hormonal ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11450536/]
• 24. Oral Contraceptive Pills - StatPearls - NCBI Bookshelf - NIH [https://www.ncbi.nlm.nih.gov/books/NBK430882/]
• 25. Examining the role of oral contraceptive users as an ... [https://www.sciencedirect.com/science/article/abs/pii/S0010782412010311]
• 26. Hormonal contraceptive effects on the brain [https://www.nature.com/articles/s41386-025-02267-0]
• 27. How hormonal contraceptives shape brain and behavior [https://www.sciencedirect.com/science/article/abs/pii/S0091302222000401]
• 28. Oral Contraceptives Modulate the Relationship Between ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC8967165/]
• 29. A large-scale resting-state fMRI study [https://pubmed.ncbi.nlm.nih.gov/41252278/]
• 30. Duration of oral contraceptive use relates to cognitive ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC9530450/]
• 31. Default mode network [https://en.wikipedia.org/wiki/Default_mode_network]
• 32. Oral contraceptive pill use and menstrual cycle phase are ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4113343/]
• 33. Increased Hierarchical Influence of Executive Control and ... [https://www.sciencedirect.com/science/article/abs/pii/S0028393225002489]
• 34. The colors of our brain: an integrated approach for ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC9107439/]
• 35. The effect of seed location on functional connectivity [https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2023.1120741/full]
• 36. Hormone-based models for comparing menstrual cycle and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC9649880/]
• 37. On the relationship between seed-based and ICA ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC3130118/]
• 38. An analytical workflow for seed-based correlation and ... [https://www.sciencedirect.com/science/article/abs/pii/S0168010220301838]
• 39. Seed-based connectivity measures [https://web.conn-toolbox.org/fmri-methods/connectivity-measures/seed-based]
• 40. Seed-based Correlation Analysis (SCA) and Dual Regression [https://fcp-indi.github.io/docs/latest/user/sca]
• 41. What is an Independent Component Analysis (ICA)? [https://www.polymersearch.com/glossary/independent-component-analysis-ica]
• 42. Independent Component Analysis - ML [https://www.geeksforgeeks.org/machine-learning/ml-independent-component-analysis/]
• 43. Independent Component Analysis - an overview [https://www.sciencedirect.com/topics/engineering/independent-component-analysis]
• 44. Functional connectivity as revealed by independent ... [https://www.sciencedirect.com/science/article/abs/pii/S1053811910002673]
• 45. Resting state fMRI: A review on methods in ... - PubMed Central [https://pmc.ncbi.nlm.nih.gov/articles/PMC5524274/]
• 46. The cycling brain: menstrual cycle related fluctuations in ... [https://www.nature.com/articles/s41386-019-0435-3]
• 47. Eigenvector centrality dynamics are related to Alzheimer's ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10156145/]
• 48. Abnormal amplitude of low-frequency fluctuations and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12540432/]
• 49. A resting-state functional magnetic resonance imaging study [https://pmc.ncbi.nlm.nih.gov/articles/PMC9768018/]
• 50. Altered fractional amplitude of low frequency fluctuation in ... [https://www.sciencedirect.com/science/article/abs/pii/S016503271632122X]
• 51. Source localization comparison and combination of OPM ... [https://www.sciencedirect.com/science/article/abs/pii/S0169260724002876]
• 52. Comparing MEG and fMRI views to naming actions and objects [https://pmc.ncbi.nlm.nih.gov/articles/PMC6870641/]
• 53. The Menstrual Cycle Alters Resting-State Cortical Activity [https://pmc.ncbi.nlm.nih.gov/articles/PMC8350571/]
• 54. Simultaneous EEG‐fMRI Reveals a Visual Working Memory ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12010137/]
• 55. A large-scale fMRI dataset for the visual processing of ... [https://www.nature.com/articles/s41597-023-02471-x]
• 56. A dataset of human fMRI/MEG experiments with eye tracking ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC9249601/]
• 57. Benchmarking methods for mapping functional connectivity ... [https://www.nature.com/articles/s41592-025-02704-4]
• 58. Cross-sectional vs. longitudinal studies [https://www.iwh.on.ca/what-researchers-mean-by/cross-sectional-vs-longitudinal-studies]
• 59. What is the difference between longitudinal and cross- ... [https://www.scribbr.com/frequently-asked-questions/longitudinal-study-vs-cross-sectional-study/]
• 60. Longitudinal changes in reproductive hormones through the ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7718240/]
• 61. Menstrual Cycle Phase Influences Cognitive Performance ... [https://www.mdpi.com/2079-7737/14/8/1060]
• 62. Hormonal contraceptive exposure relates to changes in ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10374315/]
• 63. Hippocampal volume and affect in response to fluctuating ... [https://www.nature.com/articles/s44294-024-00023-1]
• 64. Influence of menstrual cycle phase on resting-state functional ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4862059/]
• 65. LC-MS/MS method for the determination of hormones [https://www.sciencedirect.com/science/article/abs/pii/S0278691520300922]
• 66. Validation of urinary reproductive hormone measurements ... [https://www.nature.com/articles/s41598-023-36539-w]
• 67. Oral contraceptive use, especially during puberty, alters ... [https://pubmed.ncbi.nlm.nih.gov/32971138/]
• 68. Oral contraceptive use, especially during puberty, alters ... [https://www.sciencedirect.com/science/article/abs/pii/S0018506X20301756]
• 69. Screening and Monitoring - Hormonally Active Agents ... - NCBI [https://www.ncbi.nlm.nih.gov/books/NBK230222/]
• 70. Benchmarking of participant-level confound regression ... [https://www.sciencedirect.com/science/article/pii/S1053811917302288]
• 71. How to Interpret Resting-State fMRI: Ask Your Participants - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC7888219/]
• 72. Resting States Are Resting Traits – An fMRI Study of Sex... | PLOS One [https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0103492]
• 73. T141. EFFECTS OF MENSTRUAL CYCLE ON RESTING ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7234404/]
• 74. Cigarette smoking and effects on menstrual function [https://pubmed.ncbi.nlm.nih.gov/9916957/]
• 75. Emotional Distress and Tobacco Demand during the ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC6355362/]
• 76. Moderating effects of smoking and drinking on the ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10566120/]
• 77. Associations between Psychiatric Disorders and Menstrual ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC2588420/]
• 78. Smoking- and menstrual-related symptomatology during ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4010248/]
• 79. The Normal Menstrual Cycle and the Control of Ovulation - NCBI [https://www.ncbi.nlm.nih.gov/books/NBK279054/]
• 80. Machine learning model for menstrual cycle phase ... [https://www.sciencedirect.com/science/article/pii/S0010482525000551]
• 81. Real-world menstrual cycle characteristics of more than ... [https://www.nature.com/articles/s41746-019-0152-7]
• 82. Progestins - StatPearls - NCBI Bookshelf - NIH [https://www.ncbi.nlm.nih.gov/books/NBK563211/]
• 83. List of Progestogens [https://www.drugs.com/drug-class/progestins.html]
• 84. Clinical Use of Progestins and Their Mechanisms of Action [https://pmc.ncbi.nlm.nih.gov/articles/PMC8353691/]
• 85. Comparative effectiveness and safety of different progestins in ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12334503/]
• 86. a systematic review and network meta-analysis of ... [https://pubmed.ncbi.nlm.nih.gov/40392265/]
• 87. Power failure: why small sample size undermines ... [https://www.nature.com/articles/nrn3475]
• 88. Power failure: why small sample size undermines the ... [https://pubmed.ncbi.nlm.nih.gov/23571845/]
• 89. Sample size, power and effect size revisited: simplified and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7745163/]
• 90. Challenges and Possible Strategies to Address Them in ... [https://pubmed.ncbi.nlm.nih.gov/40079686/]
• 91. Overcoming statistical challenges in rare disease drug ... [https://www.rhoworld.com/overcoming-statistical-challenges-in-rare-disease-drug-development/]
• 92. Enhancing Statistical Power While Maintaining Small ... [https://peercommunityjournal.org/articles/10.24072/pcjournal.636/]
• 93. Oral Contraceptives Modulate the Relationship Between ... [https://www.frontiersin.org/journals/behavioral-neuroscience/articles/10.3389/fnbeh.2022.775796/full]
• 94. Transforming drug development with statistical ... [https://pharmaphorum.com/rd/transforming-drug-development-statistical-methodologies]
• 95. Schizophrenia and Sex Hormones: What Is the Link? - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC7373790/]
• 96. Experimental and Therapeutic Medicine [https://www.spandidos-publications.com/10.3892/etm.2020.9017]
• 97. The Menstrual Cycle Alters Resting-State Cortical Activity [https://www.frontiersin.org/journals/human-neuroscience/articles/10.3389/fnhum.2021.652789/full]
• 98. Functional brain connectivity predictors of prospective ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11160855/]
• 99. Use of functional imaging across clinical phases in CNS ... [https://www.nature.com/articles/tp201343]
• 100. Oral contraceptive pill use and menstrual cycle phase are ... [https://pubmed.ncbi.nlm.nih.gov/24365676/]
• 101. 28 days later: A prospective daily study on psychological well-being... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12017372/]
• 102. Effects of Hormonal Contraceptives on Mood: A Focus on Emotion... [https://link.springer.com/article/10.1007/s11920-019-1095-z]
• 103. Frontiers | Stress-Hormone Dynamics and Working Memory in Healthy... [https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2021.731994/full]
• 104. Effects of oral contraceptives and natural menstrual cycling on... [https://bmcwomenshealth.biomedcentral.com/articles/10.1186/s12905-018-0671-4]
• 105. Assessment of Impact of Various Contraceptive Methods on ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12563454/]
• 106. Changes in Functional Connectivity with Cognitive Behavioral ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7329578/]
• 107. The problem of medicating women like the men [https://pmc.ncbi.nlm.nih.gov/articles/PMC7032965/]
• 108. Effects of Oral Contraceptive Pills on Brain Networks [https://pmc.ncbi.nlm.nih.gov/articles/PMC12335007/]
• 109. Impact of Menstrual cycle-based Periodized training on ... - Trials [https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-024-07921-4]
• 110. Menstrual cycle rhythmicity: metabolic patterns in healthy ... [https://www.nature.com/articles/s41598-018-32647-0]
• 111. Effects of an Oral Contraceptive on Dynamic Brain States ... [https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2022.855582/full]
• 112. Mechanism-Centric Approaches for Biomarker Detection and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC8365516/]
• 113. Stability of resting state networks in the female brain during ... [https://www.sciencedirect.com/science/article/abs/pii/S0006899315005909]